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ABSTRACT 
NEW SYSTEMS FOR CATALYTIC ASYMMETRIC EpOXIDATlON 
BENJAMIN R. BUCKLEY 
This thesis describes the catalytic asymmetric epoxidation of olefins mediated by 
oxaziridinium salts. The introduction highlights some of the most successful methods 
for preparing chiral oxiranes and hints at the synthetic utility of this versatile 
molecule. 
The second chapter is dedicated to our efforts to synthesize chiral iminium salts as 
catalysts for asymmetric epoxidation. The first part of this chapter describes previous 
Page group findings and leads on to the current author's efforts in this area. Initial 
results from modified amino acids, cyclo-condensed to form dihydroisoquinolinium 
salts, showed that an aromatic unit at C4 of our catalysts was vital for asymmetric 
induction. Following this, several catalysts substituted at the 4-position of the 
aromatic functionality were tested, and found to be effective mediators for asymmetric 
epoxidation. Triphenylethylene was epoxidized with up to 7 I % ee when using oxone 
as the stochieometric oxidant. 
Modification of the "backbone" of the catalyst was also tested to see what effect 
replacing the dihydroisoquinoIinium moiety would have. Initially this was replaced by 
a biphenyl structure fused to form a seven-membered azepinium salt. These catalysts 
were found to be more reactive than their dihydroisoquinolinium counter-parts, but 
the selectivity pattern was somewhat different, with up to 63 % ee for 1-
phenyicyclohexene oxide when using oxone as the stoicheiometric oxidant. Further 
modification, incorporating a binaphthyl unit as the "backbone", resulted in up to 95 
% ee in the epoxidation of I -phenyl-3,4-dihydronaphthylene. 
Development of a new stoicheiometric oxidant, tetraphenylphosphonium mono-
peroxysulfate, which is soluble in many organic solvents, has allowed epoxidation 
reactions to be carried out at sub-zero temperatures. This has resulted in the highest 
reported ee for oxaziridinium salt mediated epoxidation (97 % ee) and the highly 
enantioselective synthesis of the anti-hypertensive agent levcromakalim. This chapter 
concludes with a few suggestions for future researchers in this area. 
The third chapter is the experimental section and is dedicated to the methods of 
synthesis and characterization of the compounds mentioned in the previous chapter. 
X-ray reports regarding the crystallographic representation of the structures presented 
in chapter two are provided in appendix A. Appendix B contains the analytical spectra 
for the determination of enantiomeric excess of the epoxides. 
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Chapter One 
Introduction 
1.0 Introduction 
1.1 Epoxides, general considerations. 
Epoxides, or oxiranes as they are otherwise known, are reactive heterocycles and are 
unlike most other cyclic ethers, which are generally used as unreactive organic 
solvents. The reason for their reactivity can be attributed to the ring strain associated 
with their structure, where the bond angles are close to 60° rather than the ca. 109° 
that is expected for tetrahedral carbon or oxygen atoms. Thus, ring opening of the 
epoxide functionality is the driving force behind many reactions. Epoxides readily 
undergo reactions in which the three membered ring is opened by nucleophiles, and 
this can take place under neutral, basic or acidic conditions, giving the corresponding 
alcohols (Scheme 1). 
Scheme 1: Ring opening of the epoxide functionality. 
This high degree of reactivity has established the epoxide moiety as an important 
molecule not only in organic synthesis but also in biological systems. Epoxides are 
found in a large variety of natural products and as key intermediates in the synthesis 
of several biologically active compounds. 
1.2 Epoxides fouud in natural products. 
A growing class of naturally occurring antitumor agents are the epothilones. 
"Epothilones have occupied centre stage on the scenes of total synthesis, chemical 
biology and medicine for the last five years, no doubt because of their intriguing mode 
of action and unusually high potency against tumour cells".' The epoxide 
functionality is very important for biological activity within these systems, and the de-
oxy derivatives were less efficient against lymphoblastic leukaemic cells than the 
1 
epoxide-containing epothilone B (Figure 1). Epothilone B was found to be more 
effective than taxol, vinbastine and etoposide, thus making epothilone B one of the 
most active anti-cancer drugs to date. Novartis have found epothilone B to be a viable 
drug candidate and it is currently in phase II clinical trials, having been successfully 
evaluated in phase I clinical trials. 1 
HO 
s 
I ~Me 
~~-- N 
o o 
Epothilone B 
Figure 1: One of the most active anti-cancer drugs to date. 
Another series of compounds with potent biological activity are the leukotrienes 
(Figure 2). Of these, Leukotriene C is the compound known as the slow reacting 
substance responsible for anaphylactic shock, the body's response to a foreign 
substance that provokes a severe allergic reaction, as in the case of asthma or insect 
stings.2 
o 
OH 
Leukotriene A 
o HO ,H 
00--"-::;4·· 
OH 
H· ..... sHO 
:~N~: ).NH2 
o OH 
Leukotriene C 
Figure 2: Two of the biologically active leukotrienes. 
Leukotriene A is the biogenetic precursor of the Leukotriene C, and the 
transformation of A to C involves addition of glutathione ( a peptide) to the oxirane. 
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The gypsy moth, Lymantria dispar, is a devastating pest of hardwood forests and fruit 
orchards because the larvae damage tr~es severely by eating their leaves. Female 
gypsy moths do not fly, so they must attract males by secretion of their volatile 
pheromones if mating is to take place. At present, sex pheromones are used as lures in 
traps that allow control of such pests. 
(+)-Disparlure 
Figure 3: The sex pheromone of the gypsy moth. 
The sex pheromone for the gypsy moth is a chiral OXlrane (Figure 3). The 
dextrorotatory compound, known as disparIure, is a potent attractant to male gypsy 
moths while the other enantiomer, the laevorotatory compound, has no activity. This 
is just one example of biological systems that recognise the members of a pair of 
enantiomers as different compounds and as a consequence, different responses are 
observed. 
The synthesis of enantiopure compounds is achieved through a number of methods: 
resolution, separation of diastereomers, chromatographic separation of enantiomers, or 
asymmetric synthesis. The latter may be achieved by chiral auxiliary methods or 
chiral reagents. More importantly, catalytic asymmetric synthesis is the most elegant 
and challenging approach. This has not gone unnoticed in the pharmaceutical and 
agrochemical industries which have invested time and money to advance technology 
in this area. 
1.3 Epoxides as versatile synthetic intermediates. 
The usefulness of epoxides as key intermediates in organic synthesis is well 
documented. There are plethoras of elegant synthesis using this moiety and some of 
these will touched upon later. Of the many synthetically useful examples chiral 
3 
epoxides have been successfully used to gIve enantiomericaIly enriched 1,2 
aminoalcohols,3 by attack of the epoxide with either ammonia or sodium azide; 1,2 
diamines,4 by ring opening with a secondary amine and subsequent aziridinium 
formation followed by attack of a primary amine; and aziridines,5 through reaction of 
the epoxide with sodium azide followed by treatment with triphenylphosphine 
(Scheme 2). 
l,2-amino aleohols 
R 
J... ..-<'C{.R' BoeN- l 'V 
H OH 
l,2-diamines 
o 1 )pyrrolidine, EtOH. reflux 0 fl --,2'-1,) !:!.M~sC~I;-,. E~!S~N,:-:--::-:-::__ ~ 
Ph . 3)MeNH2, Et3N. H20 Ph~NHMe 
Aziridination 
Scheme 2: Some useful manipulations of the epoxide functionality. 
1.4 Achiral synthesis of epoxides. 
The most widely used method for the production of epoxides is through the oxidation 
of alkenes using organic peracids and was first discovered in 1909 by Prileshaev.6 The 
oxidants required for this type of reaction are generally made from hydrogen peroxide. 
These are usually perbenzoic acid, its substituted derivatives or, mainly used in 
industry, aliphatic peracids. 
Of the percarboxylic acids, commercially available m-chloroperbenzoic acid (m-
CPBA) (1) is the most favoured and inert solvents such as dichloromethane, 
chloroform and benzene are commonly used in the reaction media (Scheme 3). 
4 
+ 01 C~CA.OH 
o 
1 
Scheme 3: Epoxidation ofalkenes mediated by m-CPBA. 
Peracid oxidation is an electrophilic process in which the driving force of the reaction 
is provided by the electron donating nature of the alkene double bond and the electron 
accepting nature of the peracid group. The transition state of this type ofreaction was 
originally believed to be planar or "butterfly"? However, recent calculations favour 
the spiro transition state (Scheme 4).8 The transfer of oxygen is concerted and hence 
the reactions are stereospecific. 
Planar 
Spiro 
R 
'=Q I;\.;.. 
0. ... ~ 
",,·A···" 
< 0 ~ A + RCOj-l 
Scheme 4: The planar and 'piro transition states in the oxygen transfer from peracids to alkenes. 
Hydrogen peroxide is important in the production of oxidizing agents but enones can 
be directly oxidized by this compound. Weitz and Scheffer described the first 
method,6 where the oxidation is performed with an alkaline source of hydrogen 
peroxide. A reversible attack by the nucleophilic hydroperoxy anion (2). in a 
conjugated enone system, followed by ring closure and hydroxide elimination from 
the intermediate enolate anion (3), affords the epoxide (Scheme 5). 
5 
2 3 
Scheme 5: Hydrogen peroxide mediated epoxidation. 
Good yields are generally observed for this type of reaction; however, it is non-
stereospecific, due to the extended life time of the intermediate enolate anion, which 
has time to rotate around the alpha and beta carbon-carbon bond. Oxides oftransition 
metals are often used as catalysts with hydrogen peroxide to afford the epoxides of 
electron poor alkenes. 
Payne has also reported that alkenes present in an alkaline solution of hydrogen 
peroxide can be epoxidized. The presence of a nitrile is required and alkenes are 
epoxidized in good to excellent yields.9,1O It is thought that the reaction proceeds 
through a peroxyimidic acid (4), which is the addition adduct resulting from 
nucleophilic attack of hydroperoxide on the nitrile carbon atom, but this intermediate 
has never been isolated (Scheme 6). In the absence of substrate, the hydroperoxyimine 
(or peroxyimidic acid) disproportionates to give the corresponding primary amide and 
molecular oxygen, and this process constitutes the Radziszewski reaction.9 In the 
presence of an olefin the reactive intermediate is intercepted, and epoxidation occurs, 
with the primary amide (hydrated nitrile), being the only side product of the reaction. 
The transition state for the oxygen transfer step presumably resembles that described 
for the epoxidation of alkenes by peracids but no definite proof exists. The reaction is 
stereospecific and therefore retention of alkene geometry is observed. 
R-C=N 
NH R~ 
O-OH 
R = Alkyl. aryl 
4 
Scheme 6: Formation ofPeroxyimidic acid, the reactive intermediate in the Payne epoxidation of 
alkenes. 
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1.5 Catalytic Asymmetric Epoxidation methods. 
Approaches to chiral epoxides from carbonyl compounds are known and these 
reactions are usually mediated by chiral sulfur ylides and good to excellent ees have 
been observed (Scheme 7).1l·12.IJ.14 However, epoxidation of alkenes remains the 
usual mode of access. 
PhCHO ArCHN2 
PlC 
- '" N 40'C Ar/"':W 'Ts 
NaH I 
1.4·dioxane I 
PTC = Phase Transfer Catalyst 
Scheme 7: The sulfur ylide approach towards enantiomerically enriched epoxides from carbonyl 
compounds. 
Non-racemic chiral peracids are also of limited value for asymmetric epoxidation. ls A 
asymmetric version of the related Payne procedure, mediated by a nitrile and 
hydrogen peroxide, has provided high ees. 16 2-CyanoheptaheJicene (5) was reported to 
epoxidise (rans-stilbene and a-methylstyrene under Payne conditions, with high 
enantiocontrol. The use of helicenes in asymmetric epoxidation, however, has not 
been elaborated, presumably due to the difficulty of synthesis of helicenes in 
enantiomerically pure form (Scheme 8).17 
p'f 
97%ee >99 % ee 
5 
Scheme 8: 2-Cyanoheptahelicene as a chrial mediator in the classical Payne epoxidation. 
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1.5.1 The Sharpless catalytic asymmetric epoxidation of allylic alcohols. 
There is a large variety of systems that have been used as mediators in asymmetric 
epoxidation. Processes catalysed by transition metal complexes have proven to be 
synthetically useful, for example the Sharpless epoxidation process developed in the 
early 1980's. Transition metal mediated epoxidation has received much attention over 
the past 20 years and in this section the major accomplishments are covered, but no 
attempt is made to describe all of the reported approaches. 
Sharpless and Katsuki first reported the highly enantioselective epoxidation of allylic 
alcohols in 1980. 18 This process was mediated by a titanium (IV) a1koxide, a chiral 
tartrate ester and tertiary-butylhydroperoxide (TB HP) as the oxidant. Generally this 
process produced 2,3-epoxyalcohols in good yield and with enantiomeric excesses of 
greater than 90 % ee. 
This process is now widely used in asymmetric synthesis and has established itself as 
one of the most important discoveries in organic chemistry in the past 25 years. This 
was acknowledged by the award to K. B. Sharpless of the Nobel Prize for chemistry in 
2001. 
The success of this method depends on the presence of the hydroxyl group of the 
allylic alcohol which coordinates to the metal and binds the molecule to the chiral 
complex (Scheme 9). The latter activates the oxidant and controls the delivery of 
oxygen to the substrate preferentially to one of the two enantiotopic faces of the 
alkene. The hydroxyl group also enhances the rate of reaction aod provides selective 
epoxidation of the allylic olefin in the presence of other types of double bonds. 
8 
HO?-R 
Allylic Alcohol 
tSuOOH 
-2 iprOH 
Scheme 9: The Sharpless epoxidation procedure. 
One of the most important features of this procedure is the ability to predict the 
absolute configuration of the epoxide produced by using a simple model (Scheme 
10).19 
(-)-tartrate 
~ 
4 A mol sieves, DCM 
t 
(+ )-tartrate 
Scheme 10: The Sharpless prediction model. 
The effectiveness of this epoxidation process is indicated by the large number of 
differently substituted allylic alcohols which can be oxidized with high 
enantioselectivity. In fact nearly all types of prochiral primary allylic alcohols are 
epoxidized with high enantiomeric excess. 
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The Sharpless epoxidation of allylic alcohols which contain asubstituent at Cl can 
also be predicted even though this is complicated by the fact that these compounds 
have an additional stereogenic centre (Scheme 11). Of the four possible 
diastereoisomers shown in Scheme, the two syn- isomers are disfavoured through 
hinderance of the approach of the tartrate by the R group, producing the 
corresponding anti-epoxides as the major products'. 
(-)-tartrate 
~ Slower Reaction 
AD? t Faster Reaction 
(+ )-tartrate 
(-)-tartrate F t R t' R02~R3 as er eac IOn ~ RI ,OH 
""AD? R2~:3 
t Slower Reaction, 0"" • I,., OH (+)-tartrate RI 
R 
Scheme 11: Prediction of en anti os electivity for substrates containing additional chiral centres. 
This method has been harnessed for kinetic resolution. 19 High yields and 
enantioselectivities have been observed, and there are many examples in the literature. 
One example is shown in Scheme 12: compound (6) contains two double bonds that 
have the potential to undergo Sharpless epoxidation; the more nucleophilic of the two 
reacts more readily. One of the two enantiomers of (6) reacts faster than the other, and 
only one epoxide is formed, giving a yield of 35 % (out of a possible 50 %) and an 
enantiomeric excess of greater than 95 % ee. The unreacted alcohol is also 
enantiomerically enriched. 
10 
'BuOOH 
6 
Scheme 12: kinetic resolution mediated by the Sharpless asymmetric epoxidation method. 
Mechanistic studies of the Sharpless epoxidation have revealed the key step in the 
reaction. In solution, titanium(IV) alkoxides undergo rapid ligand exchange with other 
aIcohols. 19,20,21 Upon reaction with the tartrate ester, the equilibrium lies on the side of 
the chelate (7) (Scheme 13). 
Ti(OR)4 + 2 tartrate Ti(tartrate)z(ORh + 2ROH 
7 
Scheme 13: Titanium(IV) alkoxides undergo rapid ligand exchange with alcohols. 
Epoxidation will only occur when the catalyst ligands (alkoxides RO-) have been 
completely replaced with tert-butyl hydroperoxide and the allylic alcohol. After 
epoxidation takes place the titanium complex releases the product and "re-loads" itself 
for the next allylic alcohol. The active species is thought to be dimeric and is shown in 
Figure 4. 22 
Figure 4: The dimeric active species believed to be involved in the asymmetric epoxidation process. 
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The Sharpless asymmetric epoxidation is limited in that the substrate must posses a 
group which can coordinate with the catalyst, a hydroxyl group and therefore the 
procedure is limited to allylic alcohols. Despite this, the catalytic procedure has 
prompted much interest from industrial companies and has been scaled up by AReo 
for the production of both enantiomers of glycidol (Scheme 14) on at least a 600 
g/mol scale?3 This process has also been operated by Upjohn to give enantiomerically 
pure (3-heptyl-oxiranyl)-methanol (Scheme IS)?] 
o 
~OH _. - =yOH -- o ~OH 
Scheme 14: AReo's scaled up synthesis of glycidol using the Sharp less asymmetric epoxidation. 
~OH __ .~OH 
Scheme 15: Upjohn's synthesis of(3-heptyl-oxiranyl)-methanol using the Sharp less method. 
The Sharpless asymmetric epoxidation has also been used to produce key 
intermediates in the syntheses of various natural and biologically active compounds. 
Percias and Riera have recently used this method to access an intermediate in 
glycosidase inhibitor synthesis (Scheme 16).24 
tsuOOH 
[ .,,0 ] ~OH ~OH L'(+)-DlPT (12 %) 
TiePrO)4 (10 %) 1 Et3N CH2C12.3 A M.S. ~NCO Et20 
60 QC 
OTBDMS 
(Go Steps ~O ~N)"O 
0 H 
96 % ee 
Scheme 16: Percias and Riera's synthesis ofa key intermediate of glycosidase inhibitors utilising the 
Sharpless asymmetric epoxidation. 
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1.5.2 Metalloporphyrins as catalysts for asymmetric epoxidation. 
The Sharpless procedure is effective for the asymmetric epoxidation of allylic 
aicohols; however, obtaining high enantioselectivities in the epoxidation of alkenes 
bearing no functionality remains a challenging problem. It is difficult to obtain high 
enantioselectivity in the asymmetric epoxidation of unfunctionalized alkenes, because 
only the steric and electronic properties of the substrate can influence the 
stereochemical course of the reaction. However, the asymmetric epoxidation of simple 
olefins is particularly important due to the large range of substrates available. 
Interest in transition metal porphyrin complexes for asymmetric epoxidation arose 
from Groves discovery that Fe(III) porphyrin complexes are models for cytochrome 
P-450 monooxygenase,zs In 1983 Groves and Meyers described the first example of 
catalytic asymmetric epoxidation of simple olefins mediated by chiral porphyrin 
complexes (Figure 5).26 Hence cytochrome P450 analogues based upon porphyrin-
transition metal complexes have been used in an attempt to mimic the biosynthetic 
pathway of epoxide formation.27 Many chiral complexes based on cyclic 
polyamines/polyimines have been synthesized,28 but enantioselectivities are low, and 
the reaction is limited in scope, styrenes usually being the best substrates.29.3o 
R*= o ~ CI~ 
51 % ee 
Figure 5: Groves chiral porphyrin giving 51 % ee for p-chlorostyrene oxide. 
Many groups have been involved in the synthesis of metalloporphyrins, and these 
systems have encompassed a wide variety of ligands and metal centres [iron(III), 
manganese(III) and ruthenium(III)]. One of the most successful systems, developed 
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by Berkessel, employs a carbonyl ruthenium (Il) metalloporphyrin and a novel D4 
symmetric ligand developed by Halterman (Figure 6);)1,)2 dihydronapthylene oxide 
was epoxidized in 77 % ee. Greater enantiomeric excesses have been achieved by 
other groups, but the metalloporphyrin catalysts used are relatively inaccessible, 30,)) 
o OJ 
77%ee 
Figure 6: Berkessel's carbonyl ruthenium (Il) metalloporphyrin. 
The usually poor yielding multi-step synthesis of these types of catalyst unfortunately 
limits this approach to chiral epoxides. However, recent development of the related 
salen systems which are easily accessed and exhibit excellent ees are an attractive 
alternative, 
1.5 J Chiral Salen Complexes for asymmetric epoxidation, 
Achiral salen complexes were first shown to catalyse the epoxidation of 
unfunctionalized alkenes by Kochi in 1986,)4,)5 In contrast to the related 
metalloporphyrins, salen complexes are not completely planar, and are able to contain 
asymmetric centres at the tetrahedral carbons atoms near the metal/reaction site. This 
is the key feature for the origin of the improved asymmetric induction observed in the 
catalytic epoxidation mediated by salen complexes.)6 
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1.5.3.1 The Jacobsen Epoxidation. 
Jacobsen has produced a variety of catalysts using Manganese(III) salen complexes of 
chiral Schiff bases; 19.23,37,38.39 these permit the epoxidation of a range of alkyl- and 
aryl- substituted oletins. The ligands are generally derived from chiral 1,2-diamines 
and substituted salicylaldehydes, Epoxidations are usually carried out with 1-10 mol 
% of the chiral manganese(III) salen complex and 1 or 2 equivalents of a 
stoicheometric oxidant. A variety of oxidizing agents have successfully been 
employed including dioxiranes,4o periodates,41 peracids,42 hydrogen peroxide,43 
Oxone,44 and molecular oxygen.45 However, the usual method employs sodium 
hypochlorite (bleach).46,47 
NaOCI A 
r('yO--( ~. 
o 
98 % ee 
NaCI F\ 
8 
Scheme 17: Jacobsen's most effective chiral sal en complex for asymmetric epoxidation. 
After the synthesis of many salen catalysts, Jacobsen discovered several factors which 
govern the level of enantioselectivity induced, and that asymmetric induction was 
highly dependent on the electronic properties of the chiralligand, 46 The bulky tertiary 
butyl and electron donating groups were therefore introduced into the catalyst· 
structure, and the catalyst (8) was produced giving excellent enantiomeric excesses 
ranging from 85 to 98 % ee for cis-disubstituted alkenes. This has proved to be 
Jacobsen's most successful catalyst to date (Scheme 17).48 
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1.5.3.2 Katsuki' s Salen Complex. 
Katsuki has also independently reported chiral manganese(III) catalysts for 
asymmetric epoxidation, and these focus on a chiral residue attached at the aromatic 
carbon ortho to the phenolic group.49 These are also good catalysts for asymmetric 
epoxidation; they differ from Jacobsen's catalysts in that the best systems contain 
axial chirality at the 5,5' postions as well as asymmetric centres (Figure 7).50 This 
axial chirality is achieved by incorporation of enantiomerically pure binapthyl groups 
in the catalyst's substructure. In comparison to the Jacobsen catalyst the Katsuki 
system exhibits similar enantioselectivities for eis-alkenes but greater 
enantioselectivities for trans-alkenes. 
CQ 
o 
96 %ee 
Figure 7: Katsuki's binapthylene based Salen complex for catalytic asymmetric epoxidation. 
A major problem associated with the salen-mediated epoxidation method is the 
scrambling of olefin geometry in the epoxides of acyclic eis-disubstituted alkenes. 
This is believed to be due to the formation of radical intermediates at the metal centre. 
Jacobsen's proposed mechanism is highlighted in Scheme 18.51 The extent of 
degradation is rather dependent on the substitution pattern of the olefin, but in general 
no loss of geometry is observed for eis-dialkyl alkene substrates, and so the 
mechanism is believed to be concerted. Conjugated eis-alkenes are thought to proceed 
stepwise through a electron transfer process, which gives rise to radicals and hence 
scrambling of the double bond geometry. Mono-epoxidation of conjugated double 
bonds, whether eis-eis, trans-trans or eis-trans related all give mixtures of geometrical 
products. A method for increasing the eis-trans ratio of epoxidation products by 
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addition of a cinchona alkaloid has been developed by Jacobsen.52 However, the 
additive only has a limited effect on some substrates. 
Ph'=lMe H T Ph-{' Me 
o 0 0'''( ~-~-~-~ 
'<1!C>--'   
rotation 
Ph 
Ho:( Me ~ 
Collapse H.. .,H 
Ph'DMe 
Collapse Ph,.. .,H H~Me 
Scheme 18: Jacobsen's proposed mechanism for salen mediated epoxidation and possible cause of 
scrambling of olefin geometry. 
Salen-Mn(III) complexes also undergo decomposition under the reaction conditions 
and cannot be recovered and re-used. 53 Many groups have directed their research to 
modifications of typical salen-Mn(III) complexes, such as polymer-supported 
systems.54 These modified catalysts have been found to separate well, but this has 
generally compromised the catalytic activity of the complex, and ees have rarely 
reached that of the original salen-Mn(III) complex. Recent independent work reported 
by Seebach55 and Zheng has shown some advances in this area.53 Zheng has shown 
that a poly-salen-Mn(III) complex (9), which can be regarded as a polymer of 
Jacobsen's original salen-Mn(III) catalyst, gives consistently high ees even after 
being recycled up to 4 times (Scheme 19). 
CQ-"" "" _9 __ • ccJ"" 0 6' 0 NaOCI 6' 0 
DCM 
Entry Cycle tIh yield (%) Ee (%) 
1 Fresh 1.5 81 96 
2 11.57795 
321.57594 
4 3 2.0 70 96 
n 5 4 2.0 63 95 
9 
Scheme 19: Zheng's polymeric salen-Mn(lII) complex. 
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Salen catalysts have also been used for kinetic resolution of racemic alkenes,56 
allenes,57 and racemic terminal epoxides.58 Asymmetric epoxidation of an alkene 
intermediate in the synthesis of leukotriene methyl ester, an important inhibitor of 
phosphodiesterases, has also been achieved using this methodology.59 
The salen mediated asymmetric epoxidation has proven to be one of the most 
successful methods for producing unfunctionalized aryl epoxides of high enantiomeric 
purity. However, loss of stereospecificity, problems with catalyst turnover, and a 
preference for eis-substituted substrates renders this approach of limited value. 
Over the past couple of decades there have been major advances in catalytic methods 
based on metal-free organic molecules. There are many advantages in using this type 
of system; for example the reactions can usually be performed under an aerobic 
atmosphere with wet solvents, and the catalysts are generally inexpensive and air-
stable.6o 
1.5.4 The Juliil epoxidation of a,~-unsaturated ketones. 
Synthetic polypeptides were found, by Juliil, to epoxidize a,~-unsaturated ketones 
with high enantioselectivity.61 The Juliil process can be easily performed at 0 QC, and 
using a triphasic system comprising of toluene, water and polyalanine in the presence 
of alkaline hydrogen peroxide, chalcone oxide was produced in 97 % ee (Scheme 20). 
The Julia process has become the method of choice for the epoxidation of trans-I ,3-
diarylenones. However, this methodology is extremely substrate-specific, and enones 
with enolisable a-protons are usually poor substrates. 
o Poly-(L)-alanine, 
H202, NaOH (aq.) 
toluene 
Scheme 20: The Julia catalytic asymmetric epoxidation of chalcone. 
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Roberts has shown that the asymmetric epoxidation of chalcone can be catalysed by 
polyamino acid derivatives under non-aqueous conditions.62 This improved reaction 
involves the use of a urea-hydrogen peroxide complex in THF, in the presence of an 
organic base (DBU) and immobilized POlY-(L)-leucine. Under these conditions, the 
reaction of chalcone derivatives and related substrates provided the corresponding 
epoxides in 70-99% yield and 83-95% ee within 30 minutes. Several substrates with 
enolisable enones have also been epoxidized successfully.63 
The asymmetric epoxidation of the chalcone type of substrate has also been 
accomplished using other types of chiral catalysts.64 Wynberg was the first to use 
chiral ammonium salts, and obtained chalcone oxide with 55% ee using alkaline 
hydrogen peroxide as the stoicheometric oxidant and a quinine-derived quaternary 
ammonium salt as the chiral phase transfer catalyst.65 More recently, Lygo re-
examined the effect of the structure of the chinchona derived ammonium salt on the 
enantioselectivity of the process (Figure 8).66 Optimization led to superior catalysts 
for the asymmetric epoxidation of 1,3-diarylenones and some substrates with aliphatic 
substituents. The enantioselectivities for the substrates tested ranged between 69 and 
89% ee. Further modification by Adam has produced ees of up to 98 %.67 
.$' 
--j H r-.( 
OH U 
Br - I .0 CF
3 Br-
.0 
Lygo Adam 
° 
"" 
~ 0> 
"" j .0 
.0 
° 
Reagents and Conditions: Lygo's PTC (10 mol%), 11 % ag. NaOCI (2 eg.), toluene, 48 h, 25 C. 
Figure 8: Lygo's and Adam's chinchona-derived quaternary ammonium salts for catalytic 
asymmetric epoxidation. 
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1.5.5 Dioxirane-based systems for asymmetric epoxidation. 
Dioxirane-based systems for asymmetric epoxidation have received much attention 
over the past decade, and they have emerged as one of the most effective methods for 
producing enantiomerically enriched oxiranes. Their reactivity stems from the ring 
strain associated with the three membered ring and the relatively weak 0-0 bond. 
They are readily attacked even by poor nucleophiles such as olefins. The general 
method to produce a dioxirane is through the use of a ketone and a stoicheometric 
oxidant (usually Oxone) in either acetonitrile or dimethoxymethane (Scheme 21). 
0'0 Rl-t 
R2 
KHSOs 
Dioxirane 
Scheme 21: Generation of dioxiranes using Oxone as stoicheometric oxidant in the epoxidation of 
alkenes. 
Initially several research groups (Curci and Marples) studied chiral ketones as 
catalysts for asymmetric epoxidation, but until recently enantioselectivities with these 
systems were only up to ca. 20 % ee (Figure 9).68.69.70 
Xro 
Curci 
Me 
Ph . lo 
Me>('" 
H 
Marples 
Figure 9: Initial chiral ketones screened by Curci and Marples for dioxirane-based asymmetric 
epoxidation. 
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1.5.5.1 Highly enantioselective systems developed by Yang. 
In 1996 Yang first reported the asymmetric epoxidation of olefins mediated by a C2 
symmetric dioxirane generated from the corresponding ketone.71 
Yield: > 90% 
ee: up to 95 % 
Oxone (10 equiv.) 
NaHC03 (3 equiv.) 
DME/aq. Na2EDTA (1.5:1) 
o ·C. 
Scheme 22: Yang's chiral ketone derived dioxirane based on BINAP. 
The chiral ketone was derived from BINAP, and exhibited enantioselectivities 
typically between 5 and 50 % ee under stoicheometric conditions, and 87 % ee in the 
epoxidation of trans-4,4'- diphenylstilbene. With modification of the original C2 
symmetric ketone and development of the reaction to run catalytically, Yang was able 
to increase the enantioselectivity of the process.n ,73 With very hindered alkenes, such 
as trans-4,4' -ditert-butylstilbene, enantioselectivities of up to 95 % ee were achieved 
(Scheme 22). 
1.5.5.2 Denmark's dioxiranes for asymmetric epoxidation. 
After establishing oxo ammonium salts (Figure 10) as useful mediators in the catalytic 
epoxidation of several alkenes,'4,75 Denmark developed two chiral systems which 
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imparted moderate enantioselectivities (Figure 10), catalyst (10), for example, 
producing l-phenyIcycIohexene oxide with 58 % ee. 
10 
Figure 10: Denmark's Oxo Ammonium Salts. 
Furthering this work, Denmark produced a range of oxo bis(ammonium) salts to 
enhance the electrophiIicity of the carbonyl carbon and it was hoped this would 
eliminate the Baeyer-VilIiger reaction. The first two attempts resulted in no formation 
of epoxide in the oxidation reaction. Oxone decomposition studies revealed that the 
catalysts were rapidly destroyed by oxone. 
It was believed that aIiphatic bis(ammonium) ketones would not suffer the oxidative 
instability displayed by the aromatic counterparts (Figure 11). Indeed ketone (11) 
when using 10 mol % epoxidized a variety of olefins in good yield, but the chiral 
variants only gave poor ees, for example, ca 10 % ee for trans-~-methylstyrene (using 
catalyst 12). 
11 
0;;OTf-
MeYMe 
o 
12 
Figure 11: Denmark's aliphatic Oxo Bis(ammonium) salts. 
Fluorine-containing ketones have proven to be one of the most successful types of 
catalyst for dioxirane-mediated epoxidation.76 Denmark has shown that good to 
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excellent enantioselectivities can be achieved with catalyst (13) for trans-olefins 
(Scheme 23). However, catalyst loadings are high (30 mol %).77 
Ph 
pI / 
Ketone 13 (30 mol %) 
Oxone (4 equiv.) 
K2COa (12 equiv.) 
MeCN/H20 (3:2) 
O·C 
Yield: 46% 13 
ee: 94 % 
Scheme 23: Denmark's most successful system containing a fluoro ketone. 
1.5.5.3 Armstrong's a-fluoroketone as a precursor in dioxirane mediated epoxidation. 
Several other attempts at producing highly enantioselective dioxirane-based catalysts 
for asymmetric epoxidation have been reported;78,79 of these Armstrong's tropinone-
derived a-fluoroketone was found to be a good mediator (Scheme 24).80 The ketone 
exhibited enantioselectivities in the range of 64-83 % ee for various substrates. 
Armstrong argued that the a-fluoro group exerts a stabilizing and directing effect by 
interacting with the olefinic proton in the substrate during the transition state of 
oxygen transfer. 
Ketone (10 mol %) 
Oxone (10 equiv.) 
NaHCOa (15 equiv.) 
• 
MeCN/aq. Na2EDTA (3:2) 
Scheme 24: Armstrong's tropinone-derived a-fluoroketone gave ees of up to 83 %. 
1.5.5.4 Shi's highly enantioselective dioxirane epoxidation mediated by a fructose-
derived dioxirane. 
A breakthrough in dioxirane-mediated epoxidation was achieved by Shi in the late 
1990's. He reported excellent ees for a wide variety of substrates using the fructose-
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derived ketone (14).81 This catalyst is easily prepared in two steps, and typical 
enantioselectivities range from 80 to 95 % ee. However, the chiral ketone decomposes 
under the reaction conditions (pH 7-8), presumably through Baeyer-Villiger oxidation, 
and initially a large excess of the mediator had to be used (3 equivalents, with respect 
to the substrate) (Scheme 25). 
o\; 
(0'l .. ,,/ 
o"~o 
-To 14 
Ketone (1 equiv.) 
Oxone (5 equiv.) 0°\; (u'l .. ,'/ 
NaHC03 (15.5 equiv.) o,,·~o 
MeCN/aq Na2·EDTA (1.5:1) J.-o 
O·C. ~ \ 
() \p() 
Yield: 39% 
ee: 95% 
Scheme 25: Shi's fructose derived ketone for asymmetric epoxidation. 
After experimentation it was found that Baeyer-Villiger oxidation could be suppressed 
and the amount of catalyst could be reduced to 20 mol % if the reaction was carried 
out between pH 10 and 11 (Scheme 26).82.83 Yields were increased (65-95 %) and the 
catalytic system resulted in slightly higher ees (91-97 % ee). The synthetic utility of 
this system has been widely explored with the successful asymmetric epoxidation of 
various hydroxyalkenes (90-94 % ee),84 enol ethers and enol esters (80-91 % ee),85 
enynes (90-97 % ee),86 vinylsilanes (84-94 % ee),87 cis-alkenes (84-97 % ee),88.89 
terminal alkenes (30-94 % ee),90 and mono-epoxidation of conjugated dienes (90-97 
% ee).91 
24 
O~ 
... ,,/ 
, OH 
Baeyer-Villiger 
Reaction a o 0" 'O-() (suppressed \ ~ --To "S03 at high pH) 
o 0-'( ~ ""Qb~ -~ o , o'lo 
--To C'S03 
Scheme 26: Shi's proposed mechanism of dioxirane mediated epoxidation, 
Shi has even expanded this work to the kinetic resolution of racemic cyclic olefins,92 
Successful resolution of cyclic olefins with the chiral centre at the aIIylic position has 
been achieved (Scheme 27). 
Ketone 14 (35 mol %) 
OTMS Oxone (2.3 equiv.) 
~Ph __ K2_C_O_3_(9_.5_e_q_UiV_') ____ _ 
U MeCN/DMM/0.05 M 
Na2B40i10H20 in 
aqueous EDTA (4 x 10-4 M) 
Solution (1 :2:2, v/v/v). 
9™S 
, Ph () + 
96%ee 
49 % cony. 
Scheme 27: Shi's Kinetic resolution of cyclic olefins. 
trans/cis 
>20:1 
Shi has also recently reported asymmetric epoxidation mediated by alkaline hydrogen 
peroxide. 93,94 High yields and ees were obtained under these reaction conditions with 
up to 95 % ee for I-phenylcyclohexene oxide using the original fructose derived 
catalyst (14). Peroxyimidic acid (15) is postulated to be the active oxidant (Scheme 
28). 
25 
CH3CN 
Scheme 28: Postulated formation ofperoxyimidic acid in the asymmetric epoxidation reaction using 
hydrogen peroxide as primary oxidant. 
In his most recent publication, highly efficient asymmetric epoxidation of a.,~­
unsaturated esters has been achieved using a modified fructose catalyst. 9S It was found 
that the original catalyst (14) was not effective toward a.,~-unsaturated esters due to 
its decomposition under the reaction conditions by Baeyer-ViIIiger oxidation. 
Replacement of the fused ketal in (14) with more electron withdrawing groups 
(acetates) produced a active and highly enantioselective catalyst (16, Scheme 29). 
Ketone 16 (20-30 mol %) 
BU4NHS04 (0.06 equiv.) 
Oxone (5 equiv.) 
NaHC03 (15.5 equiv.) 
MeCN/aq Na2(EDTA) (4 x 10-4) 
(1.5:1 ). 
o QC 
R = Ar, Aliphatic. conjugated alkynes. 
00-\ (V"{",,,/ 
ACO""~O 
OAc 
ees of upto 98 % 
Yields of upto 96 % 
16 
Scheme 29: Shi's new fructose derived catalyst for (X.p-unsaturated esters. 
The success of Shi's catalyst is believed to stem from a well ordered transition state, 
and results favour the spiro transition state (Scheme 30). The favoured transition state 
for trans or trisubstituted olefins is shown mediated by catalyst (14) and the favoured 
transition state for cis disubstituted olefins is shown, mediated by the BOC protected 
catalyst (17). 
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O~ 
~()~.",. NBOC ~, R" 
d Oo·&; 
X 17 
Favoured Major 
Scheme 30: Shi's proposed transition states for dioxirane mediated epoxidation. 
A recent application in the synthesis of (-)-glabrescol, by Corey, illustrates the scope 
of dioxirane-mediated asymmetric epoxidation (Scheme 31).96 
HO 
Oxone 
MeCN/OMM/H20 DgC 
1.5 h 
OH 
OH 
66 % yield 
Scheme 31: Corey's Synthesis of(-)-glabrescol using Shi's fructose derived ketone. 
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1.5.6 Oxaziridines. 
Oxaziridines, the nitrogen analogues of dioxiranes, also act as oxygen transfer agents. 
Major accomplishments in this area have been pioneered by Davis. It was shown that 
oxaziridines can epoxidize simple alkenes, but the reaction is significantly slower (3-
12 hours at 60°C) than for dioxiranes. 97 Oxaziridines are generally accessed by 
oxidation of the corresponding imines, which are produced upon oxygen transfer to 
substrates.98•99 This is a stoicheometric method, and at present no catalytic procedure 
for the epoxidation reaction mediated by oxaziridines has been described. However, 
this method appears attractive for sensitive substrates because epoxidations can take 
place under neutral conditions with no additional reagents. The oxygen transfer occurs 
with retention of configuration of the original olefin geometry and is therefore 
believed to be a concerted process. 
Davis has described many examples of asymmetric epoxidation mediated by 
oxaziridines. The first chiral oxaziridine reported was derived from bromocamphor, 
but the observed enantioselectivities were low, the best being 40 % ee for 1-
phenylcyc10hexene oxide (Scheme 32).100 
Oxaziridine (100 mol %) 
Chloroform 
60 QC 
4h 
ee: 40% 17 
Scheme 32: Davis's first chiral oxaziridine for asymmetric epoxidation. 
Increased enantioselectivities were observed when oxaziridine (18) was employed, 
and ees of greater than 90 % for trans-a-methylstilbene oxide were observed. 
However, reaction times were extremely long (2 weeks at 60°C) (Scheme 33).101 
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Oxaziridine (100 mol %) 
Chloroform 
60 QC 
2 weeks 
ee:>90% 18 
Scheme 33: Davis's highly enantioselective oxaziridine for asymmetric epoxidation. 
A large proportion of Davis's work has been involved in the elucidation of the 
transition state employed in the transfer of the oxygen from the oxaziridine to the 
olefin substrate. Davis favoured the planar transition state and was at the time 
supported by theoretical calculations; however, more recent calculations favour the 
spiro transition state.8 Davis has also described the asymmetric oxidation of enolate 
anions by chiral oxaziridines, which led to a-hydroxyketones with enantioselectivities 
of up to 95 % ee. 102,103 Silyl enol ethers have also been reported to give epoxides when 
treated with oxaziridines, but the instability of these compounds is too great to allow 
isolation,104,105,106 To date, only Davis has reported successful isolation of a-silyloxy 
epoxides. 107 
Davis has also successfully transferred the oxygen moiety from oxaziridines to 
sulfides 108 to form chiral sulfoxides, with ees of up to 78 %. 109 This procedure has 
been successfully modified into a catalytic system by Page and Bethell,1I0,1I1 The 
most successful system is derived from a camphor sulfonyl imine (19), giving 
enantiomerically enriched sui fides with ees of greater than 98 % (Scheme 34),111 
More recently, 3-substituted-1 ,2-benzisothiazole-I, I-dioxides have been 
employed. I 12,1 13 
DBU, CH2CI2, H20 2 
, 
Yield: 100% 19 
ee: > 98 % 
Scheme 34: Page and BetheU's sulfonyl imine (19) giving ees of up to 98 %. 
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1.5.7 Oxaziridinium/iminium salt systems for asymmetric epoxidation. 
Oxaziridinium salts are the quarternized analogues of oxaziridines, and as a result of 
being more electrophilic, transfer oxygen efficiently to nucleophilic substrates. 
1.5.7.1 Initial studies, by Lusinchi. 
The first oxaziridinium salt, described by Lusinchi in 1976,114.115,116 was based on a 
steroidal pyrrolinic skeleton. Through peracid oxidation of the steroidal imine and 
quaternization using methylfluorosulfonate it was shown that an oxaziridinium species 
can be formed (Scheme 35). This new species was rather unstable, and upon 
decomposition reverted to an iminium salt, which could be directly prepared from the 
imine. However, it was not until some eleven years later that the potential of this type 
of system to transfer oxygen was realised. 1 17,118 
FSO"3 \;/-
ROOH j I Decamp. 
FS03Me 
Scheme 35; The first example of an oxaziridinium salt developed by Lusinchi. 
Using an oxaziridinium salt derived from dihydroisoquinoline, Lusinchi was able to 
transfer the oxygen to several simple alkenes in good yield (Scheme 36),118,119 
Following this work, the first enantiomerically pure oxaziridinium salt was 
prepared, 120 Quaternization of a chiral oxaziridine, derived from (lS,2R)-(+)-
norephidrine, produced the oxaziridinium salt (20) (Scheme 37). 
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Scheme 36: Oxygen transfer to alkenes mediated by a oxaziridinium salt derived from 
tetrahydroisoquinoline. 
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Scheme 37: The first enantiomerically pure oxaziridinium salt derived from (\ S,2R)-(+)-
norephidrine. 
This oxaziridinium salt was also able to transfer oxygen to olefins, and induced 
moderate enantiocontrol, epoxidizing trans-stilbene with 33% ee. With the side 
product of the reaction being an iminium salt, there was potential to develop this 
chemistry catalytically, If this iminium salt could be re-oxidized to the oxaziridinium 
in situ, catalytic transfer of oxygen to alkenes could be achieved (Scheme 38). 
Lusinchi was able to develop this catalytic system using Oxone, similar to that 
developed for dioxiranes; however, less pH control is required as there is no 
competitive Baeyer-Villiger oxidation, The enantiomerically pure iminium salt (21) is 
thus able to epoxidize trans-stilbene catalytically (20 mol %) with the same degree of 
selectivity as the stoicheiometric oxaziridinium salt (33 % ee). Lusinchi has also 
shown that oxaziridinium salts are capable of transferring oxygen to other 
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nucleophilic substrates such as sulfides to form sulfoxides, 12l amines to form nitrones, 
and imines to form oxaziridines.122 
~h 
R1*R3 cQMe I X-
"" NL R2 R4 I 
0 
[OJ 
o Ph pr 
33%ee 
~h R1 R3 
roMe ?=< "" I "N~ X- R2 R4 
Scheme 38: Catalytic cycle for epoxidations mediated by oxaziridinium salts. 
Lusinchi's group has reported the only X-ray determination of an oxaziridinium 
salt. 120,123 Its geometry is similar to that of the parent oxaziridine, and the N-O bond 
length of 1.468 A in the oxaziridinium salt is shortened compared with the mean bond 
length of 1.508 A observed for oxaziridines. It is also interesting to note that the 
oxaziridine ring is perpendicular to the isoquinoline ring (Figure 12). 
20 22 
Figure 12: X-ray crystal structures ofoxaziridinium species 21 and oxaziridine 22. 
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1.5.7.2 Aggarwal and Wang's binapthylene based iminium salt. 
Since Lusinchi's early work, several groups have identified an interest in 
oxaziridinium/iminium salt chemistry. Aggarwal and Wang produced a cyclic 
binaphthalene-derived iminium salt, which was shown to be effective in the 
epoxidation of l-phenylcyclohexene giving 71 % ee. 124 However, this catalyst 
appeared somewhat substrate dependent, the best ee for other olefins tested being only 
45 % (Figure 13). 
71%ee 
A -Ph p'f~-r;e 
45%ee 
Figure 13: Aggarwal's Binapthylene based iminium salt catalyst. 
1.5.7.2 Armstrong's acyclic iminium salts. 
Armstrong has shown that even acyclic iminium salts can mediate epoxidation by 
Oxone/25 however, enantiomeric excesses are low. 126 By condensing N-
trimethylsilylpyrrolidine (23) with a range of of aromatic aldehydes in the presence of 
trimethylsilyltriflate, Armstrong was able to produce a range of substituted exocyclic 
iminium salts (Scheme 39). 
Q 
I 
SiMe3 
23 
+ TMSOTf 
Scheme 39: Armstrong's synthesis of exocyclic iminium salts. 
33 
It was found that only those compounds with electron withdrawing groups present on 
the aromatic ring were active mediators. Catalytic reactions were carried out with the 
ortho-Cl (24) derivative, giving good conversion to epoxide (Scheme 40). 
Iminium salt 24 
(5-100 mol %) 
Oxone (2 equiv) 
Na2COa (4 equiv) 
MeCN/H20 (24:1) 
o Ph 
P~ 
Upto 100 % cony. 
o TFO 
N+ 
H~CI 
V 
24 
Scheme 40: Epoxidation of trans-stilbene with Armstrong's catalyst (24). 
Despite many attempts at producing chiral variants of this catalyst system, Armstrong 
was unable to gain significant ees, catalyst (25) giving only 22 % ee for 1-
phenylcyclohexene (Figure 14). 
22%ee 
25 
Figure 14: Armstrong's most successful chiral iminium salt catalyst. 
1.5.7.3 Komatsu and Wong's exocyclic iminium salts. 
Recently, two other groups have shown that exocycIic iminium salts can be useful 
mediators in asymmetric epoxidation. Komatsu has developed a system based on 
ketiminium saIts,127 through the condensation of aliphatic cyclic amines and ketones. 
A chiral variant was also produced, derived from prolinol and cycIohexanone, which 
gave 70 % yield and 39 % ee for cinnamyl alcohol (Scheme 41). 
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P~OH 
Iminium Salt (10 mol %) 
Oxone (1 equiv) 
NaHC03 (4 equiv) 
70 % yield 
39%ee 
Scheme 41: Komatsu's ketiminium salt mediated epoxidation. 
Moderate ees have been achieved by Yang using another exocyclic iminiurn salt 
system. 128 However, these salts are not isolated and are generated in situ, thus 
obviating the difficulties inherent in the preparation and isolation of unstable iminium 
salts. 
KHSOs 
pPh 
Ph 
65%ee 
Scheme 42: Wong's in situ based iminium salt epoxidation system. 
A major drawback to this type of system is the catalyst loadings; for an efficient rate 
of reaction up to 50 mol % of iminium salt is generally required. Nevertheless, ees of 
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up to 65 % have been achieved. A range of amines and aldehydes were screened, and 
a novel proline based amine and a branched hexanal were found to be the best 
precursors (Scheme 42). 
1.5.7.4 Armstrong's intramolecular epoxidation. 
Armstrong has also published an in situ epoxidation, mediated by an intramolecular 
oxaziridinium salt, which gave good regio selectivity (Scheme 43).129 
i, ii, iii, iv 
o 
H H 
I 
Reagents and Conditions: i: BnNH" 4A mol. sieves, DCM; ii: Oxone, NaHCO" MeCN/H,O; iii: 
MeOTf, DCM; iv: NaHCO, (aq.). 
Scheme 43: Armstrong's intramolecular epoxidation. 
With modification of this procedure, using an oxaziridine, Armstrong was able to 
demonstrate the synthetic utility of this method by introducing a chiral amine to afford 
enantiomerically enriched products, and greater than 98 % ee was obtained for (26), 
which is a terminal epoxide (Scheme 44).\30 However, a loss of selectivity was 
observed when chain lengths between the aldehyde and alkene exceeded 3 atoms. 
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1) MeOn, 
2,6-di-tert-butylpyridine, 
DCM,O·C. 
2) Aq, NaHC03 
ee: >98 % 
yield: 55 % 
Scheme 44: Arrnstrong's chiral version of the intramolecular epoxidation reaction. 
1.5.7.5 Bohe's improved achiral catalyst. 
More recently Bohe, a former co-worker with Lusinchi, has reported an improved 
achiral catalyst which prevents some common side reactions observed in iminium salt-
mediated epoxidation. 131 Two factors are known to reduce the catalytic efficiency of 
the epoxidation process; hydrolysis of the iminium salt directly by the reaction 
medium generally only affects the acyclic systems. However, loss of active oxygen 
from the intermediate oxaziridinium species, through a reaction which does not 
regenerate the iminium can occur to all systems containing protons et to the nitrogen 
atom. This is an irreversible base-catalysed isomerization (Scheme 45). 
CQH 1.0 N~ 0) 
Scheme 45: Boh"'s proposed irreversible base-catalysed isomerization. 
A dramatic increase in catalyst efficiency is observed when the 3,3-disubstituted-
dihydroisoquinolinium salt (27) is used in place of catalyst (28), thus eliminating the 
base catalysed isomerization (Scheme 46). 
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f 
CQ~Jpr o PH 
Ph CCk Pt! / 
28 
16 h, 83 % Yield. 
7 h, 83 % Yield. 
Scheme 46: Bohe's improved achiral catalyst for catalytic epoxidation. 
1.6 Conclusions. 
A wide variety of methods for producing enantiomerically enriched epoxides has been 
presented in this chapter and these can be roughly split into two categories: transition 
metal catalysts and organo-catalysts. Many of these systems are able to produce 
oxiranes with high enantioselectivities, but one problem still remains: the formation of 
a general catalyst that works at low catalyst loadings, produces excellent 
enantoselectivities and yields has yet to be invented. One exception to this may be the 
fructose-derived dioxirane catalysts developed by Shi, although high catalyst loadings 
are still employed (i.e. the catalyst quickly decomposes) and ees for terminal epoxides 
are still only moderate to good (ca 80 % ee). 
Of the areas covered in this short review, epoxidation mediated by iminium salts or 
their oxaziridinium counter-parts has emerged as one of the most attractive. However, 
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the current major drawback in this area is the low to moderate enatioselectivites 
observed. 
The discussion which follows describes the efforts of the present author toward the 
goal of low catalyst loading and high enantiose1ectivity, demonstrating new catalytic 
systems for asymmetric epoxidation. 
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Chapter Two 
Results and Discussion 
2.0 Results and Discussion 
2.1 Previous Page group findings. 
In the search for a new and highly enantioselective system for iminium salt mediated 
catalytic asymmetric epoxidation, several parameters and catalyst substructures were 
examined. The method of oxidation, using axone, was established after some 
experimentation and a possible catalytic cycle for an oxaziridinium ion as the 
oxidative intermediate is depicted in Scheme 1.1,2.3 The first stage is the formation of 
an initial adduct (1), uncharged at nitrogen, formed by (probably reversible) 
nucleophilic attack of the oxidant on the iminium salt. This is followed by irreversible 
expUlsion of sui fate to give the oxaziridinium ion, which is believed to be the rate-
determining step under the reaction conditions. Oxygen may then be transferred to a 
substrate in a subsequent step, the rate of which would not be expected to have any 
great solvent dependence. An interesting but complicating feature of these processes 
is that it is not one but two diastereoisomeric oxaziridinium salts which may be 
formed, by attack of oxidant at the si or re face of the iminium species. Each may 
deliver the oxygen atom to either of the prochiral faces of the alkene substrate with a 
different degree of enantiocontrol, and they may be in competition for the alkene 
substrate. 
KHS05 
1 
Scheme 1: Catalytic cycle for the oxaziridinium ion as an oxidative intermediate in the epoxidation 
reaction. 
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2.1.1 Catalyst Structure 
An ideal method for testing a wide variety of substructures was developed through the 
condensation of enantiomerically pure chiral primary amines with 2-(2-
bromoethyl)benzaldehyde (2) as shown in Scli.eme 2. 
co 
3 
~'R.~·~ __ ii_i __ _ ~Br ~o 
2 
Reagents and conditions: i: Br" CCI" I h; ii: HBr (cone), d, 10 min; iii: a) R*NH" EtOH, 0 'C-r.t., 12 
h, b) NaBPh" MeCN, 5 min. 
Scheme 2: The 2-(2-bromoethyl)benzaldehyde method for fonming dihydroisoquinolinium salts. 
The iminium salts prepared by this method have the advantage that they are extremely 
easy to prepare on any scale and that the structural variation available is large, because 
the chriality is resident in the amine component. Treatment of isochroman (3) with 
bromine in carbon tetrachloride under reflux for 1 hour followed by exposure to 
concentrated hydrobromic acid provides 2-(2-bromoethyl)benzaldehyde (2) in 65 % 
yield.4 Primary amines condense smoothly with this material to furnish the 
corresponding dihydroisoquinolinium bromides. These organic salts are generally oils, 
and the inherent difficulties in purification by conventional methods, necessitated a 
change in counterion. Addition of sodium tetraphenylborate, at the end of the reaction, 
in the minimum amount of acetonitrile induces rapid formation of the corresponding 
tetraphenylborate salts as crystalline solids. Overall yields of catalyst are generally 
between 30 and 80 %, limited in part as a consequence of a side reaction, elimination 
of hydrogen bromide from the bromoethyl moiety of the precursor. No 
chromatography is necessary at any point in this sequence. 
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Figure 1: Initial primary amines condensed with 2-(2-bromoethyl)benzaldehyde (2) to form iminium 
salts. 
Very hindered amines give inferior yields of iminium salt, typically 25-30 %, 
presumably due to an increased tendency to act as bases rather than nucleophiles, as 
evidenced by the increased levels of 2-vinylbenzaldehyde and derived imine. 
A range of structurally different chiral primary amines was converted to their 
corresponding iminium tetraphenylborate salts (Figure 1) and tested in the asymmetric 
epoxidation of the standard test substrate I-phenylcyclohexene, using oxone (4 
equivalents) as the stoicheiometric oxidant, sodium carbonate (8 equivalents) as base, 
in acetonitrile/water (2: I) at 0 °C (Table I). 
With the first two entries in Table I, using the structurally simplest amines, no 
asymmetric induction was observed, and it became clear that a conformationally more 
defined and rigid system was required to impart reasonable enantioselectivities. Both 
the camphor and menthyl based systems gave low ees, although these are two of the 
more common systems upon which chiral auxiliaries have been based. The fenchyl 
derivative is the most selective under these reaction conditions. However, the N-
(isopinylcampheyl) dihydroisoquinolinium salt, which is considerably less sterically 
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hindered than the fenchyl, is almost as selective, giving a better yield and increased 
rate of reaction. 
Table 1: Epoxidation of I-phenylcyclohexene with dihydroisoquinolinium tetraphenylborate salts 
derived from chiral primary amines.a 
Entry Amine Catalyst load Yield ee Configuration 
Precursor (mol %) (%) (%) 
I 4 5.0 54 0 -
2 5 5.0 70 0 -
3 6 1.0 39 25 (-)-(1 S,2S) 
4 7 0.5 63 19 (+)-(IR,2R) 
5 8 0.5 68 27 (+)-(lR,2R) 
6 9 0.5 66 12 (-)-(lS,2S) 
7 10 0.5 45 32 (+)-(IR,2R) 
8 11 0.5 60 18 (+)-(IR,2R) 
9 12 0.5 58 8 (+ )-(lR,2R) 
10 13 0.5 47 14 (-)-(lS,2S) 
aConditions: 4 equiv. Oxone; 8 equiv. Na,CO,; 0 'C; H,O/MeCN 1 :2; reactIOns monitored by TLC. 
2.1.2 The Reaction Parameters. 
Having found a catalyst which exhibited a good reaction profile in terms of ees and 
rates, an examination of some of the reaction parameters was carried out in order to 
optimize the reaction conditions with respect to the enantioselectivity of the oxygen 
transfer process. The N-(isopinylcampheyl) dihydroisoquinolinium salt (14) was 
chosen as the model catalyst for optimization studies. 
14 
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2.1.2.1 Effect of counter-ion. 
In addition to the original tetraphenylborate, the corresponding tetrafluoroborate, 
hexaflurophosphate, perchlorate and periodate salts were prepared. All of these were 
tested in the asymmetric catalytic epoxidation of l-phenylcyc1ohexene. A catalyst 
loading of 5 mol % was used in a I: 1 water-acetonitrile solvent in the presence of two 
equivalents of Oxone and four equivalents of sodium carbonate at 0 QC. The 
enantioselectivities obtained exhibited an interesting trend. The periodate salt gave a 
similar ee (35 %) to that of the tetraphenylborate species (40 % ee), while the 
fluoride-containing counterions afforded lower ees (28 %). The perchlorate salt 
furnished inferior enantioselectivities (20 % ee). All of the salts however invariably 
produced the same major enantiomer of the epoxide product (R, R), and all of the 
reactions were complete in a similar time scale (ca. 45 minutes). 
2.1.2.2 Effect of the solvent system. 
The standard conditions employed within the Page group describe the solvent system 
. as a 1: 1 mixture of acetonitrile and water, using two equivalents of Oxone and four 
equivalents of sodium carbonate at 0 QC. An increase in water to acetonitrile ratio is 
accompanied by an increase in the reaction rate. For example, the yield of 1-
phenylcyc10hexene oxide after 1 hour using catalyst (14) was 30 % at 0 QC when a I: 1 
ratio of the two solvents was used, but the yield was essentially quantitative using a 
2: 1 (water/acetonitrile) ratio. Reducing the amount of Oxone and base by a factor of 2 
(i.e. using one equivalent of Oxone and two equivalents of sodium carbonate), 
resulted in incomplete conversion after one hour in the improved (2: 1) solvent system. 
It was found that higher catalyst loadings accelerate the rate of reaction to an extent 
that outweighs the effect of water content. 
An investigation into the co-solvent employed was also carried out. The solvents were 
selected so that they differed significantly in dielectric constant (E, indicated by the 
values in brackets); dichloromethane (8.9), trifluroethanol (26.7), acetonitrile (37.5), 
water (78.4) and formamide (Ill). The epoxidation of l-phenylcyc1ohexene with 
catalyst (14) was tested using these co-solvents with water in a 1:1 ratio. Epoxidation 
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did not occur in dichloromethane; this is perhaps due to the poor miscibility of the two 
solvents, thus limiting the availability of the inorganic oxidant in the organic phase. 
No reaction was also observed in formamide. This could be due to the iminium 
species being too well stabilised/solvated and the possibility of an irreversible attack 
by the formamide cannot be dismissed. However, in trifluroethanol the reaction had a 
similar profile to that in acetonitrile; both reactions were complete in 30 minutes, but 
the ee was somewhat lower (26 % ee in trifluroethanol and 40 % ee in acetonitrile). 
2.1.2.3 Effect of temperature. 
This parameter is severely limited by the stability and solubility of Oxone. When the 
reaction was carried out at -10 °C it was sluggish because the solubility of the 
inorganic oxidant and base in water was dramatically reduced. When an increased 
volume of water was employed, (3: I ratio with acetonitrile), oxidation of 1-
phenylcyclohexene mediated by catalyst (14) (5 mol %) resulted, within 45 minutes, 
in complete consumption of the starting material, and afforded the corresponding 
epoxide in slightly improved yield. The enantioselectivity was slightly reduced (35 %) 
from that of the reaction carried out at 0 °C (40 %). 
When the oxidation was carried out at ambient temperature, negligible conversion to 
epoxide was observed; this is believed to be due to the instability of oxone at this 
temperature.5 
2.1.2.4 Effect of catalyst loading. 
This was expected to have a large effect on the enantioselectivity of the process; 
However, the effect was negligible; decreased loadings resulted in longer reaction 
times, but the enantioselectivity of the system remained fairly consistent, reaching a 
maximum at 2 mol % (Figure 2). Enantioselectivities below this loading decreased 
from 33 % ee at 2 mol % loading, to 18 % ee at 0.3 mol % catalyst loading. 
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Figure 2: Graph of catalyst loading study 
2.1.3 Initial Findings 
After this early work in setting up the optimum reaction conditions, a further, more 
detailed, study of catalyst structure was instigated. A range of dihydroisoquinolinium 
salts containing alcohol, ether and acetal functionalities was tested for possible 
catalysts.6 
2.1.3.1 Alcohol containing iminium salts. 
It was hoped that this series of catalysts might offer increased ees due to the ability of 
hydroxyl functionality, to direct the approach of the impending alkene towards the site 
of epoxidation. However, epoxidation reactions using this type of functionality 
resulted in a sluggish reactivity and Iow enantioselectivity. This inhibited reactivity is 
thought to stem from the existence of an equilibrium between the ring open iminium 
salt (active) and the ring closed oxazolidine (inactive) forms of the catalysts under the 
slightly alkaline reaction conditions (Scheme 3). In fact it is known that 
dihydroisoquinolinium salts can undergo base-induced ring closure to form the 
corresponding oxazolidines with high diastereoselectivity and yields.7 
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Base 
Scheme 3: Base induced ring closure of hydroxy dihydroisoquinolinium salts to oxazolidines. 
2.1.3.2 Catalysts from aminoether precursors. 
Several amino ether-based dihydroisoquinolinium salts were produced, and they 
proved to be much more active than the related derivatives of the parent amino 
alcohols, but again poor enantioselectivity was observed in the epoxidation of 1-
phenylcyclohexene (Figure 3). This suggested that the size of the ether substituent in 
such catalysts is not particularly important for asymmetric induction during oxygen 
transfer to the alkene. 
Figure 3: Some of the amino ether based catalysts tested in the epoxidation of I-phenylcyclohexene. 
2.1.3.3 A catalyst from an aminoacetal precursor. 
(IS,2S)-5-Amino-2,2-dimethyl-4-phenyl-l ,3-dioxane (15) reacted smoothly with 2-(2-
bromoethyl)benzaldehyde (2) under the usual conditions to furnish the corresponding 
dihydroisoquinolinium tetraphenylborate salt in greater than 75 % yield (16)(Scheme 
4). 
15 
~Br 
~O EtOH 
• 
16 
Scheme 4: The amino acetal catalyst derived from (IS.2S)-5-amino-2,2-dimethyl-4-phenyl-I.3-
dioxane. 
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This iminium salt was tested in the catalytic asymmetric epoxidation of several 
alkenes at 0 cC, and a comparison of the results with those obtained using catalyst (14) 
is presented in Table 2. These results indicated that catalyst (16) in general induces 
much higher enantioselectivity in asymmetric epoxidation than others that were 
screened, providing in some cases dramatic improvements in ee over catalyst (14). 
A feature of catalyst (16) is the syn relationship between the nitrogen heterocycle and 
the phenyl group. This implies that either the phenyl or the dihydroisoquinolinium 
group must be axial if the dioxane retains a chair conformation, as in (23) or (24) 
(Scheme 5). 
23 24 
Scheme 5: For a chair conformation one of the substituents must be axial. 
Table 2: Catalytic asymmetric epoxidation using catalysts (14) and (16)." 
Catalyst 14 16 
Epoxide Yield ee Config. Yield ee Config. 
(%) (%) (%) (%) 
Me,><1 68 8 (+)-(R) 64 20 (+)-(R) 
Ph 
Ph-1- 72 15 (+)-(1R,2R) 52 52 (-)-(IS,28) Ph 
Me 
Ph-1- 43 5 (+)-(S) 54 59 (+)-(S) Ph 
Ph 
6 Ph 68 40 (+)-(1R,2R) 55 41 (-)-(1 S, 28) 
COl Ih 34 3 (+)-(1 S, 2R) 52 17 (+)-(1 S, 2R) 
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22 c8 73 20 (-)-(IS,2R) 64 49 (-)-(IS,2R) I"" h 
a Conditions: Oxone (2 equiv), sodium carbonate (4 equiv), water/acetonitrile (1:1),0 ·C, 5 mol % 
catalyst 
Despite the similar size of the two substituents, IH NMR spectroscopy suggests the 
presence of only one conformer at ambient temperature; first, all the proton signals are 
sharp and the coupling constants corresponding to each of the protons of the 1,3-
dioxane ring are consistent with a chair conformation, in accord with previous reports 
of substituted 2,2-dimethyl-I,3-dioxane rings. 8 Secondly, in the I3C NMR spectrum, 
the geminal methyl groups appear at 17.98 and 28.68 ppm (axial and equatorial 
respectively); this is also consistent with a chair conformation.9 Conformer (24) would 
be expected to be the thermodynamically favored one as a result of reduced 1,3-
diaxial interactions. 
It is tempting to propose a stabilizing interaction between the electron cloud 
associated with the oxygen atom lone pairs and the electron-depleted carbon atom of 
the iminium unit, as shown in (24). One could envisage a bonding interaction between 
the p orbital on the carbon atom of the iminium unit and the in-phase combination of 
the axial lone pair Sp3 orbitals on the two oxygen atoms. 
C47 
Figure 4: X-ray crystal structure of catalyst (16), 
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This suggestion is supported by single-crystal X-ray analysis (Figure 4). It is 
interesting that the X-ray analysis does not indicate a twist-boat conformation. The 
relative success of the dioxane-derived catalyst may stem partly from the high 
conformational rigidity, perhaps a result of the stereoelectronic effects discussed 
above. The strong preference of similar systems, such as those shown in Figure 5, to 
exist in such a conformation has been documented both experimentally and 
theoretically by Wilson. 1O 
Figure 5: Wilson's work describing conformationally stabilizing electrostatic interactions. 
In conformer (24), the phenyl substituent may hinder the attack of the oxidant at that 
side of the iminium bond, rendering the opposite side more accessible. This 
arrangement is thus likely to produce a preponderance of one of the two possible 
diastereoisomeric oxaziridinium intermediates (Scheme 6), and enantiocontrol would 
then result solely from the process of oxygen transfer to the substrate. 
c9 [0] c9 e N+ +N·,O +N~ Obo (%0 O£co ~ ay ~ ay ~ ay 
Major Minor 
Scheme 6: The two possible diastereoisomers produed in oxaziridinium formation. 
This high conformational rigidity is absent from the dihydroisoquinolinium salt (14) 
derived from (-)-isopinocamphenylamine (Figure 6). Consequently, in that case, 
rotation around the bond between the nitrogen atom and the chiral unit may result in 
both diastereotopic faces of the iminium moiety becoming susceptible to attack by the 
oxidant, and the two diastereoisomeric oxaziridinium salts so formed may be very 
different in their potential for asymmetric induction in the epoxidation process. 
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Figure 6: X-ray crystal structure of catalyst (14). 
Two transition states have been proposed for the epoxidation of alkenes by dioxiranes 
and oxaziridines, the spiro and the planar (Figure 7). In the spiro transition state the 
alkene approaches the oxaziridinium moiety in such a way that the axis of the carbon-
carbon double bond is perpendicular to the carbon-nitrogen bond axis. In the planar 
transition state, the two components approach one another in such a way that these 
axes are parallel to one another, and they and the oxygen atom are in the same plane. 
Planar 
"""/ 
', .... ~ 
., 
,Q, + 
... j-N. \\1 \', 
Spiro 
Figure 7: Geometrical approaches between the substrate and the reactive intermediate. 
The spiro transition state is now generally accepted as the mechanism in operation 
during both dioxirane and oxaziridine mediated epoxidation, This work is also 
supported by theoretical and computational studies. I I 
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2.2 New Catalysts Based on Dihydroisoquinolinium Salts. 
2.2.1 Iminium salts derived from amino acids. 
The previous work, in section 2.1, concerning asymmetric epoxidation with iminium 
salt derived catalysts, pointed to a system containing a 1,3-dioxane unit (16), as this 
particular catalyst when tested gave the best results, i.e. when compared to the other 
systems tested, generally the enantiomeric excesses were higher. These results led to 
the idea that by altering the nature of the substituents located around the 1,3-dioxane 
unit of this catalyst we might be able to increase its effectiveness as a reagent for 
asymmetric epoxidation and investigate the properties which enable a high generality 
for differing substrates. 
The first catalyst synthesized (25), bearing a methyl group at C4, was derived from N-
Cbz protected (L)-threonine (26) in four synthetic steps. It was thought that this 
catalyst may help in elucidating the effect of large substituents at C4 of the 1,3-
dioxane ring. Formation of the mixed anhydride (27), from (26) and subsequent 
reduction in situ, afforded the desired N-Cbz protected diol (28) in 70 % yield 
(Scheme 7). 
~H-Z [NHZ 1 ~H-Z 
"""NOH """NOyO/BU ii """~ 
OH 
° OH ° ° 
OH OH 
26 27 28 
Reagents and Conditions: i: NMM, iBu-O-CO-Cl, DME, -IS·C, I min; ii: NaBH4, H20, -IS·C, I min, 
70%. 
Scheme 7: Fonnation of28 from N-CBZ protected (L)-threonine 26. 
Cyclization of (28) with 2,2-dimethoxypropane, acetone and p-toluenesulfonic acid 
produced the acetonide (29) in good yield (85 %), and subsequent removal of the N-
Cbz group, with Pd/C under H2 , afforded the primary amine required for 
cyclocondensation with the catalyst precursor 2-(2-bromoethyl)benzaldehyde (2) 
(Scheme 8), which gave the iminium salt (25) in 66 % yield. 
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~H-Z ~H-Z ~H2 
__ -S;h4) > 
"'("I """("1 ii """("1 ><:j""tl ~ /; '" iii OH OH 
°XO °XO 
28 29 30 2S 
Reagents and Conditions: i: 2,2-DMP, acetone, p-TsOH, r.t., 8 h, 85 %; ii: Pd/C, H2, ethanol, r.t., 8 h, 
90 %; iii: 2, NaBPh" ethanol, r.t., 24 h, 66 %. 
Scheme 8: Formation of catalyst 25 amino diol28. 
This was a quick and convenient method for producing this type of catalyst and in 
theory large quantities of catalyst could be easily accessed. However this method does 
not allow for large catalyst diversity. 
We envisaged that a range of primary amines could be produced from intermediate 
(31), Garner's aldehyde,12 through a previously reported Grignard addition,13 and 
subsequent manipulations would then in theory allow significant catalyst diversity 
(Scheme 9). 
ii 
Reagents and Conditions: i: RMgX, ii: Steps. 
Scheme 9: Grignard addition to Gamer's aldehyde (31) as a possible route towards C4 substituted 5-
amino-l,3-dioxanes. 
Since Garner's first reported synthesis of aldehyde (31),12 there has been considerable 
. interest in this synthetic unit and improved syntheses have been reported. 14 Of these, 
Taylor's synthetic strategy appears the most attractive,15 producing the aldehyde in 88 
% overall yield from (D)-serine in four steps. This method also avoids several 
problematic and hazardous steps present in the other methods of synthesis, such as 
DIBAL-H reduction (inconsistent yields),16 Swern oxidation,16 and the use of 
diazomethane and iodomethane. 12 
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Garner's aldehyde was therefore synthesized using Taylor's method with comparable 
yields. BOC-(L)-serine (32) was produced quantitatively, from (L)-serine (33), using 
Boc anhydride and an aqueous solution of sodium hydroxide / I A-dioxane at 0 °C 
over 48 h. Formation of the Weinreb amide (34) was also high yielding; using N-(3-
dimethylaminopropyl)-N'-ethylcarbodiimide hydrochloride as the coupling agent and 
N,O-dimethylhydroxylamine with N-methylmorpholine as base, the product was 
isolated in 89 % yield (Scheme 10). 
OMe 
HO 0 I HO 0 Me~N~ H2N~ BOC'N~ ii BOC'N'" 
OH H OH H OH 
33 32 34 
Reagents and Conditions: i: (Boc),O, NaOH (aq.), I ,4-dioxane, 0 'C-r.t., 48 h, 100 %.; ii: 
MeNH(OMe).HCI, EDCI, NMM, DCM, -15 'C, 1.5 h, 89 %. 
Scheme 10: Synthesis of the Weinreb amide 34 from (L)-serine 33. 
Subsequent cyclization of (34) with 2,2-dimethoxypropane in acetone and boron 
trifluoride-diethyletherate as the acid source provided the precursor (35) to Garner's 
aldehyde in high yield, Lithium aluminium hydride reduction of the Weinreb amide 
furnished the desired aldehyde (31) in good yield and it was found to be ca. 95 % pure 
by 'H-NMR spectroscopy. This sequence has the added benefit of not requiring 
chromatography at any stage (Scheme 11). 
OMe Meo:N~ H~ I M~N~ BO~'N'" Me £ ii BOC~NXO BOC~NXO 
H OH 
34 35 31 
Reagents and Conditions: i: 2,2-DMP, acetone, BF,.Et,O, r.t., 1.5 h, 89 %.; ii: LiAIH4' THF, 0 'C, 30 
min, 96 %. 
Scheme 11: The synthesis of Garner's aldehyde 31 using Taylor's method. 
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With Gamer's aldehyde in hand we were able to attempt a catalyst synthesis. A 
catalyst containing no aromatic substitution at C4 of the 1,3-dioxane was required. It 
was hoped that this type of catalyst would indicate whether a steric or electronic effect 
helped to induce chirality in epoxidations carried out with catalyst (16). Therefore 
efforts were concentrated on producing a 5-amino-l,3-dioxane substituted with an 
isopropyl group at C4 (36) in place of the phenyl group present in the original catalyst 
(16). A report by Joullie has shown that isopropylmagnesium chloride adds to the 
Gamer's aldehyde in a highly stereoselective manner. I) However, their reported 
selectivity (6:1 in favour of the syn product) disagrees with another group's work 
where their reported selectivity is higher (14:1 in favour of the syn product).17 In our 
hands this reaction is very efficient and a yield of 73 % was observed with only the 
syn product being detectable by I H NMR spectroscopy (only one set of doublets being 
observed for the methylene protons associated with the isopropyl group) (Scheme 12). 
31 
Reagents and Conditions: i: 'PrMgCl, THF, -78 'C, 2 h, 73 %. 
Scheme 12: Addition of iso-propylmagnesium chloride to Garner's aldehyde 31. 
The origin of selectivity is thought to stem from a chelated intermediate as shown in 
Scheme 13. The chelated Cram model (37) explains the isolation of the syn isomer 
(36) as the major product. 
37 
Scheme 13: Postulated Cram chelate intermediate in the synthesis of 36. 
The next step in the synthesis was to convert the Grignard addition product (36) into 
the corresponding 1,3-dioxane (38). We believed that this process could be achieved 
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in one step, by an intramolecular cyc1ization. Use of camphor sulfonic acid, 2,2-
dimethoxypropane and acetone, protonation of the nitrogen group and subsequent 
attack by the free oxygen of the hydroxy group should yield the desired product 
(Scheme 14). However, this attempt failed yielding only unreacted starting material. 
At elevated temperatures we believed that the 1,3-dioxane would be produced because 
we had expected it to be the thermodynamic product, but again only unreacted starting 
material was recovered. Other reagents were tried, such as trifluoroacetic acid in 
dichloromethane, which is reported to induce such transformations,18 but destroyed 
the starting material. The required product was not produced using this methodology. 
HO!;' 
BOC~~ 
H, BOC'NH >'''''~O ..••  ~ I (l""'" ,y 1----1/)--- 0 0 
BOC-NH P..7\ X 
38 
Scheme 14: Proposed mechanism for the conversion of 36 to 38. 
We therefore adopted an intermolecular approach by stirring the Grignard addition 
product (36) with Amberiyst-15 resin in methanol to give the 1,3 diol (39) in 
approximately 55 % yield. This was improved by using p-toluenesulfonic acid in 
methanol to give a yield of 80 %. The diol produced was then stirred in acetone and 
2,2-dimethoxypropane with a catalytic amount of p-toluenesulfonic acid, to afford the 
desired 1,3-dioxane (38) in 82 % yield (Scheme 15). 
Hot 
Hot 
BOC'NH 
i or ii iii Ii"",l BOc~Nx.0 BOC~NH OH °XO 
36 39 38 
Reagents and Conditions: i: Amberlyst 15, MeOH, r.t., 12 h, r.t., 55 %.; ii:p-TsOH, MeOH, r.t., 12 h, 
80 %.; iii: 2,2-DMP, acetone,p-TsOH, r.t., 82 %. 
Scheme 15: An intermolecular approach to 1,3-dioxane 38. 
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During the synthesis of this intermediate the analogous compound (40) derived from 
(L)-threonine (41) was synthesized using the same methodology. This compound 
would add a methyl group at C6 in the catalyst structure, which could in theory help 
control the approach ofthe incoming substrate during the epoxidation (Scheme 16). 
41 31a 40 
Scheme 16: An analogous catalyst derived from (L)-threonine 
The next step in the synthesis was to produce the primary amines for condensation 
with 2-(2-bromoethyl)benzaldehyde (2). However, this proved somewhat problematic. 
There are a plethora of reports describing Boc deprotection and the standard method is 
the use of trifluoroacetic acid in dichloromethane. 19 This procedure is not applicable 
to our substrates due to the presence of the acid-labile acetonide group. Indeed 
reactions using this particular method only resulted in decomposition of the starting 
material, even when reactions were conducted at low temperature (in the range -78 - 0 
A mild method of deprotection was therefore required. Work by Subhas Bose20 on 
Lewis acid removal of the N-tert-butoxycarbonyl protecting group had shown that in a 
variety of compounds, whether acid or base sensitive, the N-Boc group could be 
removed effectively using aluminium chloride in dichloromethane. Following the 
original conditions described, one equivalent of aluminium chloride, 0 °C_ r.t., the 
threonine derived 1,3-dioxane (40) was submitted to the reaction. After 24 h 
formation of product (42) had occurred, but some starting material still remained. 
Leaving the reaction mixture for a further 24 hours gave no change in the TLC, and 
work up showed that the compound had been deprotected, but in a low yield, 24 %, 
with 30 % ofunreacted starting material being recovered (Scheme 17). 
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40 42 
Reagents and Conditions: AICI" DCM, r.I., 48 h, 24 %. 
Scheme 17: Attempted deprotection of 41 using Base's method, with AICI,. 
In an effort to increase the yield the solutions were cooled to -78 cC before addition of 
the aluminium chloride. The reaction was monitored by TLC and after 8 hours at this 
temperature formation of product had not occurred. The solution was allowed to reach 
room temperature overnight; however, this method failed to increase the yield 
significantly, giving only 30 % of product (42) and 25 % of recovered starting 
material. Perhaps elevating the temperature here would have driven the reaction to 
completion; further work in this area is required to optimize this method for the 
synthesis of 5-amino-1 ,3-dioxanes. 
It therefore appeared that a more successful and reliable method of N-B oc 
deprotection was required. By moving a couple of steps back in the catalyst synthesis 
to the Grignard addition product (36), we could perform a global deprotection of both 
the acetonide and the Boc group simultaneously with trifluoroacetic acid in 
dichloromethane (Scheme 18). Exposing the substrate (36) to TF A in dichloromethane 
at 0 cC, after three hours yielded the crude deprotected diol as the trifluoroacetic acid 
salt (43). The free amine proved difficult to isolate and so the crude product was used 
directly to form the 1,3-dioxane (44). 
36 43 44 
Reagents and Conditions: i: TFA, DCM, -78 ·C-r.I., 3 h; ii: 2,2-DMP, acetone,p-TsOH, r.l., 8 h, 70 %. 
Scheme 18: Boc deprotection and subsequent cyclization to form the desired primary amine 44. 
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There is literature precedent for this type of reaction, hydrobromide salts usually being 
the preferred substrates.21 ,22 Treatment of the trifluoroacetic acid salt (43) with 2,2-
dimethoxypropane in acetone and p-toluene sulfonic acid gave only one product, the 
desired 5-amino-I,3-dioxane (44) in 70 % yield (Scheme 18). However, this method 
did not always give reproducible results and similar attempts using the threonine 
analogue proved unsuccessful. 
The primary amine (44) was then cycIocondensed with 2-(2-
bromoethyl)benzaldehyde (2) to form the corresponding iminium salt (45) in 70 % 
yield (Scheme 19). 
44 45 
Reagents and Conditions: a) 2, EtOH, 0 'C-r.t., 12 h; b) NaBPh4, MeCN, 70 %. 
Scheme 19: Formation of the isopropyl substituted iminium salt 45. 
Catalyst (25) and (45) were used for the standard epoxidation of I-phenylcyclohexene 
(46) described in section 2.1 (Scheme 20). The catalysts were quite reactive and gave 
complete conversion to epoxide within one hour when 10 mol % of catalyst was 
employed. Disappointingly, both catalysts produced near-racemic 1-
phenylcyclohexene oxide (20). 
c5 er -BPh4 )(o)-NY o R 
46 20 R=Me25 
R='Pr 45 
Reagents and Conditions: Iminium Salt (10 mol %), Oxone (2 eq.), Na,CO, (4 eq,), 
MeCNiH,O (1:1), 0 'C, I h. 
Scheme 20: Catalytic asymmetric epoxidation of I-phenyl cyclohexene 46 using catalysts 25 and 
45. 
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Due to the inherent problems of Boc deprotection, this approach to 5-amino-I,3-
dioxanes was abandoned. However, it should be noted here that an analogous 
synthesis using the Cbz protecting group in preference to the Boc group was 
attempted and good yield of the corresponding Gamer aldehyde equivalent (31 b) was 
achieved. But isopropylmagnesium chloride addition did not prove as selective and a 
complex mixture of products was observed. This is in accord with other findings in 
this area; 23 BeauIieu has reported that addition of methylmagnesium bromide to the 
Garner aldehyde equivalent (3Ib), at-78 QC, led to a 1:1 mixture ofdiastereoisomers 
(Scheme 21). Selectivity is only observed when the sterically demanding 
trichloromethane anion is employed as the nucIeophile. 
3Ib R=Me I: I 
R = CC I, 1:0 
Reagents and Conditions: Where R = Me: MeMgBr, THF, -78 'C; Where R = CCI,: CI,CCOOTMS, 
K,COJ, 18-crown-6. Neat, 90 'C. 
Scheme 21: Beau!ieu's observed selectivity for addition ofnucleophiles to compound 31c. 
2.2.2 Iminium salts derived from amino diols. 
The results described in the previous section suggest that an aromatic C4 substituent 
present in the 1,3-dioxane is vital for catalyst enantioselectivity. We therefore began 
the synthesis of a variety of catalysts containing different substitution patterns in the 
aromatic ring at C4. Fortunately we found that two amino diols, (IS,2S)-(+)-2-amino-
1-(p-nitrophenyl)-1,3-propandiol (47) and (IS, 2S)-(+)-2-amino-I-(p-
methyIthiophenyl)-1,3-propandiol [(+)-thiomicamine] (48). are commercially 
available. 
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1+ ifN'Oy:; /S'Oy:; 
OH OH 
47 
48 
OH OH 
48 
By using an analogous procedure to that described by Nordin and Thomas for the 
conversion of (lS,2S)-(+)-2-amino-I-(phenyl)-1,3-propandiol (49) to the 5-amino-
l,3-dioxane (15) (Scheme 22), we were able to produce two primary amines for 
condensation to form the corresponding iminium salts.22 
~ i, ii t iii 
OH OH 
49 
Reagents and Conditions: i: MeOCHO, MeOH, r.t.; ii: 2,2-DMP, acetone, CSA, r.t.; iii: H,NNH,.H,O, 
8,79 % from 49. 
Scheme 22: Nordin and Thomas's approach to the 5·amino-l,3-dioxane 15. 
R~2 i,ii '~" ""I iii ~ 
OH OH 7\0 7<;0 
47 R=N02 50R=N0276% 52 R=N02 78 % 
48 R= SMe 51 R=SMe84% 53 R=SMe95 % 
Reagents and Conditions: i: MeOCHO, MeOH, r.t.; ii: 2,2-DMP, acetone, CSA, r.l.; iii: H,NNH,.H20, 
~. 
Scheme 23: Formation of 5-amino-l,3-dioxanes, 52 and 53, from amino diols. 
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Treatment of the aminodiols (47) and (48) with methyl formate in methanol furnished 
the formate protected diols, subsequent cyclization with 2,2-dimethoxypropane, 
acetone and (+I-)-IO-camphor sulfonic acid (CSA) afforded the 5-amido-l,3-dioxanes 
(50) and (51), and simple deprotection with hydrazine hydrate under reflux afforded 
the desired primary amines (52) and (53) (Scheme 23). This method is convenient and 
high yielding. Conversion of the nitro compound (50) to the free amine (52) required 
some modification, as prolonged exposure to hydrazine hydrate also reduced the nitro 
functionality to the amine (54). Optimum conditions were therefore established: a 78 
% yield of the desired compound could be achieved if the reaction mixture was only 
refluxed for 1 h. Poor conversions to (52) are observed if the reactions are carried out 
at ambient temperature (Scheme 24, Table 3). 
° 02NY'n H~Jl.H ~ 
°XO 
50 
02
N
't'fl1 ~ NHH:2 
H2N.NH2.H20 ~
°XO 
52 
+ H2N'Oy:; 
°XO 
54 
Scheme 24: Deprotection offormamide 50 resulted in a mixture of two products 52 and 54. 
Table 3: Effect of reaction time on the formation of 52. 
Entry Reaction Time (h) Yield of 52 (%) Yield of 54 (%) 
1 2.5 5 89 
2 1.5 40 53 
3 1.0 78 8 
With the amines in hand, two further catalysts, (55) and (56), were produced in good 
yield, each with groups offering a different electronic effect in the aromatic group at 
C4 (Scheme 25). Again a standard epoxidation of I-phenylcyc1ohexene (46) with 10 
mol % of catalyst was performed (Scheme 26). 
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)<0 
° 
R ~ NO, (55) 74 % 
R~ SMe(56) 73 % 
Reagents and Conditions: a) 2, EtOH, 0 'C-r.t., 12 h; b) NaBPh" MeCN. 
Scheme 25: Iminium salt formation using S-amino-l,3-dioxanes 52 and 53. 
These catalysts were found to be slightly less reactive than catalyst (16) and even after 
2 hours did not afford complete conversions to epoxide. The ee of the epoxide formed 
for catalyst (55) was quite low (15 % ee) compared to the ee obtained with catalyst 
(16) (40 % ee). Catalyst (56) showed slightly less conversion to epoxide; the ee was 
somewhat better than catalyst (55) (31 % ee), but not as good as that obtained with the 
original catalyst (16). 
46 20 R = NO,(55)IS % ee, 82 % cony. 
R ~ SMe (56) 31 % ee, 78 % cony. 
Reagents and Conditions: Iminium Salt (10 mol %), Oxone (2 eq.), Na,CO, (4 eq.), MeCN/H,O (1: I), 
O'C,2 h. 
Scheme 26: Epoxidation ofl-phenylcyclohexene (46) using catalysts 55 and 56. 
We found that the thiomethyl catalyst (56) is susceptible to oxidation during the 
epoxidation reaction. It is well known that oxone can be used to oxidize sui fides to 
sulfoxides or sulfones.24 Analysis of the catalyst by IH NMR spectroscopy after being 
subjected to the reaction conditions showed the proton signal for the thiomethyl group 
to have shifted from 0 2.42 to 0 3.0. Comparison with authentic material, prepared by 
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isolation of catalyst (58) after exposure to the epoxidation conditions, confirmed that 
the catalyst had been oxidized to the sulfone. Interestingly no sulfoxide was observed. 
Due to the modification of this catalyst under the reaction conditions two further 
catalysts were synthesized. These cannot be altered by the reaction conditions; the 
first was a simple modification of catalyst (56). Using the previously described 
intermediate (51) m-CPBA oxidation of the sulfide to the sulfone (57) was achieved in 
85 % yield. Then, using the conditions described earlier, the formate (57) was 
deprotected with hydrazine hydrate, and cyclocondensed to form the corresponding 
iminium salt (58), again in good yield (Scheme 27). 
° ° it /Sn;(H ~1~H r; _ "'. -SPh4 ~I ° I ii,iil ~ ><: NdJ oxo °Xo 
51 57 58 
Reagents and Conditions: i: m-CPBA (2.2 eq.), DCM/CHCI" 0 'C, 4 h, 85 %.; ii: H,NNH,.H,O,~, 95 
%.; iii: a) 2, EtOH,O 'C-r.t., 12 h; b) NaBPh" MeCN, 73 %. 
Scheme 27: m-CPBA oxidation of sulfide 51 and subsequent iminium salt formation. 
The second target was to produce a catalyst bearing an electron donating group in the 
para-position of the aromatic ring at C4 (59). Initial attempts, however, proved 
fruitless. 
BPh4 
><: .. ~» 
59 
Our original strategy utilized a diazotization reaction (Scheme 28). Hydrogenation of 
the previously prepared N-{ (lS,2S)-[2-hydroxy-l-hydroxymethyl-2-( 4-nitro-phenyl)-
ethyl]}-formamide (60) to the corresponding amino compound (61) proved highly 
successful (99 % yield). However, the subsequent diazotization reaction was 
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extremely poor, giving at best 15 % yield, even though the reaction had previously 
been reported to give yields of up to 35%.25 Further manipulation of product (61) 
afforded the 4-hydroxyphenyl-l,3-dioxane (62). Methylation, after some 
experimentation, was achieved with caesium carbonate and dimethyl sulfate, 
producing the 4-methoxyformate (63), but separation from by products brought 
through from the initial diazotization reaction proved difficult. Before this approach 
was abandoned, an interesting reaction, where direct conversion from an amine group 
to a methoxy group is possible, reported by Quin and Macdiarmid, using iso-amyl 
nitrite in methanol, was attempted (Scheme 29).26 Unfortunately, when using our 
substrate, this led to a complex mixture of products, including loss of the formate 
protecting group. 
o 
02NYIl H~JlH ~ 
OH OH 
60 
62 
o 
H2NYIl H~JlH ~ 
OH OH 
61 
ii 
Reagents and Conditions: i: H,/Pd, ethanol, r.t. 24 h, 99 %; ii: a) NaNO" H,SO" b) pH 6, t., 15 %; iii, 
2,2-DMP, acetone, CSA, r.t., 4 h, 72 %; iv: Cs,CO" Me,SO" CH,CI" 48 h, 72 %. 
Scheme 28: Initial synthesis of the p-methoxy formate. 
o 
H2NYIl H~JlH ~ 
OH OH 
61 
-..:........//--
o 
/OYll H~JlH ~ 
OH OH 
64 
Reagents and Conditions: i: a) H,SO" MeOH, (CH,hCHCH,CH,ONO, 0 'c, 3 h; b) t., 1 h. 
Scheme 29: Attempted synthesis of 64 using Quin and Macdiarmid's method. 
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Methoxyaryl catalyst (65) was eventually produced from commercially available (L)-
tyrosine (66) (Scheme 30). Boc protection and methylation of the acid and phenol 
with potassium hydroxide and iodomethane afforded (67) the required precursor to 
(68). 
i, ii 
66 67 
Reagents and Conditions: i: (80c),0, NaOH (aq.), 1,4-dioxane, 0 °C-r.t., 48 h, 73 %.; ii: Mel (2.2 eq.), 
KOH (2.2 eq.), DMF, 0 °C-r.t. 3.5 h, 74 %. 
Scheme 30: Formation of80c protected, dimethylated (L)-tyrosine. 
Following the work of Ohfune,27 the benzylic position of (67) was oxidized with 
potassium persulfate (K2S20S) and copper sulfate (cat.) to form the oxazolidinone (68) 
in a highly diastereoselective manner (diastereomeric ratio;:: 98 % R at C3) (Scheme 
31). 
-10 
o=< 
~,.,NH I / '0 .0 0 0 
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0~?J~ 
tAr\NH 
H..f[J/( 0 
,,'/ .... 1{ 
H 0-
69a 
0~?J~ 
tH NH o~n; 0 / '=< u.I .. · ..~ 
H H 0-
69b 
o o~ 
dj."NH I / 
'0 .0 0 0 
68 
Reagents and Conditions: K,5,O" CUS04, H20/MeCN (I: I), 70°C, 3h, 52 %. 
Scheme 31: Ohfune's cyclic carbamate formation. 
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The authors suggest that this high selectivity in cyclic carbamate formation arises 
because the reaction proceeds via the more stable benzyl cation intermediate (69b). 
The conformer (69a) is more strained than (69b) by steric interaction between the 
ester group and the artha hydrogen. Intramolecular trapping of this cation by a 
carboxyl oxygen and subsequent release of the tert-butyl cation, which is believed to 
be more stable than the benzylic cation of (69), is thought to be a driving force for the 
reaction. This was supported by Ohfune's observation that only poor yields were 
obtained from compounds containing other amino protecting groups, such as the Cbz 
group. Confirmation of the stereoselectivity was achieved from the X-ray crystal 
structure of compound (68), as shown in Figure 8. 
Figure 8: X-ray crystal structure of compound (68). 
Although this reaction is highly stereoselective, some problems were encountered 
during the synthesis. Yields tended to vary on scale up of the reaction. Initially the 
reaction on 4 mmol of substrate afforded 50 % of desired product (a good yield 
according to the literature yield of 55 %), but on increasing the quantities up to 26 
mmol a drop in yield to 40 % was observed. Optimum conditions were found when 
carrying the reaction out on a 16 mmol scale - a 52 % yield of product was obtained. 
Attempts to drive the reaction to completion proved fruitless. Generally increased 
reaction times and temperatures decreased the overall yield due to generation of 
higher levels of the side product 4-methoxy-benzaldehyde (a product of over-
oxidation).28 Milder reaction conditions resulted in no product formation. 
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The carbamate (68) was then reduced to (70); this was initially achieved with lithium 
aluminium hydride, but sodium borohydride provided a superior yield (91 % 
compared to 77 %), probably due to the ease of work-up associated with the sodium 
borohydride reactions. Hydrolysis in refluxing I M sodium hydroxide yielded the syn-
(lR,2R)-amino diol (71) in 20 minutes (Scheme 32). Interestingly when the reaction 
was carried out at room temperature no product was observed for up to 48 h . 
.J<0 
~J..~NH 
'oJY J-o \ 
____ /O~ ~H2 
V""'(l 
OH OH 
68 70 71 
Reagents and Conditions: i: NaBH4, EtOH, 0 'C-r.t. 45 min, 91 %, ii: 1 M NaOH, Ll., 20 min, 93 %. 
Scheme 32: Formation of the p-methoxy diol69. 
The arninodiol was then subjected to the synthetic procedure outlined in Scheme 23. 
However, attempted cyclization of the formate protected diol (71) to give the 1,3-
dioxane (72) did not proceed smoothly with camphor sulfonic acid (Scheme 33). 
Instead, the uncyclized product (73) was formed as the major product in a 4: I ratio 
with (72). 
+ 
4 
71 73 72 
Reagents and Conditions: 2,2-DMP, acetone, CSA, Lt., 12 h. 
Scheme 33: Attempted formation of dioxane 72 using CSA. 
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Increased equivalents of CSA, elevated temperatures and longer reaction times failed 
to increase the ratio of (72) and (73). This problem was also noted on formation of 
the formate dioxane of the original amine (15); there the problem was rectified by 
using a catalytic amount of HBr as the acid source.22 However, under these conditions 
we only observed degradation of the starting material (71). Eventually, we discovered 
that the addition of catalytic boron trifluoride-diethyletherate to the reaction gave the 
desired 6-membered dioxane (72) exclusively in good yield. Subsequent deprotection 
and condensation with 2-(2-bromoethyl)benzaldehyde yielded the catalyst (65) 
(Scheme 34). 
ii, iii 
65 
Reagents and Conditions: i:2,2-DMP, acetone, BF,.Et,O, r.t. 45 min, 81 %: ii: H,NNH,.H,O, d, 2.5 h, 
95 %; iii: a) 2-(2-bromoethyl)benzaldehyde, EtOH, 0 'C-Lt., 12 h b) NaBPh4, MeCN, r.t., 5 min., 71 %. 
Scheme 34: Formation of the p-methoxy catalyst 65. 
With these further two catalysts in hand, a range of substrates were tested in the 
asymmetric epoxidation reaction (Table 4). 
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Table 4: Catalytic asymmetric epoxidation ofunfunctionalized alkenes using Oxone and iminium 
salts 16, 55, 56, 58 and 65a 
Catalyst 16 55 56 58 6#1 
R= (H) (N02) (SMe) (S02Me) (OMe) 
Epoxide In all cases: ee (%)" I Conversion (%)C I Configurationa 
per 411 55e I 15 I 82 I 31/78 I 39/1001 45 I 54e I 
20 (-)-IS2S (-)-IS2S (-)-IS2S (-)-lS2S (+)-lR2R 
OJ 49 I 64e I 421100/ 49/100/ 47/100/ 63/ 62e / 22 I"" (-)-lS2R (-)-lS2R (-)-lS2R (-)-lS2R (+)-lR2S 
"" 
0 40 192/ 411 52 I 35/82/ 45 161 / 46 I 83 I Cd 74 (-)-IS2R (-)-lS2R (-)-lS2R (-)-lS2R (+)-lR2S 
o Ph 15/ 56e / 01100/ 0/85/ 01 100/ 35/54e / prv 
75 (-)-S,S (+)-R,R 
APh 52/ 52
e I 351100/ 42 I 85 / 321100/ 60/ 55e I 
18 Ph Me (-)-lS2R (-)-lS2R (-)-lS2R (-)-lS2R (+)-lR2S 
APh 59/ 54
e / 331100 I 511 67 / 50/100/ 711 60e / 
19 Ph Ph (+)-(S) (+)-(S) (+)-(S) (+)-(S) (-)-(R) 
a Epoxidation conditions:Iminium salt (10 mol %), Oxone (2 eq), Na2CO, (4 eq), MeCN:H,O (1:1), 
O'C, 2 h. b Enantiomeric excess determined by 'H-NMR with Eu(hfc), (0.1 mol eq) as chiral shift 
reagent or by Chiral HPLC on a Chiracel OD column. 'Conversion evaluated from the 'H-NMR by 
integration alkene versus epoxide. d The absolute configuration of the major enantiomer was 
determined by comparison to those reported in the literature. ' Isolated yield. f Catalyst configuration 
(4R,5R). 
We found that the thiomethyl catalyst (56) gave the poorest epoxide conversions; we 
believe this to be due to the reason presented above (the susceptibility of the 
thiomethyl group to undergo oxidation during the epoxidation reaction). 
Iminium salt (55), containing the strongly electron-withdrawing 4-nitro group, 
generally gave lower conversions than did catalysts (16), (58), and (73), all of which 
gave similar conversions to epoxide. By far the most active catalysts were (16) and 
(73), both of which completely epoxidized I-phenylcyclohexene (46) in under 3 
minutes. 
In terms of enantioselectivity the 4-nitroiminium salt (55) gave the worst results, 
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giving at best 41% ee for 1,2-dihydronaphthalene (entry 3). Both sui fur-based 
catalysts (55) and (56) gave similar ees (probably due to the oxidation of (55) to (56) 
under the reaction conditions). One interesting point to note is that catalysts with an 
electron-withdrawing group at the 4-position (55, 56 and 58) are unable to epoxidize 
trans-stilbene enantioselectiveiy (entry 4). 
Undoubtedly the best catalyst was the 4-methoxyiminium salt (65). It imparted the 
highest enantioselectivity we have observed, giving triphenylethylene oxide with 71 % 
ee in 60% yield in only 30 minutes (entry 6). In general, the ees for each of the 
alkenes tested have been improved by this catalyst over others we have tested, and 
even trans-stilbene oxide (75) is formed with 35% ee. 
2.3 Catalysts Based on Dibenzo[c,e]azepinium salts. 
In our ongoing efforts to develop new and more selective catalysts based on iminium 
salts a new family of catalyst was produced, in which the dihydroisoquinolinium 
moiety has been replaced by a biphenyl structure fused to a seven-membered 
azepinium salt.29 A similar system was developed some years ago by Aggarwal but 
with axial chirality, achiral at the nitrogen;30 the system reported some good results, 
although the enantioselectivity of the catalyst was dependent upon the substitution 
pattern of the alkene. 
2.3.1 Introduction. Previous findings using dibenzo[c,e ]azepinium salts.3l 
The preparation of this new family of catalyst was achieved by starting from an 
enantiomerically pure primary amine and 2-[2-(bromomethyl)phenyl]benzaldehyde 
(76) (Scheme 35). 2-[2-(bromomethyl)phenyl]benzaldehyde was prepared from the 
corresponding dibenzoxepine (77), by treatment with molecular bromine in refluxing 
carbon tetrachloride for 1 h, following a similar procedure already proven in the 
dihydroisoquinoilinium salt series. The catalysts are synthesized in three steps starting 
from commercially available 2,2' -biphenyl dimethanol (78). 
79 
OH ii Br iii 
OH "'0 
78 77 
Reagents and Conditions: i: HBr (24 %, in water), 100 'C, 40 min, 85 %; ii: Br" CCI" 6, I h, 59 %; iii: 
a) R*NH" EtOH, 0 'C-r.t., I 2 h, b) NaBPh" MeCN, 5 min. 
Scheme 35: Formation ofth. dibenzo[c.e]azepinium salts. 
Initially two new iminium salt catalysts were prepared following this procedure: 
catalyst (79), derived from the (-)-IPC amine (8), in 60 % yield, and the 1,3-dioxane 
catalyst (80), derived from amine (15), in 68 % yield. These two amine precursors 
were selected as they are the parent compounds of our earlier most effective 
dihydroisoquinolinium catalysts (14 and 16 respectively). 
79 80 
A range of epoxidations were carried out using these new iminium salts and a 
comparison of the results obtained with the original dihydroisoquinolinium catalysts 
(14) and (16) is displayed in Table 5. I! is clear that both of the new seven membered 
catalysts are more reactive in the epoxidation reaction than the six-membered 
equivalents. Catalyst (79) gives in general poorer ees than the catalyst (80) but in 
some cases provides superior ees to that of its six membered counter-part (14). For 
example, l-phenyl-3,4-dihydronapthylene oxide (22) is formed with 20 % ee when 
catalyst (14) is employed, but when catalyst (79) is used an ee of 38 % is observed. 
Catalyst (80) provides ees of up to 60 %, although with a somewhat different pattern 
of selectivity from catalyst (16), for example giving an improved 60 % ee for 1-
pheny1cyc1ohexene oxide (20) (catalyst 16 gives 41 % ee), but an identical 59 % ee 
for triphenylethylene oxide. It is also worth noting that all the reactions with catalyst 
(80) are complete within 10 minutes or less at 0 °C, making it one of our most reactive 
iminium salt catalysts discovered to date. 
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Table 5: Catalytic asymmetric epoxidation mediated by the new dibenzo[c,e]azepinium salts (79 and 
80); a comparison to the corresponding dihydroisoquinolinium salts (14 and 16)." 
Catalyst 
Epoxide 14 I 79 I 16 I 80 
In each case: ee (%)h; Conv. (%)C, major enantiomerd 
Me,><1 8,68e 3,90 20,64e 24, 10O 
17 Ph (+)-R (+)-R (+)-R (+)-R 
o Ph 
- 0,95 15,56e 15,90 
75Pt 
- (-)-S,S (-)-S,S 
Ph-1- 15,72
e 14,93 52, 52e 37,95 
Ph 
18 Me (+)-IR,2R (+)-IR,2R (-)-1 S, 2S (-)-IS,2S 
Ph-1- 5,43
e 17,100 59,54e 59,90 
Ph 
19 Ph (+)-S (+)-S (+)-S (+)-S 
d-Ph 40,68e 29, 10O 41, 55e 60, 10O 20 (+)-IR,2R (+)-IR,2R (-)-1 S, 2S (-)-IS,2S 
cCr 20,73e 38,95 49,64e 41,90 I"" (-)-IS,2R (-)-IS,2R (-)-IS,2R (-)-IS,2R 22 ,.,:; 
o:? 3,34e 8,95 17,52e 10,100 211,.,:; (+)-IS,2R (+)-IS,2R (+)-IS,2R (+)-IS,2R 
"Epoxidation conditions: Iminium salt (5 mol %), Oxone (2 eq), Na,CO, (4 eq), MeCN:H,O (I :1), O'C, 
2 h. b Enantiomeric excess determined by IH-NMR with Eu(hfc), (0.1 mol eq) as chiral shift reagent or 
by Chiral HPLC on a Chiracel OD column. 'Conversion evaluated from the 'H-NMR by integration 
alkene versus epoxide. d The absolute configuration of the major enantiomer was determined by 
comparison to those reported in the literature. e Isolated yield/Catalyst configuration (4R,5R). 
2.3.2 New dibenzo[c,ejazepinium salt catalysts, 
Following the success of the dibenzo[c,e jazepinium catalysts (79 and 80) and the 
substituted catalysts (55), (56), (58), and (65) reported in section 2.2, cyclo-
condensation of the more effective amines in the dihydroisoquinolinium series, with 
the bromo-aldehyde (76) to produce the corresponding azepinium salts was achieved. 
Again, the new catalysts (81), (82), and (83) were prepared in good yields (Scheme 
36). These catalysts were tested in the asymmetric epoxidation of three substrates 
81 
(Table 6). These new catalysts in general provided poorer ees than their 
dihydroisoquinolinium counterparts. However, catalyst (S3) epoxidized 1-
phenylcyclohexene with 63 % ee (compared to 45 % ee for catalyst 16). 
Disappointingly, for reasons which at this moment are unclear, triphenylethylene 
proved to be a poor substrate with catalysts (SI) (11 % ee), (S2) (10 % ee), and (S3) 
(26 % ee), but we have previously reported 59 % ee when catalyst (SO) is employed. 
Br 
76 
Ar~ H (SO) 68 % 
NO, (S\) 60 % 
SO, Me (S2) 66 % 
OMe" (S3) 64 % 
Reagents and Conditions: a) R*NH" EtOH, 0 'C·r.t., 1 2 h, b) NaBPh4, MeCN, 5 min. 
Scheme 36: Synthesis of the substituted dibenzo[c,e]azepinium salts. 
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Table 6: Catalytic asymmetric epoxidation ofunfunctionalized alkenes using dibenzo[c,e]azepinium 
salts 80, 81. 82, and 83," 
Catalyst 
Alkene 80 81 82 83 
R= H N02 S02Me OMeb 
In each case: ee (%)C I Conv. (%)a I Configuration' 
ejPh 60/1001 38 148 I 47 I 56 I 63 150' I 
20 (-)-IS,2S (-)-IS,2S (-)-IS,2S (+)-IR,2R 
Ph-1- 37 I 95 I 17 I 30 I 21/1001 50/6Jf I Ph 
18 Me (-)-IS,2S (-)-IS,2S (-)-IS,2S (+)-IR,2R 
Ph-1- 59 I 90 I 11 122 I 10 I 55 I 26 I 63' I Ph 
19 Ph (+)-S (+)-S (+)-S (-)-R 
"Epoxidation conditions:Iminium salt (5 mol %), Oxone (2 eq), Na,CO, (4 eq), MeCN:H,O (1: 1), O·C, 
2 h. b Catalyst configuration (4R,5R). C Enantiomeric excess determined by IH_NMR with (+)-Eu(hfc), 
(0.1 mol eq) as chiral shift reagent.d Conversion evaluated from the IH_NMR by integration alkene 
versus epoxide. 'The absolute configuration of the major enantiomer was determined by comparison to 
those reported in the literature. f Isolated yield. 
2.4 Catalysts Based on a Binaphthalene Structure. 
Due to the encouraging findings described in the previous section we felt that a logical 
continuation of this work would be in the synthesis of the axially chiral binaphthalene 
analogues. As mentioned previously, Aggarwal has described an iminium salt based 
upon a binaphthalene unit; however, this catalyst is unsubstituted at the nitrogen atom. 
We believed that addition of a chiral group on the nitrogen could lead to greater 
substrate control and hence higher enantioselectivity. One of the inherent problems 
associated with the addition of other chiral centres in this type of molecule is the 
advent of matched and mis-matched pairs of diastereoisomers, something which had 
to be considered during the catalyst synthesis. We predicted that if the binaphthalene 
component was of the R-configuration and the I ,3-dioxane component is of the 4S,58 
configuration, then this would be a matched pair, as Aggarwal's S-iminium salt 
(Chapter I, Figure 13) produced, in general, the oppositely configured epoxides to 
those obtained with either catalysts (16) or (80). 
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2.4.1 Catalyst Synthesis. 
We envisaged that the mode of access to these catalysts would be through the familiar 
bromoaldehyde unit (84) (Scheme 37). This in turn could be synthesized from the 
oxepine (85) by ring opening with bromine; again, synthesis of the oxepine (85) could 
be accomplished by cyclization of the bis-methanol compound (86), as previously 
proven in the dibenzo[c,e]azepinium salt synthesis (section 2.3.1). This material (86) 
is not commercially available, but several syntheses of compound (86), in 
enantiomerically pure form, have been reported.)),)4,)S These generally involve a 
resolution at some point during the synthesis, but to avoid this, the synthesis can be 
achieved from commercially available enantiomerically pure R (87 R) or S (87 s) 
BINOL. Formation of the desired bis-methanol compound (86) has been described by 
Mazaleyrat from a bis-methyl binaphthalene, which in turn can be synthesized from 
BINOL (87).)4 
Br 
"'0 
OH 
OH 
86 85 
Scheme 37: Retrosynthetic analysis of the desired iminium salt. 
The initial reaction required in the synthesis was the formation of the bis-triflate 
protected binaphthalene (88R). Using R -BINOL (87 R) in dichloromethane with 
trifluoromethanesulfonic anhydride, DMAP, and 2,6-lutidine, the product was 
produced in near-quantitative yield after 4 hours (Scheme 38),)6 Subsequent cross-
coupling with methylmagnesium bromide and the nickel catalyst [NiCh(dppp)z] 
afforded the bis-methylene compound (89R), again in excellent yield (90 %).37 
84 
OH_.!...-_ 
OH 
OTt 
OTt 
ii 
Reagents and Conditions: i: Tf,O, DMAP (cal.), 2,6-lutidine, DeM, -30 'C-r.l., 99 %; ii: MeMgBr, 
NiCI,(dppp)" Et,O, 12 h, 90 %. 
Scheme 38: Formation of the bis-methylene compound 89 •. 
Synthesis of the desired bis-bromomethyl binaphthalene (90R ) has also been reported 
in the literature. The route reported involved the use of NBS in refluxing carbon 
tetrachloride using benzoyl peroxide as the initiator,34 and afforded the product in 64 
% yield (Scheme 39, Table 7). However, this process was occasionally unreliable, and 
what we believe to be the tribromo compound (9h) was sometimes formed as the 
major product, as indicated by the presence of a proton signal at 6.22 ppm (singlet, H 
adjacent to the two bromine atoms) and a double doublet at 4.24 ppm (CH2-Br) in the 
IH-NMR spectrum. This side product has also been described, under these reaction 
conditions by RajanBabu.38 
Slight modification of this procedure, however, had a dramatic effect upon the yield of 
the reaction. Replacing the initiator with AIBN, removing the heat, and stirring at 
room temperature for 5 h under visible light (150 W) afforded the desired compound 
(90R) in up to 88 % yield. Further modification, by removing the carbon tetrachloride 
and replacing with cyclohexane, surprisingly, did not alter the rate or yield of the 
reaction. 
85 
Br 
Br 
Reagents and Conditions: NBS (2 eq.), Solvent, ~ or light. 
Scheme 39: Bromination of the bis-methylene 89. with NBS. 
Table 7: The effect of several reaction parameters on the formation of90. 
Entry Solvent Initiator Ll or Light Time (h) Yield (%) 
1 CCl4 Benzoyl Peroxide Ll 24 64 
2 CCl4 AIBN Light (r.t.) 5 88 
3 Cyclohexane AIBN Light (Lt.) 5 88 
Conversion of the bis-bromomethyl binaphthalene (90R) species to the bis-methanol 
binaphthalene (86R) required the formation of the intermediate ester (92R) with 
potassium acetate and a catalytic amount of tetrabutylammonium bromide in DMF 
(Scheme 40). Subsequent hydrolysis with aqueous potassium hydroxide (l M) 
afforded the bis-methanol binaphthalene (86R) as colourless plates in 88 % overall 
yield. 
Br 
ii 
Br 
Reagents and Conditions: i: KCO,CH" Bu,NBr (cat.), DMF, 80 'c, 20 h; ii: KOH (aq. 50 %): 1,4-
dioxane (I:I),~, 24 h, 88 %. 
Scheme 40: Formation of the bis-methanol compound 86. 
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OH 
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However, attempted cyclization to form the desired oxepine (85R ) under the 
conditions developed for the corresponding biphenyl derivative (77) [HBr (aq. 24 %), 
lOO °C, I h] did not work (Scheme 41). Increasing the concentration of the HBr or the 
reaction time also had no effect, and complete recovery of the starting material was 
observed in each case. 
OH 
OH 
_
__ ""I/L/ __ 
11-
Reagents and Conditions: HBr (aq. 24 %), 100 'C, 1 h. 
Scheme 41: Attempted formation of the oxepine 85R 
Fortunately, upon closer inspection of the Mazaleyrat paper, a brief comment on 
"cyclic ether" formation indicates that the bis-bromomethyl binaphthalene (90R) can 
be directly converted to the oxepine by refluxing in 1,4-dioxane/saturated sodium 
carbonate solution (Scheme 42).34 Indeed cyclization, under these conditions, did 
occur and the oxepine (85R) was produced in 65 % yield after 24 h. When the reaction 
mixture was heated for 36 h, yields could be increased to 76 %. Ring opening of the 
oxepine (85R) under the standard conditions employed previously using bromine in 
refluxing carbon tetrachloride afforded the bromoaldehyde (84R) in 68 % yield. 
Repeating the synthetic sequence with the S-enantiomer of BINOL (87 s) produced the 
corresponding bromoaldehyde (84s) in comparable yields. HPLC analysis of the 
bromo- aldehydes indicated them to have greater than 99 % ee. 
87 
Br Br 
ii 
Br "'0 
Reagents and Conditions: i: Na,CO, (sat. aq.)/I,4-dioxane (1:1), d, 36 h, 76 %; ii Br" Cel4, d, I h,65 
%. 
Scheme 42: Formation of the catalyst precursor 84, 
With both enantiomers of the bromoaldehyde (84) available several new iminium salts 
were synthesized and tested in the asymmetric epoxidation reaction (Scheme 43, 
Table 8). Similar yields to those obtained with the other bromoaldehydes were 
observed for iminium salt formation. 
• 
84R or 84s 
Reagents and Conditions: a) NH,-R*, EtOH, r.t. 12 h; b) NaBPh4, MeCN, r.t. 5 min. 
Scheme 43: Iminium salt formation using bromo-aldehydes 84, or 84" with a range of primary 
amines. 
88 
Table 8: Yields ofiminium salt formation using bromo-aldehydes 84. or 84, with a range of primary 
amines. 
Entry Bromo- Amine Compound No. Yield (%) 
aldehyde 
1 84R Ph NH2 ~ 93 66 
2 84s Ph NH, ~ 94 63 
3 84s Ph_ .NH2 ~ ent-93 64 
4 84R 
H'N".;;( 
95 71 
5 84s H'N'~ 96 73 
2.4.2 Catalytic asymmetric epoxidation. 
With these new catalysts in hand we were able to test their effectiveness in a variety 
of epoxidation reactions. Initially we screened the catalysts with our usual test 
substrates, I-phenylcyclohexene (46), o:-methylstilbene (97), and triphenylethylene 
(98) (Table 9). Catalyst (93) showed the best reaction profile, being far more reactive 
than the other catalysts. Catalyst (93) formed I-phenycyclohexene oxide (20) with 91 
% ee in under 20 minutes when 5 mol % of the iminium salt was employed, whereas 
the other catalysts (apart from ent-93) were not as selective and the reaction times 
were low when compared to catalyst (93). It appears that the isopinocampheyl moiety 
offers little enantiocontrol, leading to epoxides with only moderate ees. The poor 
reactivity of catalysts (94-96) is highlighted by the attempted epoxidation of 0:-
methylstilbene (97), and triphenylethylene (98), where no epoxides were formed after 
4 hours when employing 5 mol % of catalyst. Catalyst (93) however afforded 
complete conversion to the corresponding epoxides in a much shorter time and yields 
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of ca 60 %, although the ees were somewhat disappointing (49 % and 12 % ee 
respectively). 
Table 9: Epoxidation of several unfunctionalized alkenes with catalysts 93-96." 
Alkene Catalyst Time Yield ee Configuration" 
(h) (%t (%)C 
Ph 93 0.20 69 91 (-)1 S,2S 
460 ent-93 0.20 66 88 (+)IR,2R 
94 2.0 54 78 (+)IR,2R 
95 2.0 40 53 (-)1 S,2S 
96 2.0 44 58 (+)IR,2R 
Ph.A:::yPh 93 0.40 
97 Me 
58 49 (-)1 S,2S 
94 4.0 0 - -
95 4.0 0 - -
96 4.0 0 - -
Ph~Ph 93 0.50 60 12 (+)-S 
98 Ph 
94 4.0 0 - -
95 4.0 0 - -
96 4.0 0 - -
Q Conditions: Iminium salt (5 mol %), Oxone (2 equiv.), Na,CO, (4 equiv.). MeCN/H20 (1:1), 0 'C. 
b Isolated yield. 'Enantiomeric excess determined by 'H-NMR with (+)-Eu(hfc), (0.1 mol eq) as chiral 
shift reagent. d The absolute configuration of the major enantiomer was determined by comparison to 
those reported in the literature. 
Catalyst (93) was subsequently used to epoxidize several other olefins. Again the 
reactivity of the catalyst (5 mol %) was good, but a wide range of ees were observed 
(Table 10). 1-Phenyl-3,4-dihydronapthylene (99) was epoxidized with high 
enantioselectivity (95 % ee and 66 % yield after 35 minutes). para-Phenyl styrene 
(100) was also epoxidized using catalyst (93) and gave the highest reported ee (29 %) 
for any terminal epoxide using iminium salt catalysis. 
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Table 10: Epoxidation of various alkenes with catalyst 93.' 
Alkene Time (h) Yield (%)b ee (%t Configurationd 
Ph 
101P{ 
0.45 58 20 (-)-S,S 
1020+-
0.25 63 25 (-)-IS,2S 
CO 103 1 .0 0.30 60 17 (-)-IS,2R 
cO 0.35 66 95 (-)-IS,2R 99 1 .0 
104 2.0 67 38 (-)-2S,3S 
~OH 
lOO 1.0 70 29 (+)-S 
~ Ph "'" 
a Conditions: Iminium salt 93 (5 mol %), Oxone (2 equiv.), Na,CO, (4 equiv.), MeCNlH,O (1:1), 0 'C. 
b Isolated yield. 'Enantiomeric excess determined by 'H-NMR with (+)-Eu(hfch (0.1 mol eq) as chiral 
shift reagent or by chiral HPLC using a Chiracel OD column. d The absolute configuration of the major 
enantiomer was determined by comparison to those reported in the literature. 
Having established the most successful epoxidation substrates for catalyst (93), 
several cycIoalkenes with various ring sizes were prepared (Scheme 44). Both 
cyclopentanone (105) and cycloheptanone (106) were treated with phenylmagnesium 
bromide in tetrahydrofuran to afford the alcohols (107) and (108) in excellent yields 
(95 and 98 % respectively); subsequent treatment with a five-fold excess of TFA in 
chloroform, as described by de Costa,39 provided 1-phenyJcyclopentene (109) and 1-
phenylcycloheptene (110), again in very good yields (99 %). 
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0 ~Ph Ph Q ii Q 
105 107 n= 1 =95 % 109n= 1 =99% 
106 108 n= 3 =98 % 110 n = 3 = 99 % 
Reagents and Conditions: i: PhMgBr, THF, r.t., 2 h; ii: TFA, CHCI" 5 min. 
Scheme 44: Formation ofcyclo-alkenes 109 and 110. 
These new substrates were tested in the asymmetric epoxidation reaction. Reactions 
were carried out using just 1 mol % of catalyst (93) (Table 11). Again good 
conversions to epoxides were achieved, and, interestingly, the five- (109) and seven-
(110) membered ring cycloalkenes were less reactive than I-phenylcyclohexene (46). 
The reactions took almost five times as long to approach completion, and 
enantioselectivities were poorer than those observed for l-phenylcyclohexene: 1-
phenylcyclopentene oxide was formed in 55 % ee and l-phenylcycloheptene oxide in 
76 % ee. 
Table 11: Effect of ring size on the epoxidation of several cyclo-alkenes with catalyst 93." 
Alkene Time (h) Yield (%)b ee (%t Configurationd 
1096
h 5.0 52 55 (-)-IS,2S 
Ph 1.1 64 91 (-)-IS,2S 
460 
1100 
Ph 5.0 57 76 (-)-IS,2S 
a Conditions: iminium salt 93 (I mol %), Oxone (2 equiv.), Na,CO, (4 equiv.), MeCN/H,O (1:1), 0 QC. 
b Isolated yield.' Enantiomeric excess determined by IH-NMR with (+)-Eu(hfc), (0.1 mol eq) as chiral 
shift reagent. d The absolute configuration of the major enantiomer was determined by comparison to 
those reported in the literature. 
Using catalyst (93) we also conducted a catalyst loading study using our test substrate 
I-phenylcyclohexene (46), with catalyst loadings ranging from 0.1 to 5 mol % (Table 
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12). We were delighted and extremely surprised to observe high levels of asymmetric 
induction with low catalyst loadings. We have previously reported that it is possible to 
use just 0.5 mol % of catalyst, but we usually observe a loss in selectivity. In this case, 
however, catalyst loadings are so low that effective epoxidation of 1.0 g of 1-
phenylcyc10hexene (46), with 78 % yield and 88 % ee, can be achieved using just 5 
mg (0.1 mol %) of catalyst (93). 
Table 12: Catalyst loading study on the epoxidation of l-phenylcycJohexene 46 with catalyst 93.a 
Entry Cat. Time Yield ee Configurationd 
(mol %) (h) (%i (%)" 
1 5.0 0.2 69 91 (-)-IS,2S 
2 1.0 1.1 64 91 (-)-IS,2S 
3 0.5 2.0 65 91 (-)-IS,2S 
4 0.1 6.0 68 88 (-)-IS,2S 
a Conditions: iminium salt 93, Oxone (2 equiv.), Na,CO, (4 equiv.), MeCNlH,O (1:1), 0 'C. b Isolated 
yield. 'Enantiomeric excess determined by 'H-NMR with (+)-Eu(hfc), (0.1 mol eq) as chiral shift 
reagent. d The absolute configuration of the major enantiomer was determined by comparison to those 
reported in the literature. 
2.5 Catalytic Asymmetric Anhydrous Epoxidation, Mediated by 
Tetraphenylphosphonium mono-peroxysulfate and Iminium salts. 
2.5.1 Introduction. Reasons for employing a new stoicheiometric oxidant. 
The standard conditions employed in epoxidation reactions catalysed by iminium salts 
involve the use of oxone as stoicheiometric oxidant, a base (2 molar equivalents of 
Na2C03 per equivalent of oxone) and water I acetonitrile as solvent mixture (Scheme 
45): the presence of water is essential for oxone solubility. Under the reaction 
conditions, there are separate aqueous and organic phases; it is possible that the 
catalyst acts as a phase transfer agent in these reactions. 
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Iminium salt (0.1 - 10 mol %) 
Oxone (2 eq), Na2C03 (4 eq) 
CH3CN:H20 (1:1), 0 ·C. 
Scheme 45: The standard conditions applied for catalytic asymmetric epoxidation mediated by 
oxone and iminium salts. 
The principal limitation to this system is the restricted range of temperatures in which 
the epoxidation can be performed (0 °C to room temperature). The upper limit is 
determined by the oxone, which decomposes relatively quickly in the basic medium at 
room temperature.5 The lower limit is determined by the use of the aqueous medium; 
the normal ratio of the water and acetonitrile solvents used is I: 1, and this mixture 
freezes at around -8 °C. 
One potential opportunity to enhance the enantioselectivity of the process would be 
provided if the reaction could be carried out at a lower temperatures. This would 
require the development of non-aqueous reaction conditions, and because of the 
solubility profile of oxone, which has no significant solubility in any organic solvent, 
this in turn dictates a need for a new stoicheiometric oxidant, soluble in organic 
solvents at low temperatures. Crucially, this oxidant must not oxidize alkenes under 
the reaction conditions in the absence of the catalyst (background oxidation). 
2.5.2 Selection of tetraphenyl phosphonium mono-peroxysulfate. 
Several oxidants were tested in an epoxidation reaction in the presence of iminium salt 
catalysts to determine which offers the best profile in the absence of water.40 These 
reactions were carried out at 0 °C with I-phenylcyclohexene (46) as substrate and (14) 
and/or (16) as catalysts (5-20 mol %), in dichloromethane as solvent. Most of the 
systems examined showed either high levels of background epoxidation (alkaline 
hydrogen peroxide, peracids, persulfates) or very low rates of reaction even in the 
presence of 20 mol % of the catalysts (perselenates, percarbonates, perborates and 
iodosobenzene diacetate). Tetra-N-butylammonium oxone, reported by Trost,41 was 
also unsuccessful as oxidant. 
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From all of those tested, tetraphenylphosphonium mono-peroxysulfate (TPPP), 
reported by Di Furia in 1994 for oxygen transfer to manganese porphyrins,42 showed 
the best profile. A modification of oxone, TPPP is prepared by cation exchange (K+ to 
P~P+) between oxone and tetraphenyl phosphonium chloride (Scheme 46). Further 
crystallization of the triple salt from CH2Clz and hexane afforded the desired 
compound as a colourless solid in 75 % yield, which iodometric titration reveals to 
have ca 85% of the theoretically available oxygen. This composition was also 
confirmed by IH-NMR spectroscopy (CD2CIz), by integration of the aromatic 
hydrogen of the tetraphenyl moiety and the peroxyacidic proton (8.5 ppm). 
Scheme 46: Formation oftetraphenylphosphonium mono-peroxysulfate from oxone. 
For epoxidation to proceed, the presence of base is essential under the aqueous 
conditions when using oxone as oxidant. We were pleased to discover that, in 
contrast, the addition of one equivalent of any of a range of bases (KF, TBAF, CsF, 
pyridine, 2,6-lutidine, DBN, DBU, DABCO, LiH, NaH) to the test reaction in 
dichloromethane at 0 °C, with TPPP as oxidant, did not improve the reaction; indeed, 
the amine bases suppressed epoxidation altogether. 
Formation of epoxide was not observed upon treatment of l-phenylcyclohexene (46) 
with TPPP in dichloromethane solution at 0 °C in the absence of catalyst. Indeed, such 
background epoxidation only becomes competitive with the catalyzed reaction when 
the temperature reaches ca. 40 °C. 
The optimum conditions for the asymmetric epoxidation reaction were developed. 
Due to the exothermic nature of the reaction, a solution of TPPP in the reaction 
medium is cooled to the desired temperature; the catalysts and substrate are also 
separately dissolved in the reaction solvent and cooled to the desired temperature. The 
solution of catalyst is added dropwise to the solution of oxidant, to minimize the 
increase in reaction temperature, which is allowed to stabilize before dropwise 
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addition of the substrate. The alkene is added last to help maintain the epoxidation 
process at a constant temperature. The reaction is stopped by high dilution with 
diethyl ether, in which both the catalyst and oxidant display a low solubility profile. 
We have also found that when the catalyst reacts with TPPP an anionic interchange 
between the two salts occurs. The tetraphenyl borate (BPh4f is displaced from the 
iminium salt by the monoperoxysulfate anion (HSOsf, and the corresponding 
tetraphenylphosphonium tetraphenylborate is formed. This is rather insoluble in 
dichloromethane and can be isolated and characterized by filtration from the reaction. 
2.5.3 Asymmetric epoxidations using TPPP. 
2.5.3.\ Temperature studies. 
Several reactions with our test substrate I-phenylcyclohexene (46) were performed 
using catalyst (80) and our dihydroisoquinolinium catalyst (16) under these new 
conditions. Runs were conducted using 10 mol % of catalyst over a range of 
temperatures; the results obtained are displayed in Table 13 (it is important to note 
here that the corresponding catalysts derived from the (-)-IPC amine (8) (14 and 79) 
gave poor conversions and ees under these conditions. For example, catalyst (79) (10 
mol %) afforded only 60 % conversion to l-phenylcyc1ohexene oxide (20) and 13 % 
ee after two hours at -40 QC). As a comparison the reported aqueous/acetonitrile 
results are inc1uded.6,29 
We observed that in each case the highest enantiomeric excess is obtained at the 
lowest temperature (entries I to 5 and 10 to 14 for catalyst (80), and 6 to 9 and, 15 to 
18 for catalyst (16». The increase in ee is coupled with a decrease in epoxide 
conversion at lower temperatures. A comparison of the two catalysts show that the 
biphenyl catalyst (80) is much more reactive (as it is under the oxone conditions) at 
lower temperatures and far more selective regardless of solvent. 
The best selectivities are obtained when a mixture of solvents is employed (entries 10-
18). AI: 1 ratio of dichloromethane/acetonitrile allows the reaction mixture to be 
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homogeneous at -78 'C (acetonitrile alone freezes at -45 'C) and catalyst (80) has 
produced one of the best ee values obtained in any epoxidation reaction mediated by 
iminium salts previously described by us or others (70 % ee, entry 10). Even when the 
catalyst loading is reduced to 2 mol % (entry 11) we are able to gain 25 % conversion 
(a better result than catalyst (16) with 10 mol % at -78 'c), and the ee remains 
consistent (70 %). 
With the co-solvent system the biphenyl catalyst (80) outperforms the 
dihydroisoquinolinium catalyst (16), which is still rather unreactive at -78 'C (entry 
15). The levels of enantioselectivity observed for catalyst (16) under the new 
anhydrous conditions do not exceed those obtained using the oxone, acetonitrile/water 
conditions, but in contrast it appears that the new experimental conditions enhance 
selectivity in the case of the biphenyl catalyst (80). Hence this catalyst was selected to 
screen a range ofunfunctionalized alkenes (Table 14). 
These olefins were not as reactive towards catalyst (80) as the previously tested 
substrate I-phenylcyclohexene (46), therefore the majority of reactions were carried 
out at -40 'C. Again, the dichloromethane/acetonitrile conditions produce the better 
results in terms of both enantiomeric excess and epoxide conversion, over the 
dichloromethane conditions. Triphenylethylene (98) was extremely unreactive when 
compared to all the other alkenes tested (entries 3, 4, 10 and 11). The best ee obtained 
was for I-phenyl-3,4-dihydronaphthalene (99) at -40'C In 
dichloromethane/acetonitrile which in three hours gave 100 % conversion and 65 % 
ee. This is even more remarkable when one considers that l-phenyl-3,4-
dihydronaphthalene (99) also gave the poorest result in dichloromethane (7 % ee). 
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Table 13: Catalytic asymmetric epoxidation of l-phenylcycIohexene (46) using TPPP and catalysts 
(16) and (80).a 
a Iminium salt (10 mol %) () TPPP (2 equiv) Solvent 
re (-)-18,28 
Entry Solvent Catalyst T'C t (min) Conv. (%)" ee (%t 
1 DCM 80 -78 120 52 50 
2 DCM 80 -60 120 50 36 
3 DCM 80 -40 90 100 28 
4 DCM 80 0 10 100 26 
5 DCM 80 40 <5 100 23 
6 DCM 16 -78 480 15 23 
7 DCM 16 -40 120 70 37 
8 DCM 16 0 10 100 16 
9 DCM 16 40 25 75 0 
10 DCM/MeCN 80 -78 240 80 70 
11 DCM I MeCN 80 -78 480 25 70d 
12 DCM/MeCN 80 -40 30 100 53 
13 DCM/MeCN 80 0 <5 100 51 
14 DCM/MeCN 80 40 <5 100 43 
15 DCM/MeCN 16 -78 480 35 45 
16 DCM/MeCN 16 -40 120 83 46 
17 DCM/MeCN 16 0 10 100 34 
18 DCM/MeCN 16 40 10 100 25 
19 MeCN IH20e 80 0 5 100 60 
20 MeCN IH2a' 16 0 10 51 41 
a Conditions: Iminium salt (10 mol %), TPPP (2 equiv.), Solvent, T 'C. b Conversion evaluated from the 
'H-NMR by integration alkene versus epoxide. ' Enantiomeric excess determined by 'H-NMR with (+)-
Eu(hfc), (0.1 mol eq) as chiral shift reagent.' 2 mol % catalyst. ' Conditions: Oxone (2 equiv), sodium 
carbonate (4 equiv), water/acetonitrile (I: I), 0 'C/ Isolated yield. 
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Overall, the differences in enantiomeric excess between the two solvent systems was 
not as vast as those observed in reactions with I-phenylcyclohexene (46). However 
the conversions to epoxide differed significantly; all the experiments recorded in 
dichloromethane required longer reaction times and in some cases still did not reach 
the level of conversion observed using the dichloromethane/acetonitrile system. 
Table 14: Catalytic asymmetric epoxidation of several alkenes mediated by catalyst (80)." 
Entry Alkene Solvent TOC t (h) Conv. ee Epoxide 
(%)b (%)" Config.d 
I Ph DCM -78 8 5 20 (-)-IS,2S ;=< 
2 97Ph CH3 DCM/MeCN -78 2 IS 44 (-)-IS,2S 
3 DCM --40 6 lOO 50 (-)-IS,2S 
4 DCMlMeCN --40 2 86 50 (-)-IS,2S 
5 Ph DCM -78 8 0 98P~Ph 6 DCMlMeCN -78 8 0 
7 DCM --40 2 7 47 (+)-S 
8 DCMlMeCN --40 I 30 29 (+)-S 
9 Ph DCM --40 4 lOO 39 (-)-IS,2S 
101pr 10 DCMlMeCN --40 2 lOO 33 (-)-IS,2S 
11 05 DCM --40 4 lOO 7 (-)-IS,2R 12 DCMlMeCN --40 3 lOO 65 (-)-IS,2R 99 .6 
"Conditions: Iminium salt (10 mol %), TPPP (2 equiv.), Solvent, T 'C. h Conversion evaluated from the 
'H-NMR by integration alkene versus epoxide. ' Enantiomeric excess determined by 'H-NMR with (+)-
Eu(hfc), (0.1 mol eq) as chiral shift reagent or by Chiral HPLC, on a Chiracel OD column. d The 
configuration of the major enantiomer was determined by correlation to the known epoxides. 
A temperature study was also carried out using dichloromethane as solvent and two 
molar equivalents of TPPP over a range of temperatures with the substituted 
dihydroisoquinolinium catalysts (SS), (56), (58), and (65), described above in section 
2.2. The results obtained are collected in Table IS. As it can be seen from the table, 
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again we observe that as the temperature of reaction decreases, the enantioselectivity 
increases significantly. Unfortunately at the same time the conversion decreases, 
probably due to a decrease in reaction rates with the temperature. 
The highest ee (50 %) was obtained when the reaction was carried out at -78°C (entry 
18). Under these conditions (using 10 mol % of catalyst), the conversion to epoxide is 
rather low (15 %). Surprisingly, the p-methoxyaryl catalyst (65) is not as selective as 
it is under the aqueous conditions, the best ee being only 29 % (45 % ee in the original 
aqueous conditions). 
We were also surprised to find that when the R group at C4 ofthe catalyst is electron-
withdrawing we observe a change in the configuration of the epoxide formed. 
The thiomethyl catalyst (56) gives the (+ )-IR,2R enantiomer of I-phenycyclohexene 
between temperatures of 0 °C and -50°C (Table 15, entries 3, 8, 12), but at -78°C 
the (-)-18,28 enantiomer is fonmed (Table 15, entry 18). This we believe is due to the 
sulfide being oxidized at temperatures above -78°C to the sulfone, therefore altering 
the electronic nature of the catalyst. Catalyst (65), which also has an electron-donating 
group at C4 (OMe), cannot be altered by the epoxidation conditions, and regardless of 
temperature produces the same enantiomer of epoxide. This perhaps indicates that at 
-78°C it is the un-oxidized sulfide group which is present as the active catalyst. 
X-ray structure analysis may offer one explanation as to why we observe the change 
in enantiomer of epoxide formed (Figure 9). A comparison of catalyst (16) and the 
sulfone catalyst (58) shows that in the case of(16) the iminium carbon sits above 0(1) 
and the re-face is blocked by the phenyl ring. In the case of the sulfone catalyst (58) 
the iminium carbon faces away from the dioxane ring and so the re-face is now open 
to attack from the oxidant, therefore producing the oppositely configured 
oxaziridinium. However, this may only be true in the solid state and cannot directly 
indicate what occurs in solution phase. 
lOO 
Table 15: Catalytic asymmetric epoxidation of I-phenycyclohexene using TPPP in CH,CI,." 
c5 
Entry Temp COc) 
1 0 
2 
3 
4 
5 
6 -30 
7 
8 
9 
10 
11 -45 
12 
13 
14 
15 
16 -78 
17 
18 
19 
20 
Iminium Salt (10 mol %) 
TPPP (2 equiv.) 
CH2CI2 TOC 
Catalyst Cony. (%)" 
16 R=H 100 
55 R=N02 100 
56 R=SMe 72 
58 R= S02Me 100 
65e R=OMe -
16 -
55 100 
56 92 
58 100 
65e 76 
16 70 
55 54 
56 67 
58 96 
65e -
16 15 
55 no rxn 
56 15 
58 no rxn 
65e 13 
ee (%)" Configuration" 
16 (-)-IS,2S 
25 (+)-IR,2R 
16 (+)-IR,2R 
33 (+)-IR,2R 
- -
-
-
28 (+)-IR,2R 
33 (+)-IR,2R 
36 (+)-IR,2R 
25 (+)-IR,2R 
31 (-)-IS,2S 
30 (+)-IR,2R 
33 (+)-IR,2R 
42 (+)-IR,2R 
- -
23g (-)-IS,2S 
-
-
5if (-)-IS,2S 
-
-
29g (+)-lR,2R 
"Conditions:lminium salt (10 mol %), TPPP (2 eq), DCM, T 'C, 4.0 h. b Conversion evaluated from the 
'H-NMR spectrum by integration of alkene versus epoxide. 'Enantiomeric excess determined by 'H-
NMR with (+)-Eu(hfc), (0.1 mol eq) as chiral shift reagent. "The absolute configuration of the major 
enantiomer was determined by comparison to those reported in the literature. ' Catalyst configuration 
(4R, 5R). f Reaction carried out at -40 ·C. K Reaction time 8 h. 
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16 58 
Figure 9: X-ray crystal structures of catalysts 16 and 58. 
To prove that the active catalyst at temperatures above -78°C was the oxidized 
sulfone a standard epoxidation reaction was performed in deuteriated dichloromethane 
and subjected to IH NMR spectroscopic analysis. We noticed that the chemical shift 
for the thiomethyl group shifted from 0 2.42 to 3.03, indicating that the sulfide had 
been oxidized to the sulfone (by comparison to authentic catalyst 58). This was an 
extremely rapid and exothermic process, and the sulfoxide intermediate was not 
observed. Further to this the pattern of the AA'BB' aromatic system was consistent 
with that of a sulfone, the chemical shifts being around 0 8.00. 
2.5.3.2 The effect of reaction solvent. 
To determine if the electronic effect could enhance enantiomeric excess, in the 
epoxidation reaction several other solvents were screened, using our three most 
effective dihydroisoquinolinium salt catalysts (16), (58) and (65) (Table 16). TPPP 
was found to be insoluble in carbon tetrachloride, ethyl acetate and dimethoxyethane. 
In dimethylformamide the TPPP dissolved but no reaction occurred when employing 
catalyst (16). However, TPPP was soluble in 1,2-dichloroethane, and epoxidation 
reactions performed in this solvent gave almost identical results to those obtained with 
dichloromethane for catalysts (58) and (65) (Table 16, entries 3). Catalyst (16) was far 
less reactive in this medium (compared to the corresponding reaction in 
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dichloromethane, 70 % conversion to 29 % after 4 h) and gave a lower ee (24 % 
compared to 37 %), When the reactions were repeated in chloroform (Table 16, 
entries 4) we observed a dramatic decrease in ee for catalyst (65), catalyst (16) giving 
similar results to those obtained in dichloromethane (33 % ee). Catalyst (58) in 
chloroform, however, gave the best ee for I-phenylcyclohexene oxide (20) that we 
have observed with this set of iminium salt catalysts, Interestingly, in acetonitrile the 
change in major epoxide enantiomer formed did not occur with catalyst (58), and at 
-30°C we observe a similar degree of selectivity to that of the reaction carried out in 
chloroform (48 % ee, (+)-(lR2R) enantiomer) producing in acetonitrile, H-(lS2S)-
phenycyclohexene oxide with 45 % ee, 
Table 16: Asymmetric epoxidation of I-phenylcyclohexene using various solvents," 
Entry Solvent Catalyst 
(16) (58) (65) 
. 
R=H R= S02Me R= OMe b 
In all cases: ee (%t / Conv, (%)d / time (h) / 
Config: 
I CH)CN 43J, 42, 1,0 h, 45, 89, 2.5 h, 44, 30, 0.2 h, 
H-IS,2S H-IS,2S (+)-IR,2R 
2 CH2Cb 37,70,4 h, 36, 100,4 h, 25,76,4 h, 
H-IS,2S (+)-IR,2R (+)-IR,2R 
3 C2H4Ch 24,29,24 h, 32,97,4 h, 17,87,24 h, 
H-IS,2S (+)-IR,2R (+)-IR,2R 
4 CHCh 33,52,24 h, 48, lOO, 12 h, 11, 73, 24h, 
H-IS,2S (+)-IR,2R (+)-IR,2R 
"Epoxidation conditions:lminium salt (10 mol %), TPPP (2 eq), solvent, -30°C T 0c, b Catalyst 
configuration (4R,SR). 'Enantiomeric excess determined by lH·NMR with (+)·Eu(hfc), (0.1 mol eq) as 
chiral shift reagent. d Conversion evaluated from the lH_NMR by integration alkene versus epoxide. ' 
The absolute configuration of the major enantiomer was determined by comparison to those reported in 
the literature. f Reaction carried out at - 40 'C. 
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The substituted dibenzo[c,e ]azepinium salts (80), (81), (82), and (83) were also tested, 
using the optimum conditions established from Table 4, at a temperature of -40 QC 
(Table 17). Under these conditions, acetonitrile appears to be the solvent of choice, 
with the p-methoxyaryl catalyst (83) producing I-phenylcyciohexene oxide (20) in 73 
% ee. However, catalyst (82) was not as effective as the corresponding 
dihydroisoquinolinium salt (58), in either of the solvents. Interestingly no asymmetric 
induction was observed in chloroform, previously our most effective reaction solvent. 
Epoxidation of other substrates using catalyst (80) in acetonitrile has been previously 
reported by other members of the Page group,4) and generally the ees are 
disappointing, with triphenylethylene (98) and I-phenylcyclohexene (46) being the 
best substrates (60 and 67 % ee respectively). 
Table 17: Catalytic asymmetric epoxidation of I-pheny\cyclohexene using the 
dibenzo[c,e]azepinium salts and TPPP," 
Catalyst Solvent Conversion (%)" Ee(%t Configurationa 
80 CH)CN''' 100 67 (-)-( 1 S,2.5) 
R=H CHCh 84 19 (-)-( 1 S,2.5) 
81 CH)CN 100 38 (-)-( 1 S,2.5) 
R=N02 CHCh no rxn - -
(82) CH)CN 100 40 (-)-( 1 S,2.5) 
R=S02Me CHCh 75 0 -
(83) CH)CN 100 73 (+ )-( 1 R,2R) 
R=OMee CHCh 57 5 (+)-(1 R,2R) 
a Epoxidation conditions:lminium salt (10 mol %), TPPP (2 eq), solvent, -40 QC T ·C. h Conversion 
evaluated from the 'H-NMR by integration alkene versus epoxide, numbers in brackets represent 
isolated yield. C Enantiomeric excess detenmined by 'H-NMR with (+)-Eu(hfc)J (0.1 mol eq) as chiral 
shift reagent. d The absolute configuration of the major enantiomer was determined by comparison to 
those reported in the literature.' Catalyst configuration (4R,SR). 
As previously found under the aqueous oxone conditions, the enantioselectivity of the 
dibenzo[c,e ]azepinium salt catalysts is quite substrate dependent. The corresponding 
dihydroisoquinolinium salts; however, show less substrate dependency and, further to 
the interesting phenomena observed with these catalysts, we wanted to see whether 
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the change in major enantiomer formed is observed in the epoxidation of alkenes other 
than l-phenylcycIohexene (46). Using the most selective dihydroisoquinolinium 
catalyst (58) from the above study, in acetonitrile and choloroform we were able to 
epoxidize several unfunctionalized alkenes (Table 18). Reactions were carried out at 
a temperature of -40 QC, with 10 mol % of the catalyst. 
Again, we observed the switch in major enantiomer on changing the reaction solvent, 
and the catalyst appeared less-substrate dependent than the corresponding 
dibenzo[ c, e ]azepinium salts. 
Table 18: Catalytic asymmetric epoxidation of various alkenes using TPPP and catalyst 58.a 
Solvent 
Alkene 
Ph 
460 
Ph 
101pr 
Ph 
97 prCH, 
Ph 
98prPh 
cO 99 1 -<' 
Iminium Salt (10 mol %) 
TPPP (2 equiv.) 
Solvent 
-40·C 
CH,CN 
Yield ee 
(%j' (%)' 
73 45 
13' 30 
42 48 
25 27 
56 38 
CHCI, 
Con£." Yield ee Conf." 
(%)' (%)' 
H-IS,2S 77 48 (+)-IR,2R 
(-)-S,S 31 67 (+)-R,R 
(-)-IS,2R 35 2 (+)-IR,2S 
(+)-S 11' 63 H-R 
(-)-IS,2R 98 59 (+)-IR,2S 
a Epoxidation conditions: Iminium salt (10 mol %), TPPP (2 eq), Solvent, --40 ·C, 24 h. b Isolated 
yield, 'Enantiomeric excess determined by 'H-NMR with (+)-Eu(hfc), (0.1 mol eq) as chiral shift 
reagent or by Chiral HPLC on a Chiracel OD column. d The absolute configuration of the major 
enantiomer was determined by comparison to those reported in the literature. ' Conversion evaluated 
from the 'H-NMR by integration alkene versus epoxide. 
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However, enantioselectivies were dramatically increased in chloroform (apart from 
the anomalous reaction with a-methyl-stilbene 97), when compared to those achieved 
in acetonitrile. We found that trans-stilbene (101), usually a poor substrate with our 
catalysts, is epoxidized with 67 % ee in chloroform, whereas the corresponding 
reaction, performed in acetonitrile only affords trans-stilbene oxide (75) with 30 % ee. 
Further to this work, a range of unfunctionalized cis-alkenes was subjected to the 
reaction conditions (Table 19). Interestingly, we found that no change in configuration 
of epoxide occurred with this type of substrate. However, the general trend of 
increased enantiomeric excess in chloroform over acetonitrile was still present. 1,2-
Dihydronaphthylene (103) was epoxidized with 82 % ee in 89 % yield when 
chloroform was employed as the reaction solvent. Good ees for the epoxidation of cis-
,B-methylstyrene (111) and indene (112) were also observed (70 % ee and 61 % ee 
respectively). Asymmetric epoxidation of the non-aryl substrate (113) did not occur 
with any selectivity, giving rise to racemic product. 
Table 19: Catalytic asymmetric epoxidation of various eis-alkenes using TPPP and catalyst SS." 
Solvent MeCN CHCI3 
Alkene T Yield ee Conf.a T Yield ee Conf.a 
(h) (%)b (%)C (h) (%/ (%/ 
111 CJI 24 71 53 (+)-IS,2R 24 85 70 (+)-lS,2R 
103 CO 16 80 56 (-)-IS,2R 17 89 82 (-)-lS,2R 
112 CO - - - - 24 83 61 (+)-IS,2R 
113 ~ - - - - 24 lOO' 0 -
"Epoxidation conditions: Iminium salt (10 mol %), TPPP (2 eq). Solvent, -40 ·C. b Isolated yield. ' 
Enantiomeric excess determined by 'H-NMR with (+)-Eu(hfc), (0.1 mol eq) as chiral shift reagent. d 
The absolute configuration of the major enantiomer was determined by comparison to those reported in 
the literature. 'Conversion evaluated from the 'H-NMR by integration alkene versus epoxide. 
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The asymmetric epoxidation of cis-alkenes is particularly important when one 
considers the importance of some of the biologically active compounds that ring-
opening of the oxirane moiety can give. Cromakalim (114),44 a anti-hypertensive 
agent, is just one of the compounds available from ring opening of the epoxide 
functionality, and was traditionally synthesized in enantiomerically pure form by 
resolution,45 until Jacobsen's chiral salen complexes became available.46 It has been 
found that the main biological activity resides in the leavorotatory enantiomer 
(levcromakalim), while the dextrorotatory compound exhibits no significant activity.45 
The powerful cyano electron withdrawing group at C6 of the benzopyran system was 
found to be essential for good blood pressure-lowering activity.45 Several other 
research groups have reported the enantiopure synthesis of levcromakalims precursor 
(115).47 However, Shi's fructose-derived ketone catalyst produces the inactive 
dextrorotatory enantiomer.48 
~O 
NC'CQ:""OH Ib 
o 
NeW-
114 115 
Oxidized benzopyrans are also postulated to be the bioactivated intermediates 
responsible for the cytotoxic activity of the precocenes (benzopyrans) in insects and in 
mammalian tissues.46 Cyano-benzopyran (116) was prepared using North's method,49 
in one step from 4-cyanophenol (117) and 1, I-diethoxy-3-methyl-2-butene (118), 
which in turn was synthesized from 3-methyl-2-butanal (119) (Scheme 47),50 
Epoxidations of (116) using catalyst (58) in both acetonitrile and chloroform produced 
the desired (-)-3S,4S enantiomer of (115) in good to excellent enantiomeric exceses 
(Table 20). In acetonitrile the epoxide was formed with 80 % ee, and 63 % yield, but, 
in chloroform the epoxide was formed with 97 % ee in 59 % yield. 
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NCU E'Oli NC'CQ-+ • I 
d OH d 0 
117 118 116 
I iii
~~ 0 ii H~ 
119 
Reagents and Conditions: i: 3-picoline (0.25 equiv.),p-xylene, 110-120 'C, 24 h, 63 %; ii: PDC:DCM, 
r.t. 6 h, 82 %; iii: CH(OEt)J, KHS04, EtOH, 0 'C-r.t, 2 h, 74 %. 
Scheme 47: Fonnation ofthe benzopyran 116 using North's method. 
Table 20: Highly enantioselective epoxidation ofbenzopyran 116 using catalyst 58 and TPPP," 
CHJCN CHCIJ 
Alkene Time Yield ee Conf." Time Yield ee Conf." 
(h) (%)b (%)' (h) (%)' (%)' 
NC'C(k- 24 63 80 (-)-3S,4S 24 59 97 (-)-3S,4S 
1& 
116 0 
a Epoxidation conditions:Iminium salt (10 mol %), TPPP (2 eq), Solvent, -40 ·C. b Isolated yield. ' 
Enantiomeric excess determined by Chiral HPLC on a Chiracel OD column. d The absolute 
configuration of the major enantiomer was determined by comparison to those reported in the literature. 
Treatment of compound (115) with pyrrolidone and sodium hydride afforded 
levcromakalim (114) in 52 yield (Scheme 48). 
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NC'CQ=""OH 
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o 
NC'Cq-,J? 
'-':: -
1-9 
. 0 
115 114 
Reagents and Conditions: i: Pyrrolidin-2-one, NaH, DMSO, r.t. 6 h, 52 %. 
Scheme 48: Ring opening of the epoxide to form the anti-hypertensive agent Levcromakalim. 
Efficient asymmetric epoxidation of terminal alkenes remains a challenging problem. 
A range of unfunctionalized terminal olefins were screened under our optimum 
conditions. 
Table 21: Epoxidation of terminal alkenes using catalyst 58 under non-aqueous TPPP conditions." 
Alkene Solvent Time (h) Yield (%)" ee (%) ConfigurationC 
V 120 I .& CHCl) 24 73 18a (+)-s 
Cl CHCh 24 0 - -60 121 .& 
~ CHCh 24 58 13e (+)-s 100Ph .& 
"Epoxidation conditions:lminium salt (IO mol %), TPPP (2 eq), Solvent, -40 ·C. b Isolated yield. 'The 
absolute configuration of the major enantiomer was determined by comparison to those reported in the 
literature. dEnantiomeric excess determined by 'H-NMR with (+)-Eu(hfch (0.1 mol eq) as chiral shift 
reagent. 'Enantiomeric excess determined by Chiral HPLC on a Chiracel OD column. 
Disappointingly, enantiomeric excesses were low. However, Shi has recently reported 
the highly enantioselective oxidation of a range of 2,2-disubstituted vinylsilanes, 
which on treatment with TBAF afford terminal epoxides with high ee.51 Due to the 
ability of catalyst (58) to afford good to excellent ees for eis-alkenes, epoxidation of 
the eis-vinyl silane (122) was attempted (Scheme 49). Reduction of the commercially 
available corresponding alkyne (123) was achieved using DIBAL in 90 % yield.52 
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Subsequent epoxidation at -40 QC in chloroform using catalyst (58) and TPPP did not 
afford the desired epoxide (124); in fact no reaction had occurred after 24 hours. Even 
when carrying the reaction out at elevated temperatures (0 QC - reflux at ca. 80 QC) no 
reaction occurred. 
DIBAL-H m!- Catalyst 58 01 (10 mol %), X I A -Si-I TPPP (2 eq) I CHCI3 
122 124 123 
TBAF 
.-- - - - - - - - - -- -- -- v< 
125 
Scheme 49: Attempted fonnation of styrene oxide 125 from the vinyl sitane 122. 
2.5.4 Epoxidations using the binaphthalene catalyst (93). 
Following the success of binaphthalene catalyst (93) under the aqueous oxone 
conditions, described in section 2.4, we decided to test the catalyst with TPPP as the 
stoichieometric oxidant (Table 22). Several substrates were epoxidized, using 
acetonitrile as solvent at -40 QC, and we observed a similar level of selectivity to those 
reactions carried out under the aqueous oxone conditions. The ee for a-methylstilbene 
oxide (18) is slightly increased under these conditions (61 % ee compared to 49 % ee 
under the oxone system). 
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Table 22: Epoxidation of several unfunctionalized alkenes using catalyst 93 and TPPP." 
Alkene Time (h) Yield (%)" ee(%t Conf.a 
crPh 14 77 39 (-)-IS,2S 109 
()Ph 7 (18)e 81 (67)e 89 (82)e (-)-IS,2S 
46 
OPh 14 74 77 (-)-IS,2S 
110 
101Ph~Ph 24 45 11 (-)-S,S 
Ph~Ph 24 66 61 (-)IS,2S 
97 Me 
Ph~Ph 24 26 0 -
98 Ph 
a Epoxidation conditions:Iminium salt 93 (10 mol %), TPPP (2 eq), MeCN, -40 ·C. b Isolated yield. ' 
Enantiomeric excess determined by 'H-NMR with (+)-Eu(hfc), (0.1 mol eq) as chiral shift reagent. d 
The absolute configuration of the major enantiomer was determined by comparison to those reported in 
the literature. 'Numbers in brackets refer to the corresponding reaction carried out in chloroform. 
The reaction remained highly enantioselective when using chloroform as the reaction 
solvent. I-Phenylcyclohexene is epoxidized with 89 % ee in acetonitrile and 82 % ee 
with chloroform. This is in contrast to the corresponding dihydroisoquinolinium (16) 
and dibenzo[c,e]azepinium salts (80). which give poorer enantioselectivities in 
chloroform. Catalyst (16) gives I-phenylcyclohexene oxide (20) in 43 % ee in 
acetonitrile and 33 % ee in chloroform, and catalyst (80) gives I-phenylcyclohexene 
oxide (20) with 67 % ee in acetonitrile and only 19 % ee in chloroform. 
2.6 Conclusion 
Through this research project we have developed a number of new iminium salt 
catalysts based around a 1,3-dioxane unit. These have incorporated different aryl 
groups in the C4 position, and we have shown that catalysts bearing biphenyl and 
binaphthalene backbones can also be, effective mediators in the asymmetric 
epoxidation of unfunctionalized alkenes. 
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Of the systems tested, two catalysts have been developed which have provided 
epoxides with excellent enantioselectivity. The binaphthalene derived catalyst (93) 
gave up to 95 % ee and catalyst loadings as low as 0.1 mol %. 
58 93 
The development of the anhydrous TPPP conditions has allowed us to perform 
reactions at low temperature, and this has resulted in the highest ever reported ee for 
iminium salt mediated epoxidation. Catalyst (58) provided levcromakalims precursor 
(115) in up to 97 % ee, and the enantiopure synthesis of the anti-hypertensive agent 
levcromakalim (114) was achieved. 
NC'CQ-"'" 
1.0 
o 
Iminum salt 58 NC'Cq-",'9 
(10 mol %), • 1 "'" . 
.0 TPPP (2 eq), 0 
CHCI3, -40 'c 
~o 
Pyrrolidin-2-one, NC~'OH 
NaH, DMF, 1 "'" ' 
r.t. 4 h, 52 % .0 0 
116 115 114 
With the development of iminium salt catalysts that give high enantioselectivity, we 
hope that iminium salt mediated asymmetric epoxidation can now be considered as a 
viable method for the formation of enantiomerically enriched epoxides. 
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2.7 Future Work 
One could envisage a wide range of new catalyst structures which may give rise to 
higher enantioselectivity in the asymmetric epoxidation of alkenes. Those depicted in 
in the following schemes are thought to be the most promising. Catalysts of the type 
(125) are thought to benefit from added control of the incoming substrate by having 
methyl groups in the C6 position of the 1,3-dioxane ring. This type of catalyst could 
be synthesized in a similar manner to those reported in section 2.2, with addition of 
methylmagnesium bromide to the ester (126) to give compound (127). 
ArU1rHN'p Ar~HN,P 
"" I 0 MeMgBr "'" I 
._------- .,,',' 
p~ ~Me pA OH 
126 127 
A similar system could also be developed with the bromo aldehyde (128), with 
similarities to Bohe's achiral catalyst described in chapter one. 
Br 
Br2. Cyclohexane. 
---------------
II 07 
o 
128 
----------------
Modifications to the binaphthalene system could also be achieved by addition of 
groups to the 3,3'-positions (129), as in Yang's dioxirane catalyst (chapter one). 
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Further catalyst developments should preferably be made after computational studies 
have been carried out with our current range of catalysts. This may help in the 
elucidation of a transition state model which can account for the range 
enantioselectivities we have observed, not only in the new anhydrous TPPP conditions 
but also under the original Oxone, water/acetonitrile system. 
Greater understanding of the transition state for the transfer of oxygen from the 
catalyst to the substrate could therefore lead to the synthesis of new catalysts which 
are less substrate dependent than the current range of catalysts described in this thesis. 
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Chapter Three 
Experimental 
3.0 Experimental 
3.1 General experimental 
All infrared spectra were obtained using a Perkin·Elmer Paragon 1000 FT·IR 
spectrophotometer; thin film spectra were acquired using sodium chloride plates. 
All iH and I3C NMR spectra were measured at 250.13 and 62.S6 MHz using a Bruker 
AC 250 MHz spectrometer or at 400.13 and 100.62 MHz using a Bruker DPX 400 
MHz spectrometer. The solvent used for NMR spectroscopy was CDCb (unless 
stated otherwise) using TMS (tetramethylsilane) as the internal reference. Chemical 
shifts are given in parts per million (ppm) and J values are given in Hertz (Hz). 
The mass spectra were recorded using a Jeol-SXI02 instrument utilising electron 
impact (E.!.), fast atom bombardment (F.A.B.) and by the EPSRC national mass 
spectrometry service at the University of Wales, Swansea, utilising electrospray (ES.). 
Analysis by GCMS utilised a Fisons GC SOOO series (AS SOO), using a 15 m x 0.25 
mm DB-5 column and an electron impact low resolution mass spectrometer. 
Melting points were recorded using an Electrothermal-IA 9100 melting point 
instrument and are uncorrected. 
Optical rotation values were measured with an Optical Activity-polAAar 200 I 
instrument, operating at A=5S9 nm, corresponding to the sodium line, (D), at the 
temperatures indicated. The solvents used for these measurements were of 
spectrophotometric grade. The solutions for these measurements were prepared in 
volumetric flasks for maximum accuracy of the volume of solvent used. 
Microanalyses were performed on a Perkin Elmer Elemental Analyser 2400 CRN. 
All chromatographic manipulations used silica gel as the adsorbent. Reactions were 
monitored using thin layer chromatography (TLC) on aluminium backed plates with 
Merck Kiesel 60 F254 silica gel. TLC visualised by UV radiation at a wavelength of 
254 nm, or stained by exposure to an ethanolic solution of phosphomolybdic acid 
lIS 
(acidified with concentrated sulphuric acid), followed by charring where appropriate. 
Purification by column chromatography used Merck Kiesel 60 H silica adsorbent. 
The reactions requiring anhydrous conditions were carried out using glassware dried 
overnight at ISO °C, under a nitrogen atmosphere unless otherwise stated. Reaction 
solvents were obtained commercially dry, except light petroleum (b.p. 40-60 0c) 
which was distilled from calcium chloride prior to use. Ethyl acetate was distilled over 
calcium sulphate or chloride. Dichloromethane was distilled over calcium hydride. 
Tetrahydrofuran (THF), was distilled under a nitrogen atmosphere from the 
sodiumlbenzophenone ketyl radical or from lithium aluminium hydride. 
All N-protected amino acids were either purchased commercially or produced from 
known literature procedures.1,2 
Enantiomeric excesses were determined by either proton nuclear magnetic resonance 
eH-NMR), or by Chiral High Performance Liquid Chromatography, (Chiral HPLC). 
The proton nuclear magnetic resonance spectra were recorded in deuterated 
chloroform on a Bruker AC 250, operating at 250.13 MHz, in the presence of 
europium (III) tris [3-(hepta-fluropropylhydroxymethylene )-( + )-camphorate], [( +)-
Eu(hfc)3], as the chiral shift reagent and tetramethylsiIane as the internal standard. 
The chiral column used for the determination of enantiomeric excesses (ee), of non-
racemic mixtures by chiral HPLC, was Chirace\ OD on a TSP Thermo-Separating-
Products Spectra Series P200 instrument, with TSP Spectra Series DVI 00 ultra-violet 
absorption detector set at 254 nm and a Chromojet integrator. Both solvents used to 
gain measurements (hexane and isopropanol), were of HPLC grade. 
3.2 Numbering systems. 
The assignments of the proton and carbon-I 3 resonances have been made according to 
numbering systems (Figure I). Some of these systems used are standard chemical 
nomenclature while others were introduced arbitrarily by the present author. In the 
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latter case, the introduced system was based on the structural resemblance of the 
compounds with others that possessed a formal system. 
Aromatic systems are numbered according to the standard protocol. Aromatic carbon 
atoms bearing a substituent are always quaternary (C quat., arom.). All aromatic 
carbon atoms which are attached to a hydrogen atom are termed C arom. (IlC spectra) 
or CH arom. C'H spectra). The dihydroisoquinolinium nucleus is numbered according 
to a standard system but the carbon atoms of this moiety are termed isoq. Except for 
those in the dimethylene part which are designated Ar-CH2 and CH2N in the 
assignment. The biphenyl system is also numbered and carbon atoms of this moiety 
are termed biphenyl. The binapthylene nucleus is numbered, with the carbon atoms 
termed binap. 
4' 
biphenyl-5' /" ~ 3' 
11 I 
6· ........ ~2· ....... R ,. 
! R 6--? ........ 2 ...... 
I 11 
5~,.......3 
4 
Figure 1: Numbering systems employed in the experimental procedures. 
N-protected amino acid derivatives are numbered with the carboxylic acid carbon first 
as in the example given in Figure 2. The protecting group will be referred to by its 
abbreviation. The 1 ,3-dioxane nucleus is numbered according to the standard protocol 
as are the 5-membered oxazolidines, with substituents off the ring being numbered in 
order. 
Figure 2: Numbering system employed for amino acid derivatives. 
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3.3 Individual experimental procedures and characterisation 
(lR,2R)-[2-Hydroxy-l-hydroxymethyl-propyl]-carbamic acid benzyl ester (28): 
o 
H~)lO~ 
,." .. (j(0H V 
OH 0 
26 28 
To a cooled (-IS QC) solution of (2S,3R)-2-benzyloxycarbonylamino-3-hydroxy-
butyric acid (26) (5.00 g, 19.8 mmol) in 1,2-dimethoxyethane (20 ml) were 
successively added N-methyl morpholine (2.20 ml, 19.8 mmol) and isobutyl 
chloroformate (2.50 ml, 19.8 mmol). After I min the white precipitate was removed 
by filtration, washed with 1,2-dimethoxyethane (2 x 5 ml) and the filtrate placed in a 
flask and cooled in a ice/salt bath. A solution of NaBH4 (1.13 g, 29.6 mmol) in H20 
(50 ml) was added in one portion producing a strong evolution of gas. After the 
evolution subsided H20 (250 ml) was added. The reaction mixture was then extracted 
with ethyl acetate (3 x 75 ml). The orgaoic layers washed with brine (2 x 50 ml), dried 
(MgS04) and solvents removed under reduced pressure to give a colourless oil (3.30 
g, 70%), [aID -15.0 (c 1.12, CHCh); Vmax (film) /cm· l 3334, 2971, 2360, 1698, 1522, 
1456, 1251, 1069; OH (250 MHz; CDCh) 1.20 (3 H, d, J 6.4 Hz, CH], C4), 2.74 (2 H, 
bs,2 x OH), 3.57 (I H, m, CH, C3), 3.81 (2 H, bs, CH2, Cl), 4.12 (I H, m, NCH, C2), 
5.11 (2 H, s, N-Cbz CH2), 5.54 (I H d, J 8.6 Hz, NH), 7.35 (5 H, m, 5 x CH arom., Ph 
gp.); Oc (lOO MHz; CDCh) 20.22 (CH], C4), 56.33 (NCH, C2), 64.38 (CH2, N-Cbz 
CH2), 66.98 (CH2, Cl), 128.19 (CH arom., para in Ph gp.), 128.19 (2 x CH arom., 
ortho in Ph gp.), 128.55 (2 x CH arom., meta in Ph gp.), 136.31 (C quat. arom., ipso 
in Ph gp.), 157.18 (C quat. N-Cbz C=O); mlz 239.1152; C12HI7N04 (M+) requires 
239.1158. 
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(lR,2R)-(2,2,4-Trimethyl-[1,3Jdioxan-S-yl)-carbamic acid benzyl ester (29): 
28 
o )l N-CbzCHz 
H~N.Cb~~ 
9,_, ........ 5........ :,,0 V 
'4 6 
I I 
0, ... 0 
2 
/\ 
8 7 
29 
[(lR,2R)-2-Hydroxy-l-hydroxymethyl-propyl]-carbamic acid benzyl ester (28) (0.20 
g, 0.87 mmol), was dissolved in acetone (20.0 ml) and 2,2-dimethoxypropane (1.10 
ml, 8.70 mmol). A catalytic amount of p-toluene sulphonic acid (10 mol%, 0.016 g, 
0.09 mmol) was added and the reaction left to stir overnight at room temperature. The 
solvent was evaporated under reduced pressure. The residue which remained was 
dissolved in ethyl acetate, washed with sodium hydrogen carbonate (50%)(2 x 20 ml) 
and brine (2 x 20 ml). The organic layers were combined, dried (Mg2S04) and solvent 
removed under reduced pressure to yield a colourless oil (0.24 g, 85%), [aID -8.2 (c 
1.04, CHCh); Found: C, 64.27; H, 7.46; 4.61. C1sH21N04 requires C, 64.50; H, 7.58; 
N, 5.01.; Vmax (film) fem,l 2360, 1716, 1505, 1455, 1381; OH (400 MHz; CDCh) 1.60 
(3 H, d, J 6.3 Hz, CH3, C9), 1.40 (3 H, s, CH3, C7), 1.48 (3 H, s, CH3, C8), 3.53 (1 H, 
dq, J9.8, 1.9 Hz, NCH, C5), 3.78 (I H, dd, J12.0, 1.8 Hz, upfield portion of an ABX 
system, N-CHCHH-O, C6), 4.09 (1 H, dd, J 12.0, 2.0 Hz, downfield portion of an 
ABX system, N-CHCHH-O, C6), 4.15 (1 H, ddd, J 6.3, 1.9, CH, C4), 5.16 (2 H, s, N-
Cbz CH2), 5.58 (1 H, d, J9.8 Hz, NH), 7.37 (5 H, m, 5 x CH arom., Ph gp.); Oe (100 
MHz; CDCI3) 18.17 (CH3, C9), 18.95 (CH3, C7), 30.06 (CH), C8), 49.98 (NCH, C5), 
65.34 (N-Cbz CH2), 67.24 (CH2, C6), 67.39 (CH, C4), 99.41 (C quat., C2), 127.32 
(CH arom., para in Ph gp.), 128.53 (2 x CH arom., ortho in Ph gp.), 128.87 (2 x CH 
arom. meta in Ph gp.), 136.86 (C quat. arom. ipso in Ph gp.), 156.82 (C quat., N-Cbz 
C=O); mlz 279.1471; CIsHzIN04 (M+) requires 279.1471. 
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(lR,2R)-2,2,4-Trimethyl-[1,3)dioxan-5-yl-amine (30): 
t:!H2 
9" ..... 5 ..... 
"4' .... 6 
I I 
0, .... 0 
2 
/\ 
a 7 
30 
(IR,2R)-(2,2,4-Trimethyl-[1,3)dioxan-5-yl)-carbamic acid benzyl ester (30) (1.30 g, 
4.7 mmol) was dissolved in ethanol and placed in a three necked round bottom flask 
charged with palladium (10% on carbon) (0.1 0 g) under an atmosphere of hydrogen 
(ballon). The reaction was stirred at room temperature for 12 h. The solution was 
filtered through a pad of celite and the ethanol removed under reduced pressure to 
yield a colourless oil (0.61 g, 90%), [aID -26.7 (c 1.05, CHCh); OH (250 MHz; 
CDCh) 1.16 (3 H, d, J 6.4 Hz, CH), C9), 1.41 (3 H, s, CH), C7), 1.46 (3 H, s, CH), 
CS), 1.60 (2 H, bs, NH2), 2.42 (1 H, q, J 4.0,2.0 Hz, NCH, C5), 3.72 (l H, dd, J II.S, 
2.0 Hz, upfield portion of an ABX system, N-CHCHH-O, C6), 4.11 (I H, dd, J II.S, 
2.0 Hz, downfield portion of an ABX system, N-CHCHH-O, C6), 4.09 (I H, m, CH, 
C4); Oc (100 MHz; CDCl)) IS.34 (CB), C7), 19.02 (CB), C9), 30.11 (CB3, CS), 49.23 
(NCB, C5), 67.3S (CB2, C6), 6S.01 (CB, C4), 99.11 (C quat., C2). 
General procedure for the formation of Weinreb amides from amino acid 
derivatives: 
The amino acid derivative (1.0 equiv.) was dissolved in dichloromethane (20 ml/g) 
and cooled to -15°C, followed by addition of N,O-dimethylhydroxylamine 
hydrochloride (1.02 equiv.) and N-methylmorpholine (1.02 equiv.). N-(3-
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dimethylaminopropyl)-N'-ethylcarbodiimide hydrochloride (1.02 equiv.) was then 
added portionwise as a solid over 30 min. The reaction was stirred for I h at -15°C 
and ice cold aq. hydrochloric acid (1 M) (3 mlfg) was added. The aqueous layer was 
extracted with dichloromethane (10 mUg) and the combined organic layers washed 
with sat. aq. sodium hydrogen carbonate solution (3 mUg). The organic layer was 
dried (MgS04), filtered and the solvent removed under reduced pressure. 
(5')- [2-Hydroxy-l-(methoxy-methyl-carbamoyl)-ethy I)-carbamic acid tert-butyl 
ester (34): 
32 34 
Prepared according to the general procedure from N-Boc-L-serine (32) (5.00 g, 24.4 
mmol). Colourless solid (5.4 g, 89%); m.p. 116-117 °C (lit.) mp 118-119 0C); [ajD20 
+3.8 (c 1.04, CHCi) [Lit.) [ajD -1.4 (c 2.6, CHCh for D-enantiomerj; Found: C, 
48.55; H, 8.12; N, 11.24. CIOH20N20S requires C, 48.36; H, 8.12; N, 11.29.; vmax(film) 
fcm'! 3467, 1702, 1646, 1458, 1377, 1180; OH (250 MHz; CDCh) 1.45 (9 H, s, 
(CH)))C), 3.23 (3 H, s, NCH), 3.77 (3 H, s, OCH), 3.82 (2 H, d, J2.0 Hz, CH20H, 
C3), 4.72-4.86 (l H, m, NCH, C2), 5.65 (l H, s, NH); oe (100 MHz; CDCh) 28.4 (3 x 
CH), (CH))C), 32.2 (NCH), 52.6 (NCH, C2), 61.7 (OCH) CI4), 63.4 (CH20H, C3), 
80.0 (C quat., (CH)))C), 155.8 (C quat., N-Boc C=O), 171.1 (C quat., C=O, Cl); mlz 
249.1451; CroH2oN20 s (M+H) requires 249.1451. 
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(2R,3S)-[2-Hydroxy-l-(methoxy-methyl-carbamoyl)-propylj-carbamic acid tert-
butyl ester (34a): 
34a 
Prepared according to the general procedure from N-Boc-L-threonine (5.00 g, 22.4 
rnmol). Colourless solid (5.70 g, 93%), m.p. 66-67 QC; [afoD -11.6 (c 1.07, CHCh); 
[lit.4 [a]2oD -9.8 (c 1.40, CHCh)]; vmax(film) fcm- l 3391, 1704, 1647, 1463, 1377, 
1184; OH (250 MHz; CDCh) 1.22 (3 H, d J 6.35, CH3, C4), 1.45 (9 H, s, (CH3)JC), 
2.90 (3 H, s, NCH3), 3.24 (3 H, s, OCH3), 4.08 (1 H, ddd, J2.1, 6.4 Hz, CH, C2), 4.65 
(1 H, d, J 7.6 Hz, CH, C3), 5.44 (1 H, d, J 9.1 Hz NH); Oe (lOO MHz; CDCh) 19.3 
(Cl'h, C4), 28.3 «CH3)JC), 31.2 (NCH3) 54.1 (CH, C2), 61.7 (OCH3), 67.7 (CH, C3), 
79.8 (C quat., (CH3)JC), 156.1 (C quat., N-Boc C~O), 172.2 (C quat., C=O, Cl); mlz 
263.1607; CllH22N20S (M+H) requires 263.1602. 
(S)-[2-Hydroxy-l-(methoxy-methyl-carbamoyl)-ethylj-carbamic acid benzyl ester 
(34b): 
34b 
Prepared according to the general procedure from N-Cbz-L-serine (5.00 g, 22.4 
mmol). Pale yellow oil (5.60 g, 89%); [a]D20 +5.4 (c 1.04, CHCh); vmax(film) fcm- l 
3398,1715,1652,1456,1377,1178; OH (250 MHz; CDCh) 3.22 (3 H, s, NCH 
3),3.77 (3 H, S, OCH3), 3.84 (2 H, d, J 4.4 Hz, CH20H, C3), 4.80-4.90 (1 H, m, NCH, 
125 
C2), 5.16 (2 H, s, CH2, N-Cbz CH2), 5,96 (1 H, d, J 8.2 Hz, NH), 7.32 (5 H, 5 x CH 
arom., Ph gp.); oe (100 MHz; CDCh) 32.15 (NCH3), 52.90 (CH, C2), 61.60 (OCH3), 
63.43 (CH20H, C3), 67.08 (CH2, N-Cbz CH2), 128.08 (2 x CH arom., artha in Ph 
gp.), 128.18 (2 x CH arom., meta in Ph gp.), 128.53 (CH arom., para in Ph gp.), 
136.22 (C quat. arom., ipso in Ph gp.), 156.42 (C quat., N-Cbz C=O), 170.62 (C quat., 
C=O, Cl); mlz 283.0937; CI3H1sN20 s (M+H) requires 283.0939. 
General procedure for the formation of 2,2-dimethyl oxazolanes: 
'0 
/~yo 
R..N"'·YR 
H OH 
The Weinreb amide (1.0 equiv.) was dissolved in acetone (15 ml/g), 2,2-
dimethoxypropane (5 ml/g) and boron trifluoride diethyl etherate (Cat.) was added 
dropwise until there was a permanent change in colour (colourless to dark yellow). 
The reaction was stirred for up to 90 min at room temperature and triethylamine (0.1 
ml/g) was added to quench the reaction. The solvent was evaporated under reduced 
pressure. 
(4S)-4-(Methoxy-methyl-carbamoyl)-2,2-dimethyl-oxazolidine-3-carboxylic acid 
tert-butyl ester (35): 
34 35 
Prepared according to the general procedure from (S)-[2-Hydroxy-I-(methoxy-
methyl-carbamoyl)-ethyl]-carbamic acid tert-butyl ester (34) (5.00 g, 20.2 mmol). 
Pale yellow solid, recrystallized from light petroleum to give colourless crystals (5.20 
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g, 89%); mp 66-67 °C (Lit.3 65-67 0C); [alo20 -36.5 (c 1.11, CHCb); [lit.' [alo +37.1 
for D-enantiomerl; Vrnax (film) fcm" 1716,1680,1458,1175; OH (400 MHz; DMSO-
d6, 80°C) 1.40 (9 H, s, (CH3)3C), 1.49 (3 H, s, CH3, C6), 1.58 (3 H, s, CH3, C7), 3.14 
(3 H, s, NCH3), 3.70 (3 H, s, OCH3), 3.82 (I H, dd, J3.6, 8.8 Hz, upfield portion of an 
ABX system, N-CHCHH-O, C5), 4.20 (1 H, dd, J 8.8,7.2 Hz, downfield portion of an 
ABX system, N-CHCHH-O, C5), 4.77 (I H, dd, J 3.6, 7.2 Hz, NCH, C4); Oc (62.50 
MHz; DMSO-~, 80°C) 24.45 (2 x CIf), C6,7), 27.59 «CH3)3C), 32.07 (NCH3), 56.79 
(CH, C4), 60.56 (OCH3), 65.27 (CH2, C5), 78.82 (C quat., C2), 93.50 (C quat., 
(CH3)3C), 150.53 (C quat., N-Boc C=O), 170.20 (C quat., C8); mlz 288.1686; 
CI3H24N20S (M+) requires 288.1685. 
(4S,SR)-4-(Methoxy-methyl-carbamoyl)-2,2,S-trimethyl-oxazolidine-3-carboxylic 
acid tert-butyl ester (3Sa): 
34a 3Sa 
Prepared according to the general procedure from (2R,3S)-[2-Hydroxy-I-(methoxy-
methyl-carbamoyl)-propyll-carbamic acid tert-butyl ester (34a) (5.00 g, 19.2 mmol). 
Colourless oil, (5.20 g, 91%); [al 20o -8.8 (c 1.36, CHCb); [lit.4 [al20o -9.8 (c 1.40, 
CHCb)l; Vrnax (film) fcm" 1706,1681,1452,1174; OH (250 MHz; DMSO-d6, 80°C) 
1.39 (3 H, d, J 6.1 Hz, CH3, C9), 1.45 (9 H, s, (CH3)3C), 1.59 (3 H, s, CH3, C6), 1.62 
(3 H, s, CH3, C7), 3.21 (3 H, s, NCH3), 3.78 (3 H, s, OCH3), 4.12 (1 H, quint, J6.1, 
12.4 Hz, CH, C5), 4.45 (1 H, d, J 6.1 Hz, CH, C4); Oc (62.50 MHz; DMSO-d6, 80°C) 
19.20 (CH3, C9), 24.30 (CH3, C6), 26.99 (CH3, C7), 27.62 «CH3)3C), 32.07 (NCH3), 
60.38 (NCH, C4), 62.77 (OCH3), 73.75 (CH, C5), 78.96 (C quat., C2), 93.65 (C quat., 
(CH3)3C), 150.47 (C quat., N-Boc C=O), 169.73 (C quat., C8); mlz 302.1836; 
C'4H26N20S (M+) requires 302.1842. 
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(4S)-4-(Methoxy-methyl-carbamoyl)-2,2-dimethyl-oxazolidine-3-carboxylic acid 
benzyl ester (35b): 
34b 35b 
Prepared according to the general procedure from (S)-[2-Hydroxy-I-(methoxy-
methyl-carbamoyl)-ethyl]-carbamic acid benzyl ester (34b) (5.00 g, 17.7 mmol); 
Colourless oil, (5.13 g, 90%); [afoD -5.0 (c 1.36, CHCl); [lit.5 [afoD-5.0 (c 0.60, 
CHCh)]; Vmax (film) /cm-1 1713,1680,1463,1175; OH (400 MHz; DMSO-d6, 100 °C) 
1.53 (3 H, s, CH), C6), 1.63 (3 H, s, CH), C7), 3.11 (3 H, s, NCH), 3.62 (3 H, s, 
OCH), 3.89 (I H, dd, J9.2, 3.6 Hz, upfield portion of an ABX system, N-CHCHH-O, 
CS), 4.25 (1 H, dd, J 9.2, 7.4 Hz, downfield portion of an ABX system, N-CHCHH-O, 
CS), 4.88 (I H, dd, J 7.4,3.6 Hz, NCH, C4), 5.07 (2 H, s, CH2, N-Cbz CH2), 7.35 (5 
H,5 x CH arom., Ph gp.); /le (100 MHz; DMSO-d6, 80 °C) 21.40 (CH), C6), 25.58 
(CH), C7) 33.28 (NCH), 58.01 (NCH, C4), 61.82 (OCH), 66.82 (CH2, CS), 67.02 
(CH2, N-Cbz CH2), 95.22 (C quat., C2), 128.29 (2 x CH arom., artha in Ph gp.), 
128.57 (2 x CH arom., meta in Ph gp.), 129.08 (CH arom.,para in Ph gp.,), 137.48 (C 
quat., arom., ipso in Ph gp.), 152.34 (C quat., N-Cbz C=O), 171.05 (C quat., C=O, 
C8); m/z 323.1605; C16H22N205 (M+H) requires 323.1607. 
General procedure for the formation of Garner's aldehyde and analogous 
compounds: 
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The weinreb protected oxazolidine (1.0 equiv.) was dissolved in anhydrous 
tetrahydrofuran (15 ml/g) and cooled to 0 °C. LiAIH4 in tetrahydrofuran (1.0 M) (5.19 
ml, 5.2 mmol) was added dropwise and the mixture was stirred for 30 min. The 
reaction was cooled further to -15°C and sat. aq. potassium hydrogen sui fate (10 
mllg) was added carefully, the solution was diluted with diethyl ether (30 mlfg) and 
stirred vigorously for 30 min. The organic layer was separated, dried (Na2S04), 
filtered and the solvent evaporated under reduced pressure. 
(S)-4-Formyl-2,2-dimethyloxazolidine-3-carboxylic acid lerl-butyl ester (31): 
35 31 
Prepared according to the general procedure from (S)-4-(Methoxy-methyl-
carbamoyl)-2,2-dimethyl-oxazolidine-3-carboxylic acid tert-butyl ester (35) (3.00 g, 
10.4 mmol). Pale yellow oil (2.3 g, 96%); [a]2oD -84.8 (c 1.04, CHCh); [lit.6 [a]D 
-91.7 (c 1.34, CHCb)]; Yrnax (film) fcm· 1 3453, 2980, 2936, 1739, 1708, 1478, 1392, 
1172; OH (400 MHz; DMSO-d6, 80°C) 1.38 (9 H, s, (CH3)3C), 1.43 (3 H, s, CH3, C6), 
1.49 (3 H, s, CH3, C7), 3.98 (I H, dd, J9.2, 3.6 Hz, upfield portion of an ABX system, 
N-CHCHH-O, C5), 4.04 (1 H, dd, J 9.2, 7.2 Hz, downfield portion of an ABX system, 
N-CHCHH-O, C5), 4.29 (I H, ddd, J 9.2, 7.2, 3.6, 2.0 Hz, NCH, C4), 9.48 (I H, d, 
2.0 Hz, HC=O, C8); Oc (lOO MHz; DMSO-d6, 80°C) 25.05 (CH3, C6), 26.62 (CH3, 
C7), 28.81 ((CH3)3C), 63.89 (CH2, C5), 65.36 (CH, C4), 80.96 (C quat., C2), 94.88 (C 
quat., (CH3)JC), 165.11 (C quat., N-Boc C=O), 199.87 (HC=O, C8); mlz 230.1396; 
ClI Hl9N04 (M+H) requires 230.1392. 
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(4S,5R)-4-Formyl-2,2,5-trimethyloxazolidine-3-carboxylic acid tert-butyl ester 
(3Ia): 
35a 3Ia 
Prepared according to the general procedure from (4S,5R)-4-(Methoxy-methyl-
carbamoyl)-2,2,5-trimethyl-oxazolidine-3-carboxylic acid tert-butyl ester (35a) (5.50 
g, 19.0 mmol). Pale yellow oil (3.90 g, 90%); [afoo -61.0 (c 1.05, CHCb); [lit.6 [a]o 
-65.8 (c 1.66 CHCb)]; Vrnax (film) fcm'! 3584,2980,2937,1740, 1713, 1456, 1368, 
1170; OH (400 MHz; DMSO-d6, 80°C) 1.20 (3 H, d, J 6.0 Hz, CH3, C9), 1.35 (9 H, s, 
(CH3)3C), 1.46 (3 H, s, CH3, C6), 1.48 (3 H, s, CH3, C7), 3.68 (I H, quint, J 8.0, 3.6 
Hz, CH CS), 4.09 (I H, m, NCH, C4), 9.36 (I H, d, J 4.0 Hz, HC=O, C8); Oc (100 
MHz; DMSO-d6, 80°C) 17.40 (CH3, C9), 24.77 (CH3, C6), 26.14 (CH3, C7), 27.36 
«Gh)3C), 69.37 (CH, CS), 70.21 (NCH, C4), 79.94 (C quat., (CH3hC), 93.53 (C 
quat., C2), 151.00 (C quat., N-Boc C=O), 197.37 (HC=O, C8); mlz 243.1472; 
C!2H2!N04 (M+) requires 243.1471. 
(S)-4-Formyl-2,2-dimethyl-oxazolidine-3-carboxylic acid benzyl ester (3Ib): 
° O~._H 
N-Cbz CH2 11 j 
v:0.-A.. N", " I N-CbzC",Q I l .& 7-,-0 
6 
35b 3Ib 
Prepared according to the general procedure from (S)-4-(Methoxy-methyl-
carbamoyl)-2,2-dimethyl-oxazolidine-3-carboxylic acid benzyl ester (35b) (1.80 g, 6.8 
mmol). Pale yellow oil (1.60 g, 90%); [afoo -77.5 (c 1.00, CHCb); [lit.s [a]o -80.1 
(c 1.02, CHCb)]; Vrnax (film) !cm'! 3461,3032,2981,2933, 1740, 1702, 1498, 1410, 
1379, 1160; OH (400 MHz; DMSO-d6, 80°C) 1.43 (3 H, s, CH3, C6), 1.57 (3 H, s, 
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CH), C7), 3.59 (1 H, dd, J 8.0, 8.0 Hz, upfield portion of an ABX system, N-CHCHH-
0, CS), 3.72 (I H, dd, J 8.0,4.0 Hz, downfield portion of an ABX system, N-CHCHH-
0, CS), 3.97 (1 H, m, NCH, C4), 5.01 (2 H, s, N-Cbz CH2), 7.14 (5 H, m, 5 x CH 
arom., Ph gp.), 9.32 (1 H, s, HC=O, C8). 
General procedure for the addition of Grignard reagents to Garners aldehyde 
and substituted derivatives: 
To a precooled solution of the aldehyde (1.0 equiv.) in tetrahydrofuran (50 mllg) at 
-78 "C under a stream of N2 was added, dropwise a solution of the Grignard in 
tetrahydrofuran (3.3 equiv.), over 30 min. The resulting dark yellow solution was 
stirred for an additional 2 h at -78 "C and then warmed to 0 "C. The reaction mixture 
was diluted with diethyl ether (50 ml/g) and quenched with sat. ammonium chloride 
solution (10 mllg). The organic layers were washed with brine, dried (Na2S04), 
filtered and solvent removed under reduced pressure. 
(S)-4-[(IS)-I-Hydroxy-2-methyl-propyl)-2,2-dimethyl-oxazolidine-3-carboxylic 
acid tert-buty I ester (36): 
31 36 
Prepared according to the general procedure from (4S)-4-formyl-2,2-
dimethyloxazolidine-3-carboxylic acid tert-butyl ester (31) (1.20 g, 5.2 mmol) with a 
2M solution of isopropylmagnesium chloride (8.60 ml, 17.2 mmol). Crude yellow 
solid, column chromatography eluting with ethyl acetate/light petroleum (I :8) and 
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recrystallization (ethyl acetate/light petroleum) produced colourless crystals (1.2 g, 
73%); m.p. 77-79 °C (lit' m.p. 78-80 0C); [afoo -52.2 (c 1.06, CHCh) [lit4 [a]o 
-54.3(c 1.00, CHCh)]; Found: C, 61.92; H, 9.93; N, 4.96%. Cl4H2,N04 requires C, 
61.51; H, 9.96; N, 5.12%; Vmax (film) /cm- I 3582,3396,1702,1670,1459,1377,1366, 
1174; OH (250 MHz; CDCh) 0.90 (3 H, d, J 6.7, CH3, C10), 0.98 (3 H, d, J 6.8, CH3, 
C11), 1.44 (9 H, s, (CH3)JC), 1.51 (3 H, s, CH3, C6) 1.60 (3 H, s, CH3, C7), 1.63-1.70 
(I H, m, CH(CH3)z, C9), 3.45-3.49 (I H, m, CH, C4), 3.70-3.96 (I H, m, CH2, C5), 
3.98-4.10 (I H, m, CH, C8); Oc (100 MHz; CDCh) 14.29 (Gb, C10), 20.42 (CH3, 
Cll), 24.39 (CH(CH3)2, C9), 27.25 (CH3, C6), 28.39 «CH3)3C), 31.02 (CH3, C7), 
60.59 (NCH, C4), 65.29 (CHz, C5), 78.48 (CH, CS), 81.39 (C quat., (CH3)3C), 94.11 
(C quat., C2), 155.7 (C quat., N-Boc C=O); mlz 273.1944; C I4H27N04 (M+) requires 
273.1940. 
(4S,5R)-4-[(1S)-1-Hydroxy-2-methy1-propyl]-2,2,5-trimethyl-oxazolidine-3-
carboxylic acid tert-butyl ester (36a): 
31a 36a 
Prepared according to the general procedure from (48,5R)-4-formyl-2,2,5-
trimethyloxazolidine-3-carboxylic acid tert-butyl ester (31a) (4.50 g, 18.4 mmol) with 
a 2M solution of isopropylmagnesium chloride (30.43 ml, 60.85 mmol) to give a 
crude yellow oil. Column chromatography with ethyl acetate/light Petroleum (I :9) and 
recrystallization (ethyl acetatellight Petroleum) afforded colourless crystals (1.5 g, 
70%); [a]20o -39.3 (c 1.13, acetone); Found: C, 62.21; H, 10.08; N, 4.98%. 
CIIH23NzOs requires C, 62.89; H, 9.S6; N, 4.89%; Vmax (film) /cm- l 3476, 2975, 1700, 
1663,1459,1396,1255,1174; OH (250 MHz; CDCI3) 0.92 (3 H, d, J 6.7, CH3, C10), 
1.02 (3 H, d, J 6.9, CH3, CII), 1.32 (3 H, d, J 6.45 CH3, C12) 1.50 (9 H, s, (CH3)3C), 
1.53 (3 H, s, CH3, C6) 1.64 (3 H, s, CH3, C7), 1.54-1.65 (1 H, m, CH(CH3)z, C9), 3.47 
(1 H, m, NCH, C4), 3.85 (1 H, m, CH, C8), 4.00 (1 H, dq, J2.55 and 6.83 CH, C5); 
Oc (100 MHz; CDCh) 14.4 (CH3, CIO), 17.8 (CH3, C11), 20.5 (CH3, CI2), 21.2 
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(CH(CH))2, C9), 28.3 (CH), C6), 28.4 «CH)hc), 31.1 (CH), C7), 66.2 (NCH, C4), 
74.4 (CH, C8), 79.1 (C quat., (CH)))C), 81.4 (C quat., C2) and 197.51 (C quat., N-Boc 
C=O); m/z 287.2095; C'SH29N04 (M+) requires 287.2096. 
(4S,5S)-1,1-dimethylethyl N-[2,2-dimethyl-4-(1-methylethyl)-1,3-dioxan-5-
yl]carbamate (38): 
39 38 
A solution of «IS,2S)-2-Hydroxy-I-hydroxymethyl-3-methylbutyl)-carbamic acid 
tert-butyl ester (39) (1.40 g, 6.0 mmol), p-toluene sulphonic acid (O.1lg, 0.6 mmol), 
2,2-dimethoxypropane (7.37 ml, 60.0 mmol), in acetone (85 ml) was stirred at room 
temperature for 24 h. The resulting solution was concentrated under reduced pressure, 
diluted with ethyl acetate and washed with sodium hydrogen carbonate (50%) (2 x 25 
ml) The organic layers were washed with brine, dried (MgS04) and concentrated to 
yield a colourless oil. Column chromatography was performed eluting with ethyl 
acetatellight petroleum (1:12) to give a colouless solid (1.35 g, 82%); mp 58-59°C; 
[afoD +5.7, (c 1.40, CHCh); Vrnax (film) fcm" 3583,3450,2980,2874,2252, 1705, 
1503,1367,1243, 1166; 8H (250 MHz; CDCh) 0.87 (3 H, d, J 6.6 Hz CH), CIO), 0.92 
(3 H, d, J 6.5 Hz, CH), Cl1), 1.41 (3 H, S, CH), C7), 1.43 (3 H, S, CH), C8), 1.44 (9 
H, s, (CH)hC), 1.60-1.69 (1 H, m, CH(CH))2, C9), 3.27 (I H, dd, J 9.5, 1.6 Hz CH, 
C5), 3.50 (lH, m, CH, C4), 3.62 (I H, dd, J 12.0, 1.9 Hz, up field portion of an ABX 
system, N-CHCHH-O, C6), 3.86 (I H, dd, 12.0, 1.9 Hz, downfield portion of an ABX 
system, N-CHCHH-O, C6), 5.18 (I H, d, J 9.8 Hz, NH); rnlz 273.1906; C,4H27N04 
(M+) requires 273.1940. 
(2R,3S,4S)-1,1-dimethylethyl-N-[2,2,4-trimethyl-6-(1-methylethyl)-1,3-dioxan-5-
yl]carbamate (40): 
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39a 40 
A solution of (IS,2S,3R)-[2-Hydroxy-l-(hydroxy-ethyl)-3-methyl-butyl]-carbamic 
acid tert-butyl ester (2.50 g, 10.! mmol),p-toluene sulphonic acid (0.19 g, 1.0 mmol), 
2,2-dimethoxypropane (12.43 ml, 101.2 mmol), in acetone (150 ml) was stirred at 
room temperature for 24 h. The resulting solution was concentrated under reduced 
pressure, diluted with ethyl acetate and washed with sodium hydrogen carbonate 
(50%) (2 x 25 ml). The organic layers were washed with brine, dried (MgS04) and 
concentrated to yield a colourless oil. Column chromatography was performed eluting 
with ethyl acetate/light petroleum (1:12) to give a colourless solid (2.27 g, 78%); 
[a]20o +7.4, (c 1.12, CHCh); V max (film) /cm·! 3443,3053,2982,2306, 1710, 1501, 
1367,1265,1171,739,705; OH (250 MHz; CD Ch) 0.87 (3 H, d, J 6.7 Hz, CH3, ClO), 
0.93 (3 H, d, J 6.6 Hz, CH3, Cll), 1.13 (3 H, d, J 6.3 Hz, CH3, CI2), 1.40 (3 H, s, 
CH3, C7), 1.43 (3H, s, CH3, C8), 1.44 (9 H, s, (CH3)JC), 1.67-1.76 (l H, m, 
CH(CH3)2, C9), 3.35 (1 H, dd, J 9.5, 1.6 Hz, CH, C5), 3.50 (1 H, dt, J 10.4, 1.7 Hz, 
CH, C4), 4.00 (1 H, dq, J 6.2, 1.5 Hz, CH, C6), 4.97 (1 H, d, J 10.3 Hz, NH); Oc (100 
MHz; CDCb) 17.40 (CH 3, CI2), 19.12 (CH3, CI0), 19.20 (CH3, Cll), 28.34 
((CH3)3C), 28.92 (CH3, C7), 29.87 (CHJ, C8), 48.74 (NCH, CS), 49.97 (CH(CH3)2, 
C9), 68.8 (CH, C6), 78.32 (CH, C4), 79.02 (C quat., (CHJhc), 99.13 (C quat., C2), 
156.1 (C quat., N-Boc C=O); mlz 287.2093; C!sH29N04 (M+) requires 287.2096. 
(4R,5R,6S)-2,2,4-trimethyl-6-(1-methylethyl)-1,3-dioxan-5-amine (42): 
42 
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(2R,3S,4S)-I, l-dimethylethyl-N-[2,2,4-trimethy 1-6-(I-methylethy I)-I ,3-dioxan-5-
yl]carbamate (40) (0.170 g, 0.59 mmol) was dissolved in dichloromethane and cooled 
to O°C, under a N2 atmosphere. Aluminium chloride (0.079 g, 0.59 mmol) was added 
portionwise over 5 min. The solution was then left to stir for 48 h. The mixture was 
then neutralized with sat. sodium hydrogen cabonate solution and extracted with ethyl 
acetate. The organic phase was then dried (MgS04), filtered and concentrated to give 
a crude slightly orange oil. Column chromatography, eluting with ethyl acetate/light 
petroleum (I :6) produced a colourless oil (0.027 g, 25%); V max (film) /cm-\ 3592, 
2968,2364,2301, 1680, 1476, 1259, 1142; [a]20D +40.1°, (c 1.21, CHCh); OH (250 
MHz; CDCh) 0.86 (3 H, d, J 6.7 Hz, CH), CI2), 0.95 (3 H, d, J 6.5 Hz, CH), CIO), (3 
H, d, J 6.3 Hz, CH), Cll), 1.39 (3 H, s, CH), C7), 1.40 (3 H, s, CH), C8), 1.77-1.89 (1 
H, m, CH(CHJ)2, C9), 2.42 (I H, t, J 1.6 Hz, NCH, C5), 3.25 (1 H, dd, J 9.7, 1.4 Hz, 
CH, C4), 3.94 (I H, dq, J 6.2, 1.6 Hz, CH, C6). 
(4S,5S)-2,2-dimethyl-4-(1-methylethyl)-1,3-dioxan-5-amine (44): 
36 43 44 
(S)-4-[ (I S)-I-Hydroxy-2-methyl -propy 1]-2,2-dimethyl -oxazolidine-3-carboxy lic acid 
tert-butyl ester (36) (0.10 g, 0.37 mmol) was dissolved in dichloromethane (I ml) and 
cooled to 0 °c, at which point neat trifluroacetic acid (0.50 ml, 6.50 mmol) was added 
dropwise. The reaction mixture was left to stir for 1.5 hours in ice and then warmed to 
room temperature for a further 1.5 hours, at which point the TLC showed the 
formation of product upon the baseline at expense of starting material. No attempt at 
neutralizing this compound was made. Solvents were removed under reduced pressure 
and the product was submitted directly into the cycIisation step. The compound was 
dissolved in acetone (25 ml) and 2,2-dimethoxypropane (0.45 ml, 3.70 mmol) with a 
catalytic amount of p-toluene sulphonic acid. The reaction mixture was left to stir over 
night at room temperature. The solvents were removed under reduced pressure and the 
dark oil redissolved in dichloromethane and washed with sat. aq. sodium hydrogen 
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carbonate, dried (MgS04) and solvent removed under reduced pressure to yield a pale 
yellow oil (0.045 g, 70%); Vrnax (film) fcm') 3583,2966,2361,2306, 1675, 1471, 
1265, 1138; [afoo +32.2, (c 1.02, CHCb); OH (250 MHz; CDCb) 0.86 (3H, d, J 6.7 
Hz, CH3, CI0), 0.95 (3 H, d,J6.5 Hz, CH3, Cll), 1.41 (3 H, s, CH3, C7), 1.42 (3 H, s, 
CH3, C8), 1.69-1.87 (l H, m, CH(CH3)2, C9), 2.05-2.25 (2 H, bs, NH2), 2.65 (l H, q, J 
3.8,2.0 Hz, NCH, CS), 3.32 (l H, dd, J9.6, 1.6 Hz, up field portion of an AB X system, 
N-CHCHH-O, C6), 3.72 (1 H, dd, J 11.9, 2.0 Hz, , downfield portion of an ABX 
system, N-CHCHH-O, C6), 4.06 (1 H, dd, J 11.8, 2.1 Hz, CH, C4); Oc (lOO MHz; 
CDCb) 19.01 (CH3, CI0), 19.09 (CH3, Cll), 27.63 (CH3, C7), 28.07 (CH3, C8), 
32.48 (CH(CH3)2, C9), 63.12 (NCH, CS), 64.33 (CH2, C6), 84.05 (CH, C4), 94.57 (C 
quat., C2). 
General procedure for the formation of the formate protected 5-amino-l,3-
dioxanes from commercially available amino diols: 
R'Oyt; 
OH OH 
The amino diol (1.0 equiv.) was dissolved in methanol (10 mI/g) and methyl formate 
(1.1 equiv.) was added with sodium methoxide (10 mol%). The reaction was left to 
stir for 3.5 h and the solvent removed under reduced pressure. The crude yellow oil 
was dissolved with CSA (10 mol%) in acetone (50 mlfg) and 2,2-dimethoxypropane 
(10.0 equiv.). The reaction was left to stir for up to 4 h and monitored by TLC. 
Solvents are removed under reduced pressure and the residue re-dissolved in ethyl 
acetate, which was washed with sat. aq. sodium hydrogen carbonate. The organics are 
dried (MgSO.) and solvents removed under reduced pressure. 
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N-[(4S,5S)-2,2-Dimethyl-4-[4-nitro-phenyIJ-l,3-dioxan-5-ylJformamide (50): 
o 
" -0'~'Oy\ 
OH OH 
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o 0 
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Prepared according to the general procedure from (IS,2S)-(+)-2-amino-I-(4-
nitrophenyl)-1,3-propandiol (47) (1.00 g, 4.71 mmol). Colourless oil (1.12 g, 85%); 
[alD +3.5 (c 1.02, CHCh); vrnax(fiIm) fcm-' 1674, 1520, 1346, 856; 8H (250 MHz; 
CDCh) 1.55 (3 H, s, CH), C7), 1.59 (3 H, s, CH), C8), 3.83 (I H, dd, J 12.1, 1.7 Hz, 
upfield portion of an ABX system, N-CHCHH-O, C6), 4.24 (I H, dd, J 12.1, 1.8 Hz, 
downfield portion of an ABX system, N-CHCHH-O, C6), 4.40 (I H, m, NCH, C5), 
5.26 (I H, d, J 1.0 Hz, Ar-CH, C4), 7.50 (2 H, d, J 8.9 Hz, 2 x CH arom., CI0,11), 
7.91 (I H, s, NCHO, CI6), 8.15 (2H, d, J 8.9 Hz, 2 x CH arom., CI2,13); 8c (62.5 
MHz; CDCh) 18.81 (CH), C7), 29.29 (CIfJ, C8), 45.38 (NCH, C5), 64.86 (CIh C6), 
71.91 (Ar-CH, C4), 100.70 (C quat., C2), 123.72 (2 x CH arom., CI2,13), 126.79 (2 x 
CH arom., CIO,II), 145.80 (C quat., arom., C9), 147.80 (C quat., arom.,CI4), 160.62 
(NCHO, CI6). m/z 298.1399; CllH'6N20 S (M"'NH4) requires 298.1403. 
N-[(4S,5S)-2,2-Dimethyl-4-[4-(methylsulfanyJ)-phenyJJ-l,3-dioxan-5-
ylJformamide (51): 
48 51 
137 
Prepared according to the general procedure from (lS,2S)-(+)-2-amino-I-(4-
methylthiophenyl)-1,3-propandiol (48) (5.00 g, 23.4 mmol). Colourless oil (5.50 g, 
84%); [a]D +1.3 (c 1.27, CHCh); vrnax{film) fcm'! 3315,2988,2362, 1667, 1494, 
1380, 1197, 1084,947; OH (250 MHz; CDCh) 1.54 (3 H, s, CH3, C7), 1.58 (3 H, s, 
CH3, C8), 2.45 (3 H, s, SCH3, CI6), 3.87 (1 H, dd, J 7.5, 1.0 Hz, upfield portion of an 
ABX system, N-CHCHH-O, C6), 4.24 (1 H, dd, J 7.5, 1.0 Hz, downfield portion of an 
ABX system, N-CHCHH-O, C6), 4.28 (1 H, m, NCH, CS), 5.16 (1 H, d, J 1.3 Hz, Ar-
CH, C4), 6.27 (1 H, d, J 5.8 Hz, NH), 7.20 (4 H, s, 4 x CH arom.), 7.97 (1 H, s, 
NCHO, CI8); Oc (100 MHz; CDCh) 15.80 (SCH3, CI6), 18.54 (CH3, C7), 29.69 
(CH3, C8), 45.34 (NCH, C5), 64.59 (CH2, C6), 71.41 (Ar-CH, C4), 99.72 (C quat., 
C2), 125.80 (2 x CH arom., C10,11), 126.61 (2 x CH arom., CI2,13), 134.97 (C quat., 
arom., CI4), 137.79 (C quat., arom., C9), 160.51 (NCHO, CI8); m/z281.l081; 
C!4H!9N03S (M) requires 281.1085. 
N-[ ( 4S,5S)-2,2-Dim ethyl-4-[ 4-( methyls ulfonyl)-pheny 1)-1 ,3-dioxan-5-
yl)formamide (57): 
51 57 
N-[( 4S,5S)-2,2-Dimethyl-4-[ 4-(methylsulfanyl)-pheny 1]-1 ,3-dioxan-5-yl]formamide 
(51) (4.0 g, 14.2 mmol) was dissolved in dichloromethane (lOO ml) and cooled to 0 
DC. To this solution was added m-CPBA (2.2 eq, 7.03 g, 31.0 mmol)as a solution in 
chloroform (20 ml), dropwise over 10 min. The reaction was then left to stir for 2 h. 
The reaction mixture was transferred to a separating funnel and washed with sat. aq. 
sodium hydrogen carbonate (2 x 40 ml), brine (2 x 40 ml) and dried (MgS04). 
Solvents were removed under reduced pressure to yield a colourless oil. Crystallized 
from chloroformfdiethyl ether, colourless crystals (3.80 g, 85%); m.p. 146-147 DC; 
[ab -11.6 (c 1.21, CHCh); vrnax(film) fcm'! 3054,2993, 1675, 1516, 1382, 1300, 
1239,1202,1149,1086,948; Found C, 52.68; H, 6.12; N, 4.33. CI4HI9NOsS requires 
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C, 53.66; H, 6.11; N, 4.47.; OH (400 MHz; CDCb) 1.54 (3 H, s, CH], C7), 1.57 (3 H, 
s, CH], C8), 3.01 (3 H, s, SCH], CI6), 3.82 (I H, dd, J 12.0,2.0 Hz, upfield portion of 
an ABX system, N-CHCHH-O, C6), 4.33 (I H, dd, J 12.0, 1.6 Hz, downfield portion 
of an ABX system, N-CHCHH-O, C6), 4.37 (I H, dd, J 10.0, 1.6 Hz, NCH, CS), 5.25 
(1 H, s, Ar-CH, C4), 6.51 (1 H, d, J 9.2 Hz, NH), 7.52 (2 H, d, J 8.0 Hz, 2 x CH 
arom., CIO,II), 7.85 (2 H, d, J 8.0 Hz, 2 x CH arom., CI2,13), 7.89 OH, s, NCHO, 
CI8); oe (lOO MHz; CDCb) 18.91 (CH], C7), 29.94 (CH], C8), 44.83 (SCH], C16) 
45.43 (NCH, CS), 64.93 (CH2, C6), 71.91 (Ar-CH, C4), 100.38 (C quat., C2), 126.96 
(2 x CH arom., C13,13), 127.49 (2 x CH arom., C11,12), 140.00 (C quat., arom., 
CI4), 144.95 (C quat., arom., C9), 160.86 (NCHO, CI8); mlz 314.1058; Cl4Hl9NOsS 
(M+H) requires 314.1062. 
N-[(IS,2S)-[2-(4-Amino-pheny 1)-2-hydroxy-l-hydroxym ethy I-ethyl)] -form am ide 
(61): 
o 0 
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N-[( IS,2S)-[2-Hydroxy-I-hydroxymethy 1-2-( 4-nitro-phenyl)-ethy I)) -formamide (60) 
(10.0 g, 41.7 mmol) was dissolved in ethanol (lOO ml) and placed in a three necked 
round bottom flask charged with palladium (10% on carbon) (1.00 g) under an 
atmosphere of hydrogen (ballon). The reaction was stirred at room temperature for 24 
h. At which point the tIc showed complete consumption of starting material to a new 
more polar product. The reaction mixture was filtered through celite (to remove Pd/C) 
and the ethanol was removed to yield a yellow solid. (8.70 g, 99%). 
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N-[(IS,2S)-[2-Hydroxy-l-hydroxymethyl-2-(4-hydroxy-phenyl)-ethyl))-
formamide (62): 
o 0 
"'N'Ol;(" ___ ,"0n;(H 
OH OH OH OH 
61 62 
N-{ (IS,2S)-[2-( 4-Amino-phenyl)-2-hydroxy-I-hydroxymethyl-ethyl)} -formamide 
(61) (10.0 g, 47.6 mmol) was dissolved in sulfuric acid (5%, aq., 50 ml) and cooled to 
o QC. Sodium nitrite (1.2 eq., 3.94 g, 57.2 mmol) was added portionwise so as not to 
allow the temperature to exceed 5 QC (ca 10 min). After the addition was complete the 
reaction was stirred for a further 20 min at 0 QC. Urea was then added to quench any 
excess sodium nitrite, the pH was altered to -6 by the addition of sodium hydrogen 
carbonate. The mixture was then warmed to 80 QC for 30 min. After the heating period 
was over the solution was allowed to cool and the aqueous evapourated under reduced 
pressure by the addition of toluene. The residue obtained was then taken up in 
methanol and passed through a bed of celite (to remove inorganics and residual H20). 
The methanol was then removed under reduced pressure and the residue flash 
chromatographed using ethyl acetate as eluent. (1.5 g, 15%). 
N-[(4S,SS)-2,2-Dimethyl-4-[4-hydroxy-phenyl)-1,3-dioxan-S-yl)formamide (62a): 
62 62a 
(lS,2S)-(+)-2-amino-I-(4-hydroxyphenyl)-1,3-propandiol (62) (2.00 g, 9.5 mmol) was 
dissolved in acetone (50 ml), 2,2-dimethoxypropane (25 ml) and a catalytic amount of 
camfor sulfonic acid was added. The reaction was stirred for 4 h and solvents removed 
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under reduced pressure. The residue obtained was re-dissolved in ethyl acetate and 
washed sucessively with sat. sodium hydrogen sui fate, brine and dried (MgS04). 
Solvents were removed under reduced pressure to afford a yellow oil. Column 
chromatography performed eluting with ethyl acetate/light petroleum (3:2), pale 
yellow oil (1.75 g, 72%); vmax(film) /cm· 1 3410, 1659, 1519, 1381; 8H (250 MHz; 
CDCh) 1.54 (3 H, s, CH3, C7), 1.59 (3 H, s, CH3, C8), 3.85 (I H, m, upfield portion 
of an ABX system, N-CHCHH-O, C6), 4.31 (2 H, m, downfield portion of an ABX 
system, N-CHCHH-O, C6 & NCH, C5), 5.16 (I H, s, Ar-CH, C4), 6.46 (I H, d, J9.25 
Hz, NH), 6.71 (2 H, d, J8.80 Hz, 2 x CH arom., C12, 13),7.14 (2 H, d, J 8.80 Hz, 2 x 
CH arom., CII,12), 7.96 (lH, s, NCHO, CI7). 
N- {( 4S,5S)-2,2-Dimethyl-4-[ 4-( m ethyloxy )-ph eny 1]-1 ,3-dioxan-5-y I} form amide 
(65): 
62a 63 
N-{ (4S,5S)-2,2-Dimethyl-4-[ 4-hydroxy-phenyl]-1 ,3-dioxan-5-yl} formamide (62a) 
(0.24 g, 1.0 mmol), was dissolved in dichloromethane (40 ml) and placed under a 
nitrogen atmosphere. To this was added cesium carbonate (0.62 g, 1.91 mmol) and 
dimethyl sulfate (0.18 ml, 1.91 mmol), the reaction was left to stir for 48 h. A colour 
change was observed; pale yellow after addition of cesium carbonate to colourless 
solution at completion of reaction. The organic solution was transferred to a 
separating funnel, washed with water (2 x 25 ml), brine (2 x 20 ml) and dried 
(MgS04). Solvents were removed under reduced pressure to yield a colourless oil 
which was purified by column chromatography, eluting with ethyl acetate/light 
petroleum (1:1). Colourless oil (0.19 g, 72%); Having almost identical spectroscopic 
data to compound (72): [a]20D +2.1 (c 1.11, CHCh). 
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(2S)-tert-Butoxycarbonylamino-3-(4-methoxy-phenyl)-propionic acid methyl 
ester (67): 
66 67 
A solution of (2S)-tert-Butoxycarbonylamino-3-(4-hydroxy-phenyl)-propionic acid 
(66) (8.00 g, 28.5 mmol) in dimethylformamide (80 ml) was treated with ground 
potassium hydroxide (1. 72 g, 31.3 mmol) and iodomethane (1.95 ml, 31.3 mmol) (in 
20 ml dimethylformamide) was added dropwise over 5 min at 0 QC. The reaction was 
stirred at room temperature for 30 min and, after this time period, additional ground 
potassium hydroxide (1.72 g, 31.3 mmol) and iodomethane (1.95 ml, 31.3 mmol) (in 
20 ml dimethylforrnamide) were added at 0 QC. The reaction was then left to stir for 3 
h. The solution was poured onto ice (150 ml) and extracted with ethyl acetate (3 x 75 
ml). The organic layers were washed with water (3 x 50 ml), brine (2 x 50 ml) and 
dried (MgS04). The solvent was removed under reduced pressure to yield a colourless 
oil. Crystallization was achieved from ethyl acetatellight petroleum, to give colourless 
crystals (6.5 g, 74%); m.p. 52-53°C; vrnax(fiIm) /cm"2976, 1746, 1716, 1612, 1515, 
1391, 1366, 1248, 1175, 1058, 1034; OH (250 MHz; CDCh) 1.42 (9 H, s, «CHl)lC), 
3.02 (2 H, m, CH2, C3), 3.71 (3 H, s, OCHl ), 3.78 (3 H, s, Ar-OCHl ), 4.53 (1 H, q, J 
5.7 Hz, NCH, C2), 5.00 (I H, d, J 6.7 Hz, NH), 6.82 (2 H, d, J 8.7 Hz, 2 x CH arom., 
meta in Ar gp.), 7.03 (2 H, d, J 8.7 Hz, 2 x CH arom., ortho in Ar gp.); Oc (lOO MHz; 
CDCIl) 28.34 «CHl)lC), 37.61 (CH2, C3), 52.09 (OCHl), 54.69 (NCH), 55.25 (Ar-
OCHl), 79.89 (C quat., (CHl)lC), 114.10 (2 x CH arom., meta in Ar gp.), 128.10 (C 
quat., arom., ipso to C3 in Ar gp.), 130.31 (2 x CH arom., ortho in Ar gp.), 155.12 (C 
quat., N-Boc C=O), 158.81 (C quat., arom., ipso to OCHl in Ar gp.), 172.43 (C quat., 
C=O); mlz 309; C'6H2lN05 requires 309.15762. 
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Methyl (4S,5R)-5-[4-(methyloxy)phenyIJ-2-oxo-l,3-oxazolane-4-carboxylate (68): 
67 68 
(2S)-tert-Butoxycarbonylamino-3-( 4-methoxy-phenyl)-propionic acid methyl ester 
(67) (5.0 g, 16.2 mmol) was dissolved in CHlCN (200 ml). To this was added K2S20 g 
(8.75 g, 32.4 mmol) as a solution in water (210 ml) and CUS04 (0.52 g, 3.2 mmol) 
also as a solution in water (50 ml). The reaction mixture was then heated to 70°C, 
under a blanket of N2, for 3 h. The solution was allowed to cool and extracted with 
ethyl acetate (3 x 150 ml), dried (MgS04), concentrated under reduced pressure to 
yield a crude dark yellow oil. Column chromatography eluting with ethyl acetate/light 
petroleum (1:10-1:1) afforded a colourless solid, which was recrystallized from ethyl 
acetate/light petroleum to afford colourless crystals (2.1 Og, 52%); m.p. 94-96 QC; 
[a]2oD +83.5 (c 1.15, CHCh); vrnax(film) /cm· l 3316,2956,2362,2337,1762,1613, 
1515, 1382, 1250, 1224, 1026,834,763; OH (400 MHz; CDCh) 3.81 (3 H, s, OCHl), 
3.83 (3 H, s, Ar-OCHl), 4.31 (I H, d, J 5.20, CHN, C2), 5.56 (I H, d, J 5.20, Ar-CH, 
C3), 6.81 (I H, s, NH), 6.93 (2 H, d, J 4.80 Hz, 2 x CH arom., ortho in Ar gp.), 7.33 
(2H, d, 4.80 Hz, 2 x CH arom., meta in Ar gp.), Oc (100 MHz; CDCh), 53.50 (Ar-
OCHl), 55.74 (CHl, OCHl), 61.83 (CHN, C2), 79.91 (Ar-CH, C3), 114.76 (2 x CH 
arom., ortho in Ar gp.), 127.51 (2 x CH arom., meta in Ar gp.), 130.34 (C quat., 
arom., ipso to C3 in Ar gp.), 158.65 (C quat., arom., ipso to OCHl in Ar gp.), 160.65 
(C quat., NC=O), 170.66 (C quat., C=O); mlz 251.0794; C12HIlNOs (M+) requires 
251.0794. 
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(4R,SR)-4-(hydroxym ethyl)-S-[4-( m ethyloxy )pheny 1]-1 ,3-oxazolan -2-0 ne (70): 
68 70 
Methyl (4S,5R)-5-[ 4-(methyloxy)phenyl]-2-oxo-1 ,30xazolane-4-carboxylate (68) 
(2.20 g, 8.8 mmol) was dissolved in ethanol (25 ml) and cooled to 0 °C. To this was 
added dropwise NaBH4 (0.70 g, 19.3 mmol) as a solution in ethanol (8 ml). After the 
addition was complete the ice bath was removed and the reaction stirred at room 
temperature for 45 min. The reaction was cooled down to 0 °C and conc. HCl (1.5 ml) 
was added, followed by water (15 ml). The ethanol was evaporated under reduced 
pressure and the remaining aqueous solution extracted with ethyl acetate (3 x 50 ml). 
The organics were dried (MgS04) and solvents removed to afford a crude off white 
solid, which was re crystallized from ethyl acetateflight petroleum, to afford colourless 
crystals (1.75 g, 90%); m.p. 140-142 °C; [afoD +74.8 (c 1.08, CHlCOCHl); 
vmax{nujol) fcm" 3239, 1725, 1614, 1514, 1459, 1376, 1251, 1174, 1062, 1016,828; 
OH (250 MHz; acetone-d6) 3.78 (3 H, m, CRN, C2 & CH2, Cl), 3.86 (3 H, s, Ar-
OCHl), 5.35 Cl H, d, J 5.3 Hz, Ar-CH, C3), 7.01 (2 H, d, J 8.6 Hz, 2 x CH arom., 
ortho in Ar gp.), 7.41 (2 H, d, J 8.6 Hz, 2 x CH arom.); Oc (100 MHz; CDCh) 56.03 
(Ar-OCHl), 63.05 (CHN, C2), 64.24 (CH2' C6) 80.39 (Ar-CH, C3), 115.35 (2 x CH 
arom., ortho in Ar gp.) 128.67 (2 x CH arom., meta in Ar gp.), 133.24 (C quat., arom., 
ipso to C3 in Ar gp.), 159.61 (C quat., arom., ipso to OCHl in Ar gp.), 161.28 (C 
quat., NC=O); mlz 223.0842; CllHllN04 (M+) requires 223.0845. 
(IR,2R)-H-2-Amino-l-( 4-methy10xy-phenyl)-1,3-propanediol (71): 
0.-1/..° 
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4-Hydroxymethyl-5-(4-methoxy-phenyl)-oxazolidin-2-one (70) (1.65 g, 7.4 mmol) 
was suspended in IM NaOH (40 ml) and heated under reflux for 30 min. The reaction 
was allowed to cool to room temperature and extracted with ethyl acetate (8 x 30 ml). 
The organics were dried (MgS04) and solvents removed to afford a colourless solid, 
re crystallized from methanol/diethyl ether (1.33 g, 91%); m.p. 132-134 QC; [0:]20D 
-28.3 (c 1.06,2 M aq. HCI); Found: C, 61.14; H, 7.51; N 6.96. requires C, 60.90; H, 
7.67; N 7.10.; vrnax(nujol) Icm" 3338, 1615, 1583, 1515, 1459, 1376, 1253, 1064,873; 
OH (400 MHz; CD)OD) 2.90 (I H, m, NCH, C2), 3.32 (I H, dd, J 10.8,4.4 Hz, upfield 
portion of an ABX system, N-CHCHH-O, Cl), 3.42 (I H, dd, J 10.8, 4.4 Hz, 
downfield portion of anABX system, N-CHCHH-O, Cl), 3.80 (3 H, s, OCH)), 4.49 (I 
H, d, J 7.2 Hz, Ar-CH, C3), 4.90 (2 H, bs, NH2), 6.90 (2 H, d, J 8.8 Hz, 2 x CH arom., 
meta in Ar gp.), 7.29 (2 H, d, J 8.8 Hz, 2 x CH arom., artha in Ar gp.); Oe (lOO MHz; 
CD)OD) 56.11 (OCH)), 60.31 (CHN, C2), 64.41 (CH2, Cl), 75.78 (Ar-CH, C3), 
115.17 (2 x CH arom. meta in Ar gp.), 129.22 (2 x CH arom. artha in Ar gp.), 136.35 
(C quat. arom., ipsa to C3 in Ar gp.), 161.07 (C quat. arom., ipsa to OCH) in Ar gp.); 
m/z 198.1125; CIOH,sNO) (M+H) requires 198.1130. 
(IR,2R)-N-[2-Hydroxy-I-(I-methoxy-I-methyl-ethoxymethy1)-2-(4-methoxy-
phenyl)-ethyl]-formamide (73): 
71 
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N-{ (IR,2R)-[2-Hydroxy-I-hydroxymethyl-2-( 4-methoxy-phenyl)-ethy I]} -formamide 
(71) (0.23 g, 1.0 mmol) was dissolved in acetone (15 ml) and 2,2-dimethoxypropane 
(1.26 ml, 10.2 mmol). To this was added camphorsulfonic acid (0.024 g, 0.1 mmol). 
The reaction was stirred at room temperature for 12 h. Solvents were removed under 
reduced pressure and the residue diluted with ethyl acetate (30 ml). The organic layer 
was washed with sat. aq. sodium hydrogen carbonate (2 x 15 ml), brine (2 x 15 m!) 
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and dried (MgS04). Solvents were removed to give a pale yellow oil (0.213 g, 80%); 
OH (250 MHz; CDCh) 1.34 (6 H, s, 2 X CH), C8,9), 3.19 (3 H, s, OCH), Cl), 3.53 (I 
H, m, upfield portion of an ABX system, N-CHCHH-O, C6), 3.63 (I H, m, downfield 
portion of an ABX system, N-CHCHH-O, C6), 3.78 (3 H, s, OCH), CI7), 4.28 (1 H, 
m, NCH, C6), 4.97 (I H, d, J 3.70 Hz, Ar-CH, C7), 6.86 (2 H, d, J 8.55 Hz, 2 x CH 
arom., C13,14), 7.26 (2 H, d, J8.55 Hz, 2 x CH arom., C11,12), 8.12 (I H, s, NCHO). 
N-{(4R,SR)-2,2-Dimethyl-4-[4-(methyloxy)-phenyIJ-l,3-dioxan-S-yl}formamide 
(72): 
71 
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(lR,2R)-( -)-2-Amino-I-( 4-methyloxy-phenyl)-1 ,3-propanediol (71) (1.2 g, 6.1 mmol) 
was dissolved in methanol (25 ml) and methyl formate (0.45 ml, 7.3 mrnol) was added 
with sodium methoxide (0.1 ml). The reaction was left to stir for 3.5 h and the solvent 
removed under reduced pressure. The crude yellow oil was then dissolved in acetone 
(60 ml), 2,2-dimethoxypropane (10 equiv.) and boron-trifluoride-diethyletherate was 
added until pale yellow colour persisted (ca 0.2 ml). The reaction was then left to stir 
for 45 min. Solvents were again removed under reduced pressure and the residue re-
dissolved in ethyl acetate, which was washed with sat. aq. sodium hydrogen 
carbonate. The organics were dried (MgS04) and solvents removed to yield a pale 
yellow oil (1.21 g, 75%); [aJD -2.7 (c 1.20, CHCh); vmax(film) fcm· l 2992, 1668, 
1515,1381,1248,1199,1084,1032,949; OH (250 MHz; CDCh) 1.54 (3 H, s, CH), 
C7), 1.58 (3 H, s, CH), C8), 3.78 (3 H, s, OCH), CI6), 3.87 (I H, dd, J 12.25, 1.95 
Hz, upfield portion of an ABX system, N-CHCHH-O, C6), 4.26 (2 H, m, downfield 
portion of an ABX system, N-CHCHH-O, C6 & NCH, CS), 5.16 (I H, s, Ar-CH, C4), 
6.19 (I H, d, J 8.55 Hz, NH), 6.85 (2 H, d, J 8.90 Hz, 2 x CH arom., Cl 0, 11), 7.23 (2 
H, d, J 8.90 Hz, 2 x CH arom., CI2,13), 8.00 (I H, s, NCHO, CI8); Oc (100 MHz; 
146 
CDCh) 18.56 (CH3, C7), 29.62 (CH3, C8), 45.57 (NCH, CS), 55.25 (OCH3, CI6), 
64.60 (CH2, C6), 71.40 (Ar-CH, C4), 99.70 (C quat., C2), 113.76 (2 x CH arom., 
CIO,II), 126.45 (2 x CH arom., CI2,13), 130.14 (C quat., arom., C9), 159.04 (C 
quat., arom., CI4), 160.51 (NCHO, CI8); mlz 266.1390; CI4HI9N04 (M+H) requires 
266.1392. 
General procedure for the deprotection offormamides with hydrazine hydrate: 
The formate protected acetonide was dissolved in aq. hydrazine hydrate (85%) (20 
mUg) and the solution heated under reflux for 2.5 h. The solution was allowed to cool 
to room temperature and extracted with ethyl acetate (3 x 20 mUg). The organic layers 
were washed with water (2 x 20 mUg), dried (MgS04) and solvents removed under 
reduced pressure. 
(4S,5S)-2,2-dimethyl-4-[4-nitro-phenyI]-1,3-dioxan-5-amine (52): 
50 52 
Prepared according to the general procedure from N-[( 4S,5S)-2,2-Dimethyl-4-[ 4-nitro-
phenyl]-1,3-dioxan-5-yl]formamide (50) (4.00 g, 14.9 mmol), except reaction heated 
under reflux for I h. Chromatography performed eluting with ethylacetate. Pale 
yellow plates. (2.80 g, 78%); mp 117-119 °C; [a]D20 +66.2 (c 1.13, CHCh); Found: C, 
57.05; H, 6.51; N, 10.77. CI2HI6N204 requires C, 57.13; H, 6.39; N, 11.10.; vmax(film) 
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/cm-1 1605, 1520, 1350, 1196, 1080, 941, 856; OH (250 MHz; CDCI) 1.56 (6 H, s, 
C7,8), 2.84 (1 H, q, J 1.9 Hz, NCH, C5), 3.86 (I H, dd, J 11.8, 1.9 Hz, upfield portion 
of an ABX system, N-CHCHH-O, C6), 4.31 (I H, dd, Jl1.8, 2.3 Hz downfield portion 
ofanABXsystem, N-CHCHH-O, C6), 5.17 (I H, d, J 0.7 Hz, Ar-CH, C4), 7.49 (2 H, 
d, J7.5 Hz, 2 x CH arom., CIO, 11),8.22 (2 H, d, J 7.5 Hz, 2 x CH arom., CI2,13); oe 
(100 MHz; CDCl) 18.59 (CH), C7), 29.66 (CH), C8), 49.42 (NCH, C5), 66.32 (CH2, 
C6), 73.42 (Ar-CH, C4), 99.57 (C quat., C2), 123.63 (2 x CH arom., CIO,ll), 126.66 
(2 x CH arom., CI2,13), 147.17 (C arom., quat., C9), 147.29 (C arom., quat., CI4); 
mlz 253.1191; C12H I6N20 4 (M+H) requires 253.1188. 
(4S,5S)-2,2-dimethyl-4-[4-(methylsulfanyl)-phenylj-l,3-dioxan-5-amine (53): 
51 53 
Prepared according to the general procedure from N-[( 4S,5S)-2,2-Dimethyl-4-[ 4-
(methylsulfanyl)-phenyl]-1,3-dioxan-5-yl]formamide (51) (1.50 g, 5.34 mmol). 
Colourless oil (1.28 g, 95%); [a]2oD +44.7 (c 1.20, CHC!); vmax(film) Icm-1 3369, 
2990, 1599, 1495, 1379, 1198, 1076,947; OH (400 MHz; CDCb) 1.53 (3 H, s, CH), 
C7), 1.54 (3 H, s, CH), C8), 2.47 (3 H, s, SCH), CI6), 2.72 (I H, q, 2.0 Hz, NCH, 
C5), 3.88 (I H, dd, J 12.0, 2.0 Hz, upfield portion of an ABX system, N-CHCHH-O, 
C6), 4.27 (1 H, dd, J 12.0, 2.4 Hz, downfield portion of an ABX system, N-CHCHH-
0, C6), 5.05 (1 H, d, J 1.6 Hz, Ar-CH, C4), 7.23-7.28 (4 H, m, 4 x CH arom.); oe (lOO 
MHz; CDCb) 16.01 (SCH), CI6), 18.61 (CH), C7), 29.74 (CH), C8), 49.64 (NCH, 
C5), 66.05 (CH2, C6), 73.52 (Ar-CH, C4), 99.20 (C quat., C2), 126.39 (2 x CH arom., 
CIO,II,), 126.81 (2 x CH arom., CI2,13), 136.59 (C quat., arom., C9), 137.44 (C 
quat., arom., CI4); mlz 253.1137; CllHl9N02S (M+) requires 253.1137. 
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(4S,5S)-2,2-dirnethyl-4-[4-amino-phenyl]-1,3-dioxan-5-arnine (54): 
50 54 
Prepared according to the general procedure from N-[(4S,5S)-2,2-Dimethyl-4-[4-nitro-
phenyl]-1,3-dioxan-5-yl]formamide (50) (0.80 g, 2.9 mmol). Pale yellow oil, (0.65 g, 
89%), OH (250 MHz; CDCh) 1.50 (3 H, s, CHl, C7), 1.52 (3 H, s, CHl, C8), 2.66 (1 
H, q, J 1.8, NCH, CS), 3.87 (1 H, dd, J 11.7, 1.7 Hz, upfield portion of an ABX 
system, N-CHCHH-O, C6), 4.23 (1 H, dd, J 11.7, 2.2 Hz downfield portion of an ABX 
system, N-CHCHH-O, C6), 4.98 (1 H, bs, Ar-CH, C4), 6.67 (2 H, d, J 8.4 Hz, 2 x CH 
arom., CI0,11), 7.08 (2 H, d, J8.4 Hz, 2 x CH arom., CI2,13); oc(62.5 MHz; CDCh) 
18.93 (CHl , C7), 30.11 (CHl , C8), 50.06 (NCH, C5), 66.10 (CH2, C6,), 73.86 (Ar-
CH, C4), 99.50 (C quat., C2), 115.40 (2 x CH arom., CIO,II), 127.06 (2 x CH arom., 
CI2,13), 129.50 (C arom., quat., C9), 146.00 (C arom., quat., CI4). 
(4S,5S)-2,2-dimethyl-4-[4-(rnethylsulfonyl)-phenyl]-1,3-dioxan-5-amine (57a): 
57 57a 
Prepared according to the general procedure from N-[(4S,5S)-2,2-Dimethyl-4-[4-
(methylsulfonyl)-phenyl]-1,3-dioxan-5-yl]formamide (57) (1.80 g, 5.8 mmol). Product 
isolated as a colourless oil, crystallized from diethyl etherlethylacetate. Colourless 
crystals (1.59 g, 96%); m.p. 120-122 °C; [a]D20 +50.0 (c 1.00, CHCIl ); Found: C 
54.64, H 6.69, N 4.83, requires C 54.72, H 6.71, N 4.91; vmaxCfilm) fem· l 3372,2991, 
149 
1601,1380,1198,1077,949; OH (400 MHz; COCl) 1.56 (6 H, s, 2 X CH), C7,8), 2.85 
(l H, m, NCH, C5), 3.06 (3 H, s, SCH3), 3.88 (1 H, dd, J 11.6, 2.0 Hz, upfield portion 
of an ABX system, N-CHCHH-O, C6), 3.24 (I H, dd, J 11.6, 2.4 Hz, downfield 
portion of an ABX system, N-CHCHH-O, C6), 5.18 (1 H, m, Ar-CH, C4), 7.55 (2 H, 
d, J 8.0 Hz, 2 x CH arom., CIO,II), 7.95 (2 H, d, J8.0 Hz, 2 x CH arom., CI2,13); oc 
(lOO MHz; COCh) 18.97 (Cl'h,C7), 30.04 (CH), CS), 44.93 (SCH), CI9), 49.80 
(NCH, C5), 66.77 (CH2, C6), 73.85 (Ar-CH, C4), 99.86 (C quat., C2), 127.17 (2 x CH 
arom., CIO,II), 127.85 (2 x CH arom., CI2,13), 139.87 (C quat., arom., CI4), 146.56 
(C quat., arom., C9); mlz 285.1028; CI3H'9N04S (M+) requires 285.1035. 
(4R,5R)-2,2-dimethyl-4-[4-(methyloxy)-phenyl]-1,3-dioxan-5-amine (72a): 
72 72a 
Prepared according to the general procedure from N-[(4R,5R)-2,2-0imethyl-4-[4-
(methyloxy)-phenyl]-1,3-dioxan-5-yl]formamide (72) (0.70 g, 2.6 mmol). Colourless 
oil. (0.59 g, 95%). [a]D20 -28.9 (c LOS, CHCh); vmax(fiIm) fcm·' 3050,2991,2925, 
1612, 1515, 145S, 1380, 1249, 1199, 1129, 1079,948,850; OH (250 MHz; CDCh) 
1.53 (3 H, s, CH), C7), 1.55 (3 H, s, CH), C8), 2.72 (1 H, q, 2.0 Hz, NCH, C5), 3.81 
(3 H, s, OCH3, CI6), 3.S9 (1 H, dd, J 13.4, 1.7 Hz, upfield portion of an ABX system, 
N-CHCHH-O, C6), 4.29 (1 H, dd, J 11.7, 2.3 Hz, downfield portion of an ABX 
system, N-CHCHH-O, C6), 5.05 (I H, d, J 1.9 Hz, Ar-CH, C4), 6.89 (2 H, d, J 8.8 
Hz, 2 x CH arom., CIO,ll), 7.24 (2 H, d, J 8.8 Hz, 2 x CH arom., CI2,13); Oc (lOO 
MHz; COCh) 19.01 (CH), C7), 30.07 (CH), C8), 50.16 (NCH, C5), 55.68 (OCH), 
CI6), 66.44 (CH2, C6), 73.90 (Ar-CH, C4), 99.54 (C quat., C2), 114.25 (2 x CH 
arom., CIO, 11), 127.23 (2 x CH arom., C12, 13), 132.08 (C arom., quat., C9), 159.29 
(C arom., quat., CI4); mlz 238.1443; CI3H'9N03 (M+H) requires 238.1443. 
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2-(2-Bromoethyl)-benzene-l-carbaldehyde (2):8 
co ~Br ---~O 
3 2 
To an ice cooled solution ofisochroman (3) (50.0 g, 0.37 mol), in carbon tetrachloride 
(200 ml), was added molecular bromine, slowly over 5 minutes with stirring. After the 
vigorous reaction subsides, the cooling bath was removed and the dark brown solution 
was heated under reflux until the reaction mixture becomes pale yellow, and liberation 
of hydrogen bromide gas ceases. The solution was allowed to attain ambient 
temperature and the solvent removed in vacuo. To the yellow oil obtained, (1-
bromoisochroman), hydrobromic acid (75 ml, 48% aq), was added and the reaction 
mixture was again heated under reflux, (dark green-blue). After approximately 10-15 
minutes the solution was allowed to cool and extracted with diethyl ether (4 x 50 m!). 
The organic extracts are washed with water (2 x 30 ml), then with dilute sodium 
hydrogen carbonate and dried (MgS04). Evaporation of the solvent under reduced 
pressure furnished 67.5 g (65% yield) of the crude 2-(2-bromoethyl) benzaldehyde as 
an orange oil, approximately 85-95% pure. Purification was achieved via vacuum 
distilation, ca 100°C, 0.5 mbar. vmaJcm·1 (neat) 2742,1697,1600,1575,1260,1193, 
755; OH(400 MHz), 3.54-3.63 (4H, m, Ph(CH2)2Br), 7.33 (IH, d, 17.96 Hz, CH arom., 
ortho to bromoethyl group), 7.48 (1 H, t, J 7.50 Hz, CH arom., para to bromoethyl 
group), 7.54 (!H, t, J 7.94 Hz, CH arom., para to formyl group), 7.80 (lH, d, J 7.56 
Hz, CH arom., artha to formyl group), 10.14 (lH, s, CHO); oc (62.50 MHz; CD Ch) 
33.17 (CH2, PhCH2), 36.70 (CH2, CH2Br), 128.10 (CH arom, para to bromoethyl 
group), 132.51 (CH arom., artha to bromo ethyl group), 134.14 (CH arom., para to 
formyl group), 134.33 (C quat., arom., ipsa to bromoethyl group), 134.88 (CH arom., 
artha to formyl group), 140.95 (C quat., arom., ipsa to formyl group), 193.33 (CH, 
HC;O). mJz 211.9837; C9H9BrO (~) requires 211.9837. 
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General procedure for the synthesis of dihydroisoquinolinium salts from 2-(2-
bromoethyl) benzaldehyde and primary amines: 
A solution of the amine in ethanol, (10 ml per g of amine, I equivalent), was added 
dropwise via a stoppered, pressure equalising, dropping funnel, to an ice cooled, one-
neck flask, containing 2-(2-bromoethyl) benzaldehyde, (1.60 equivalents, 1.10 if 
distiIled previously). After the addition was complete the dropping funnel was 
removed and replaced by a stopper to contain the hydrogen bromide generated 
temporarily in the reaction. The reaction mixture was stirred overnight while attaining 
ambient temperature. Sodium tetraphenylborate, (or any other anion exchanging salt, 
1.10 equivalents), in the minimum amount of acetonitrile, was added in one portion to 
the reaction mixture and after 5 minutes of stirring, the organic solvents are removed 
under reduced pressure. Ethanol was added to the residue, followed by water. The 
resulting solid was collected by filtration and washed with additional ethanol followed 
by diethyl ether. If no solid materialises after the addition of the water the suspension 
was allowed to settle and the ethanol/water phase was decanted off. The gummy 
residue which may be obtained, was macerated in hot ethanol or methanol. The 
organic salt may then precipitate but in some rare cases it does so upon slow cooling 
of the hot alcoholic solution. If solubility problems do arise, small amounts of 
acetonitrile may be added during this process. 
(+)-2-[( 4S,5S)-2,2-dimethyl-4-phenyl-l ,3-dioxan-5-y 1]-3,4-dihydroisoq uin olinium 
tetraphenylborate (16):9,10 
15 16 
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Prepared according to the general procedure. Yield 75%, recrystaUized from 
acetone/diethyl ether, yellow solid, m.p. 169-170 cC; [a]2oD +38.6 (c 2.70, CH)CN); 
vmaxlcm-1 (nujol) 1637, 1603, 1571, 1480, 1266, 1202, 1166, 1108, 1073; OH (250 
MHz; CD)CN), 1.65 (3 H, s, CH), C7), 1.94 (3 H, s, CH), C8), [2.39-2.48 (1 H, m), 
2.70-2.82 (1 H, m), Ar-CH2, isoq-4], [3.25-3.40 (1 H, m), 3.81-3.97 (I H, m), CH2N, 
isoq-3], 4.06 (I H, m, NCH, C5), 4.30 (I H, d, J 13.7 Hz upfie1d portion of an ABX 
system, N-CHCHH-O, C6), 4.58 (1 H, dd, J 13.7, 3.1 Hz, downfield portion of an 
ABX system, N-CHCHH-O, C6), 5.70 (1 H, d, J2.8 Hz, Ph-CH, C4), 6.81 (4 H, t, J 
7.2 Hz, 4 x CH arom., para in BPI4 group), 7.35-7.40 (6 H, m, 5 x CH arom., Ph gp., 
CH arom., isoq-6), 7.46 (I H, t, J7.3 Hz, CH arom., isoq-8), 7.65-7.74 (2 H, m, 2 x 
CH arom., isoq-7, isoq-9), 8.92 (I H, s, HC=N, isoq-l); oe (62.50 MHz; CD)CN) 
17.98 (CH), C7), 24.06 (Ar-CH2, isoq-4), 28.68 (CH), C8), 51.55 (CH2N, isoq-3), 
61.44 (CH2, C6), 65.46 (NCH, C5), 70.72 (Ph-CH, C4), 104.88 (C quat., C2), 121.85 
(8 x CH arom., ortho in BPI4 gp.), 124.29 (C quat., arom., isoq-10), 125.44 (2 x CH 
arom.,ortho in Ph gp.), 125.72 (2 x CH arom., meta in Ph gp.), 128.14 (CH arom., 
isoq-6), 128.46 (CH arom., isoq-8), 128.62 (CH arom., para in Ph gp.), 128.04, (4 x 
CH arom., para in BPI4 gp.), 134.39 (CH arom., isoq-7), 135.79 (8 x CH arom., meta 
in BPh4 gp.), 136.97 (C quat., arom., ipso in Ph gp.), 137.68 (C quat., arom., isoq-5), 
138.72 (CH arom., isoq-9), 163.51 (4 x C quat., arom., q, J 196.40 Hz, CoB, ipso in 
BPI4 gp.), 167.48 (HC=N, isoq-l); mlz 322.1809; C21 H24N02 (cation) requires 
322.1807. 
(-)-2-[( 4R,SR)-2,2,4-Trimethyl-l ,3-dioxan-S-yIJ-3,4-dihydroisoq uinolinium 
tetraphenylborate (25): 
oXo 
Y""', 
NH2 
30 25 
Prepared according to the general procedure from (lR,2R)-2,2,4-Trimethyl-
[1,3]dioxan-5-yl-amine (30) (0.75 g, 2.96 mmol), RecrystalIized from DCM/hexane, 
yellow plates (1.13 g, 66%); Recrystallized from acetone/ethyl acetate. Yield (0.149 g, 
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66%); mp 164-165 QC (dec.); [a]D20 -22.3 (c 1.05, acetone); vmax(film) fcm" 3054, 
1636, 1604, 1576, 1477, 1268, 1201, 1180; OH (400 MHz; CD3CN), 1.26 (3 H, d, J 6.4 
Hz, CH3, C9), 1.46 (3 H, s, CH3, C7), 1.55 (3 H, s, CH3, C8), 3.25 (2 H, t, J 8.0 Hz, 
Ar-CH2' isoq-4), 3.89 (1 H, t, 2.4 Hz, NCH, C5), 4.23 (1 H, dd, J 13.6, 0.8 Hz upfield 
portion of an ABX system, N-CHCHH-O, C6), 4.27-4.36 (2 H, m, CH2N, isoq-3), 4.46 
(1 H, dd, J 14.0, 3.2 Hz, downfield portion of an ABX system, N-CHCHH-O, C6), 
4.63 (1 H, dq, J 6.4, 2.8 Hz, CH, C4), 6.83 (4 H, t, J 7.2 Hz, 4 x CH arom., para in 
BPi4 gp.), 6.93 (8 H, t,J7.6 Hz, 8 x CH arom., ortha in BPi4 gp.), 7.22-7.33 (8 H, m, 
8 x CH arom., meta BPi4 group), 7.45 (1 H, d, J7.6 Hz, CH arom., isoq-6), 7.53 (1 H, 
t, J 7.6 Hz, CH arom., isoq-7), 7.80 (1 H, dt, J 7.6, 1.2 Hz, CH arom., isoq-8), 7.86 (1 
H, d, J 7.6 Hz, CH arom., isoq-9), 9.05 (1 H, s, HC=N, isoq-l); Oc (100 MHz; 
acetone-d6), 17.70 (CH3, C9), 18.68 (CH3, C7), 25.57 (Ar-Gh, isoq-4), 51.70 
(CH2N, isoq-3), 62.88 (CH2, C6), 66.08 (NCH, C5), 66.49 (CH, C4), 100.62 (C, quat., 
C2), 122.33 (4 x CH arom., para in BPi4 gp.), 125.65 (C quat., arom., isoq-IO), 
126.09 (8 x CH arom., artho in BPi4 gp.), 129.31 (2 x CH arom., isoq-8,-9), 135.98 
(CH arom., isoq-6), 136.98 (8 x CH arom., meta in BPi4 gp.), 138.24 (C quat., arom., 
isoq-5), 139.42 (CH arom., isaq-7), 164.85 (4 x C quat., arom., q, J 196.0 Hz, CoB, 
ipso in BPi4 gp.), 168.72 (HC=N, isoq-l); mlz 260.1655; C,6H22N02 (cation) requires 
260.1651. 
(+)-2-[( 4S,5S)-2,2-dim ethyl-4-(1-m ethy lethyl)-l ,3-dioxan-5-yl]-3,4-
dihydroisoquinolinium tetraphenylborate (45): 
44 
6 4 
7-:/ '5/ '3 -BPh ! 11 1 4 
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Prepared according to the general procedure from (4S,5S)-2,2-dimethyl-4-(l-
methylethyl)-1,3-dioxan-5-amine (44) (0.05 g, 0.29 mmol). Recrystallized from 
acetonefdiethyl ether, yellow plates (0.120 g, 70%); mp 166-167 QC (dec.); [a]2oD + 
31.7 (c 1.16, acetone); vmax(film) fcm", 3055, 1637, 1604, 1574, 1479, 1265, 1202, 
1152,1088; OH (400 MHz; CD3CN), 0.89 (3 H, d, J 7.8 Hz, CH3, CI0), 0.97 (3 H, d, 
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L. ______________________ ~~~~~~~~~_. __ .. 
J 6.4 Hz, CH3, Cll), 1.48 (3 H, s, CH3, C7), 1.51 (3 H, s, CH3, C8) 1.69-1.75 (I H, m, 
CH(CH3)2, C9), 3.14-3.22 (2 H, m, 2 x CH, C5, isoq-4), 3.89 (2 H, m, 2 x CH, C4, 
isoq-4), 4.06 (2 H, m, CH, C6, isoq-3), 4.33 (2 H, m, CH, C6, isoq-3), 6.84 (4 H, t, J 
7.1 Hz, 4 x CH arom., para in BPi4 gp.), 6.99 (8 H, t, J 7.4 Hz, CH arom., ortho in 
BPi4 gp.), 7.23-7.29 (8 H, m, 8 x CH arom., meta in BPh4 gp.), 7.44 (I H, d, J7.4 Hz, 
CH arom., isoq-6), 7.51 (1 H, t, J7.6, CH arom., isoq-7), 7.80 (2 H, m, 2 x CH arom., 
isoq-8,9), 9.13 (I H, s, HC=N, isoq-I); Oc (100 MHz; CD3CN) 16.96 (CH), C10), 
17.42 (CH), Cll), 17.88 (CH), C7), 24.54 (Ar-CH2, isaq-4), 28.27, (CH), C8), 28.60 
(CH(CH))2, C9), 50.63 (CH2-N, isaq-3), 62.04 (CH2, C6), 62.32 (NCH, C5), 74.81 
(CH, C4), 99.88 (C quat., C2), 121.47 (8 x CH arom., artha in BPi4 gp.), 124.41 (C 
quat., arom., isaq-lQ) 125.31 (4 x CH arom.,para in BPi4 gp.), 128.59 (CH arom., 
isaq-6), 129.20 (CH arom., isaq-7), 134.20 (CH arom., isaq-8), 135.44 (8 x CH arom., 
mela in BPi4 gp.), 137.00 (C quat., arom., isaq-5), 138.44 (CH arorn., isaq-9), 163.45 
(4 x C quat., arom., q, J 145.0 Hz, C-B, ipsa in BPi4 gp.), 167.77 (HC=N, isaq-I); mlz 
288.1959; C18H26N02 (cation) requires 288.1964. 
(+)-[( 4S,5S)-2 ,2-dim ethy 1-4-[ 4-( nitro )-pheny 1]-1,3-dioxan -5-y 1]-
dihydroisoquinolinium tetrapheriylborate (55): 
52 
Prepared according to the general procedure from (+)-(4S,5S)-2,2-dimethyl-4-[4-
(nitro)-phenyl]-1,3-dioxan-5-amine (52) (0.19 g, 0.8 mrnol). Recrystallized from 
DCMlhexane, yellow plates (0.36 g, 74%); rn.p. 176-178 QC (dec.); [afoD +107.7 (c 
1.30, acetone; Found C, 77.73; H, 6.23; N, 4.00; C45H43BN204·0.5H20 requires: C, 
77.66; H, 6.38; N, 4.03.; vmax(filrn) fcrn· l 1635, 1604, 1571, 1524, 1478, 1384, 1202, 
ll63, 1l07, 1032; OH (400 MHz; acetone-d6), 1.72 (3H, s, CH3, C7), 1.76 (3H, S, CH3, 
C8), [2.70-2.80 (I H, m), 2.88-2.96 (I H, m), Ar-CH2, isaq-4], [3.65-3.74 (I H, m), 
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4.19-4.23 (l H, m), CH2N, isaq-3], 4.54 (l H, d, J 13.6 Hz, upfield portion of an ABX 
system, N-CHCHH-O, C6), 4.65 (1 H, m, NCH, C5), 4.82 (l H, dd, J 13.6, 2.8 Hz, 
downfield portion of an ABX system, N-CHCHH-O, C6), 6.11 (l H, d, J 2.4 Hz, Ar-
CH, C4), 6.80 (4 H, t, J 6.8 Hz, 4 x CH arom., para in BPI4 gp.), 6.94 (8 H, t, J 7.2 
Hz, 8 x CH arom., artha in BPh4 gp.), 7.36 (8 H, m, 8 x CH arom., meta in BPI4 gp.), 
7.51 (1 H, t,J7.6 Hz, CH arom., isaq-8), 7.59-7.88 (3 H, m, 3 x CH arom., isaq-6,-7,-
9), 7.85 (2 H, d, J 8.4 Hz, CH arom., CIO,II), 7.95 (2 H, d, J 8.8 Hz, CH arom., 
CI2,13), 9.28 (1 H, s, HC=N, isaq-l); Oc (100 MHz; acetone-d6), 19.24 (CH3, C7), 
25.88 (Ar-CH2, isaq-4), 29.95 (CH3, C8), 52.80 (CH2N, isaq-3), 63.36 (CH1, C6), 
66.44 (NCH, C5), 71.85 (Ar-CH, C4), 102.20 (C quat., C2), 122.71 (8 x CH arom., 
artha in BPI4 gp.), 125.34 (2 x CH arom., CIO,II), 125.78 (C quat., isaq-lO), 126.41 
(2 x CH arom., CI2,13), 128.25 (CH arom., isaq-8), 129.68 (CH arom., isaq-9), 
129.77 (4 x CH arom., para in BPI4 gp.), 135.90 (CH arom., isaq-7), 137.42 (8 x CH 
arom., meta in BPI4 gp.), 138.44 (C quat., isaq-5), 140.13 (CH arom., isaq-6), 145.00 
(C quat., C9), 149.00 (C quat., CI4), 165.00 (4 x CH, quat., arom., J 196.0 Hz, C-B, 
ipsa in BPh4 gp.), 169.53 (HC=N, isaq-l); mlz 367.1658; C2lH23N204 (cation) 
requires 367.1658. 
(+)-[(4S,5S)-2,2-dimethyl-4-[4-(methylsulfanyl)-phenyIJ-1,3-dioxan-5-yIJ-
dihydroisoquinolinium tetraphenylborate (56): 
53 56 
Prepared according to the general procedure from (4S,5S)-2,2-dimethyl-4-[4-
(methylsulfanyl)-phenyl]-1,3-dioxan-5-amine (53) (0.50 g, 2.0 mmol). Recrystallized 
from DCMfhexane, yellow plates (1.00 g, 73%); m.p. 146-148 °C (dec.); [a]lOo 
+115.9 (c 1.41, acetone); Found: C, 79.05; H, 6.59; N, 1.93. C46H46BN01S·0.5H10 
requires C, 79.27; H, 6.66; N, 2.01.; vmax(film) fcm· l 3053,2996,2360,2341, 1634, 
1603, 1571, 1478, 1265, 1201, 1162, 1108, 1075; OH (250 MHz; acetone-d6) 1.66 (3H, 
156 
s, CH), C7), 1.72 (3H, s, CHj, C8), 2.42 (3H, s, SCHj, CI6), [2.66-2.84 (I H, m), 
2.90-3.03 (I H, m), Ar-CH2, isoq-4], [3.62-3.74 (I H, m), 4.13-4.26 (1 H, m), CH2N, 
isoq-3], 4.53 (2 H, m, upfield portion of an ABX system, N-CHCHH-O, C6 & NCH, 
C5), 4.78 (I H, dd, J 13.8, 3.1 Hz, downfield portion of an ABX system, N-CHCHH-
0, C6), 5.91 (1 H, d, J2.6 Hz, Ar-CH, C4), 6.78 (4 H, t, J7.2 Hz, 4 x CH arom.,para 
in BPh4 gp.), 6.92 (8 H, t, J 7.40 Hz, 8 x CH arom., ortho in BPh4 gp.), 7.34 (8 H, m, 
8 x CH arom., meta in BP~ gp.), 7.40-7.56 (6 H, m, 6 x CH arom., 4 x CH, Ar gp., 2 
x CH isoq-8,9), 7.76-7.87 (2 H, m, 2 x CH arom., isoq-6, 7), 9.30 (1 H, s, HC=N, isoq-
1); oe (lOO MHz; acetone-d6) 15.36 (SCfh CI6), 18.83 (Cfh C7), 25.37 (Ar-Cfh, 
isoq-4), 30.01 (CH), C8), 52.33 (CH2N, isoq-3), 62.70 (CH2, C6), 66.46 (NCH, C5), 
71.53 (Ar-CH, C4), 101.39 (C quat., C2), 122.31 (8 x CH arom., ortho in BPh4 gp.), 
125.32 (C quat., arom., isoq-JO), 126.05 (2 x CH arom., CI2,13), 126.93 (2 x CH 
arom., CIO,ll), 127.35 (4 x CH arom.,para in BP~ gp.), 129.23 (CH arom., isoq-6), 
129.29 (CH arom., isoq-7), 133.92 (C quat., arom., CI4), 135.21 (CH arom., isoq-8), 
137.01 (8 x CH arom., meta in BP~ gp.), 137.82 (C quat., arom., isoq-5), 139.47 
(CH arom., isoq-9), 140.45 (C quat., arom., C9), 165.00 (4 x C quat., arom., J 196.0 
Hz, CoB, ipso in BP~ gp.), 168.49 (HC=N, isoq-1); mlz 368.1682; C22H26N02S 
(cation) requires 368.1684. 
(+)-[(4S,5S)-2,2-dimethyl-4-[4-(methylsulfonyl)-phenyl]-1,3-dioxan-5-yIJ-3,4-
dihydroisoquinolinium tetraphenylborate (58): 
6 4 
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Prepared according to the general procedure from (4S,5S)-2,2-dimethyl-4-[4-
(methylsulfonyl)-phenyl]-1,3-dioxan-5-amine (57a) (0.75 g, 2.96 mmol). 
Recrystallized from DCMfhexane, yellow plates (1.55 g, 73%); m.p. 199-201 QC 
(dec.); [a]2oD +126.7 (c 1.20, acetone); Found: C, 75.62; H, 6.32; N, 1.84. 
C46H46BN04S·O.5H20 requires C, 75.79; H, 6.50; N, 1.92.; vrnax(film) fcm'! 1636, 
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1603,1572,1478,1383,1314,1266,1202,1150,1076,1032,956; OH (400 MHz; 
acetone-d6), 1.69 (3H, s, CH3, C7, eq.), 1.72 (3H, s, CH3, C8, ax.), [2.60-2.69 (1 H, 
m), 2.85-2.96 (1 H, m), Ar-CH2, isoq-4], 3.00 (3H, s, S02CH3, CI6), [3.65-3.72 (1 H, 
m), 4.12-4.20 (1 H, m), CH2N, isoq-3], 4.49 (I H, d, J 13.6 Hz, upfield portion of an 
ABX system, N-CHCHH-O, C6, eq.), 4.57 (1 H, m, NCH, C5), 4.77 (1 H, dd, J 13.6, 
2.8 Hz downfield portion of an ABX system, N-CHCHH-O, C6, ax.), 6.05 (1 H, d, J 
2.8 Hz, Ar-CH, C4), 6.80 (4 H, t, J7.2 Hz, 4 x CH arom., para in BP14 gp.), 6.92 (8 
H, t, J 7.2 Hz, 8 x CH arom., ortho in BP14 gp.), 7.33 (8 H, m, 8 x CH meta in BPh4 
gp.), 7.49 (1 H, t, J 7.6 Hz, CH arom., isoq-8), 7.73-7.83 (3 H, m, 3 x CH arom., isoq-
6,7,9), 7.82 (2 H, d, J 8.2 Hz, 2 x CH arom., Cl 0,11), 7.95 (2 H, d, J 8.2 Hz, 2 x CH 
arom., CI2,13), 9.28 (1 H, s, HC=N, isoq-l); Oc (lOO MHz; acetone-d6), 18.83 (CH3, 
C7), 25.40 (Ar-CH2, isoq-4), 29.45 (CH), C8), 44.26 (S02CH), CI6), 52.33 (CH2N, 
isoq-3), 62.87 (CH2, C6), 66.10 (NCH, C5), 71.54 (Ar-CH, C4), 101.69 (C quat., C2), 
122.31 (8 x CH arom., ortho in BP14 gp.), 125.33 (C quat., arom., isoq-IO), 126.09 (2 
x CH arom., CI2,13), 127.56 (2 x CH arom., Cll,12), 128.84 (CH arom., isoq-6), 
129.27 (CH arom., isoq-8), 129.35 (4 x CH arom., para in BP14 gp.), 135.41 (CH 
arom., isoq-7), 137.00 (8 x CH arom., meta in BP14 gp.), 137.01 (CH arom., isoq-9), 
137.94 (C quat., arom., CI4), 142.41 (C quat., arom., isoq-5), 143.15 (C quat., arom., 
C9), 165.00 (4 x C, quat., arom., J 196.0 Hz, C-B, ipso in BP14 gp.), 168.99 (HC=N, 
isoq-l); mlz 400.1586; C22H26N04S (cation) requires 400.1583. 
(-)-[(4R,5R)-2,2-dimethyl-4-[4-(methyloxy)-phenyl]-1,3-dioxan-5-yl]-
dihydroisoquinolinium tetraphenylborate (65): 
72a 65 
Prepared according to the general procedure (-)-( 4 R ,5 R)-2,2 -dimethy 1-4-[ 4-
(methyloxy)-phenyl]-1,3-dioxan-5-amine (72a) (0.40 g, 1.7 mmol). Recrystallized 
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from DCMlhexane, yellow plates (0.83 g, 74%); m.p. 171-173 QC (dec.); [a]zoD 
-108.6 (c 1.40, acetone); vrnax(film) !cm· l 1639, 1604, 1573, 1514, 1382, 1254, 1202, 
1107, 1031; Found C, 77.70; H, 6.50; N, 1.88. C46H46BNOyO.5EhO requires C, 
77.92; H, 6.54; N, 1.98.; OH (400 MHz; CDCh) 1.51 (3H, s, CH3, C7), 1.52 (3H, s, 
CH3, C8), [2.20-2.25 (I H, m), 2.31-2.35 (I H, m), Ar-CH2, ipso-4], [2.85-2.90 (I H, 
m), 3.00-3.\0 (I H, m), CH2N, isoq-3], 3.04 (I H, m, NCH, C5), 3.56 (I H, d, J 14.4 
Hz, upfield portion of an ABX system, N-CHCHH-O, C6), 3.72 (3 H, s, OCH3, CI6), 
3.90 (1 H, dd, J 14.0, 2.8 Hz, downfield portion of an ABX system, N-CHCHH-O, 
C6), 5.11 (I H, d, J 2.4 Hz, Ar-CH, C4), 6.79 (2 H, d, J2.0 Hz, CH arom., CIO,I1), 
6.87 (2 H, m, CH arom., CI2,13 & 4 x CH arom., para in BPi4 gp.), 7.02 (8 H, t, J 
7.6 Hz, 8 x CH arom., ortho in BPi4 gp.), 7.23 (2 H, m, CH arom., isoq-8,-9) 7.24 (1 
H, m, CH arom., isoq-6), 7.41 (8 H, m, 8 x CH arom., meta in BPi4 gp.), 7.57 (I H, 
m, CH arom., isoq-7), 8.25 (I H, s, HC=N, isoq-l); oc (100 MHz; CDCI3) 18.37 
(CliJ, C7), 24.64 (Ar-ClIz, isoq-4), 29.44 (CH3, C8), 50.52 (CHzN, isoq-3),55.38 
(OCH3, C16) 61.85 (CH2, C6), 64.88 (NCH, C5), 70.52 (Ar-CH, C4), 100.40 (C quat., 
C2), 114.40 (2 x CH arom., CI2,13), 122.19 (8 x CH arom., ortha in BPi4 gp.), 
123.70 (C quat., arom., isoq-lO), 125.86 (4 x CH arom.,para in BPi4 gp.), 127.31 (2 
x CH arom., CIO,11), 127.90 (C quat., arom., C9), 128.65 (CH arom., isoq-8), 129.50 
(CH arom., isoq-8), 134.00 (CH arom., isoq-6), 134.73 (C quat., arom., isoq-5) 136.19 
(8 x CH arom., meta in BPi4 gp.), 138.82 (CH arom., isoq-7), 159.75 (C quat., arom., 
CI4), 163.80 (4 x C quat., arom., J 147.00 Hz, CoB, ipso in BPi4), 169.53 (HC=N, 
isoq-l); mlz 352.1915; C22Hz6N03 (cation) requires 352.1913. 
5,7-dihydrodibenzo[c,e)oxepine (77): 
( ~ ~ > 
HO OH 
78 77 
A suspension of2,2'-biphenyl dimethanol (78), (4.22 g, 19.5 mmol), in hydrobromic 
acid (60 ml, 24% in water), was heated to 100 QC for 40 min. The cloudy solution was 
then allowed to cool and the aqueous phase extracted with diethyl ether (3 x 50 ml). 
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The organic layers are then washed with brine (50 ml), sat. aq. Sodium hydrogen 
carbonate and dried (MgS04). Solvent was removed to yield a colourless solid. 
Recrystallized from ethyl acetate/light petroleumto give colourless crystals, (3.25 g, 
85%); m.p. 71 QC; vrnax(fiIm) /cm" 1567, 1197, 1073, 1042,903,891,754,602; OH 
(400 MHz; CDCIJ) 4.35 (4 H, s, 2 X CH20), 7.23-7.56 (8 H, m, 8 x CH arom.); Oe 
(100 MHz; CDCIJ) 67.53 (2 x Ar-CH 20), 127.46 (2 x CH arom., biphenyl-4, 4 '), 
128.24 (2 x CH arom., biphenyl-6, 6), 128.91 (2 x CH arom., biphenyl-3,3), 129.69 
(2 x CH arom., biphenyl-5,5'), 135.16 (2 x C quat., arom., biphenyl-i,]), 141.19 (2 x 
C quat., arom., biphenyl-2, 2 ); mlz 196.0887; C'4H'20 (M+) requires 196.0888. 
2-[2-(bromomethyl)phenyl]benzene carbaldehyde (76):8 
< {5 > 
o 
77 76 
To an ice cooled solution of5,7-dihydrodibenzo[c,e]oxepine (77) (2.00 g, 10.2 mmol), 
in carbon tetrachloride (50 ml), in a round bottom flask equipped with a reflux 
condenser was added molecular bromine (1.76 g, 11.0 mmol), in carbon tetrachloride 
(6 ml), dropwise over 5 min (the reaction turns deep red). The cooling bath was 
removed and the reaction mixture irradiated with ultra violet light for 5 h (after 20 min 
solution turns pale yellow, indicative of complete consumption of bromine). The 
resultant solution was evaporated under reduced pressure, then diluted with diethyl 
ether, washed with sat. aq. Sodium carbonate, brine and dried (MgS04). Solvents were 
removed under reduced pressure to yield a orange oil. Crystallized from ethyl 
acetate/light petroleum as colourless crystal. (1.80 g, 64%); m.p. 56-58 QC; vrnax(nujol) 
/cm" 1694, 1594, 1255, 1221, 1197,761; OH (400 MHz; CDCb) 4.21 (2 H, dd, J 40.0, 
10.1 Hz, CH2Br), 7.12-7.98 (8 H, m, 8 x CH, arom.), 9.65 (I H, s, HC=O); Oe (100 
MHz; CDCIJ), 33.83, (CH2Br), 129.96 (CH, arom., biphenyl-5), 130.88 (CH arom., 
biphenyl-3), 131.02 (CH, arom., biphenyl-4), 131.40 (CH, arom., biphenyl-6), 133.00 
(CH, arom., biphenyl-4 '), 133.05 (CH, arom., biphenyl-6 '), 133.39 (CH, arom., 
biphenyl-3'), 135.95 (CH, arom., biphenyl-5 '), 136.41 (CH, quat., arom., biphenyl-2), 
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138.28 (CH, quat., arom., biphenyl-i), 140.16 (CH, quat., arom., biphenyl-i '),145.63 
(C, quat., arom., biphenyl-2,), 194.08 (C quat., HC=O); mlz 275.9977 (81 Br isotope); 
C14HllBrO (M+) requires 275.9974. 
General procedure for the synthesis of SH-dibenzo[c,e]azepinium salts from 2-[2-
(bromomethyl)phenyl]benzene carbaldebyde and primary amines: 
A solution of the amine in ethanol, (10 ml per g of amine, 1 equivalent), was added 
dropwise via a stoppered, pressure equalising, dropping funnel, to an ice cooled, one-
neck flask, containing a solution of2-[2-(bromomethyl)phenyl]benzene carbaldehyde, 
(1.10 equiv.) in ethanol (10 ml/g carbaldehyde). After the addition was complete the 
dropping funnel was removed and replaced by a stopper to contain the hydrogen 
bromide generated temporarily in the reaction. The reaction mixture was stirred 
overnight while attaining ambient temperature. Sodium tetraphenylborate, (or any 
other anion exchanging salt, 1.10 equivalents), in the minimum amount of acetonitrile, 
was added in one portion to the reaction mixture and after 5 minutes of stirring, the 
organic solvents are removed under reduced pressure. Ethanol was added to the 
residue, followed by water. The resulting solid was collected by filtration and washed 
with additional ethanol followed by diethyl ether. If no solid materialises after the 
addition of the water the suspension is allowed to settle and the ethanol/water phase is 
decanted off. The gummy residue which may be obtained, is macerated in hot ethanol 
or methanol. The organic salt may then precipitate but in some rare cases it does so 
upon slow cooling of the hot alcoholic solution. If solubility problems do arise, small 
amounts of acetonitrile may be added during this process. 
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(+)-6-[ (IR,2R,3R,5S)-2,6,6-trim ethylbicyclo [3.1.1] hept -3-yl]-5H-
dibenzo[c,e]azepinium tetraphenylborate (79):8 
~ 
NH2 
8 79 
Prepared according to the general procedure from (-)·isopinocamphenylamine (8) 
(3.12 g, 20.5 mmol). The product was isolated as yellow plates (8.00 g, 60%); m.p. 
212°C (dec.); [a]2oD +22.4 (c 1.00, CH)CN); Found: C, 87.81; H, 7.20; N, 1.95. 
C48H48BNe0.3H20 requires C, 87.79; H, 7.37; N, 1.95.; Ymax(nujol) fcm· 1 1630, 1599, 
1580, 1557, 1209, 756, 705, 612; OH (400 MHz; DMSO-d6, 80°C) 1.02 (3 H, d, J 
11.28 Hz, CHCH), CIO), 1.14 (3 H, s, CCH), C8), 1.35 (3 H, s, CCH), C9), 1.48 (I H, 
d, J 16.8 Hz, CH, Cl), 2.02 (I H, td, J 9.3,2.6 Hz, CHH, C7), 2.10-2.31 (2 H, m, 
CHH, C7 and CH, CS), 2.55-2.74 (3 H, m, CH, C2 and CH2, C4), 4.84-5.12 (3 H, m, 
Ar-CH2N and CH, C3), 6.80 (4 H, t, J 11.4 Hz, 4 x CH arom.,para in BP~ gp.), 6.93 
(8 H, t, J 11.8 Hz, 8 x CH arom., arfha in BP~ gp.), 7.20-7.29 (8 H, m, arom., mefa in 
BP~ gp.), 7.61-7.92 (6 H, m, 6 x CH arom., biphenyl-3, biphenyl-4,4', biphenyl-5,5', 
biphenyl-6), 8.02 (I H, td, J 11.64, 2.24 Hz, CH arom., biphenyl-6'), 8.07-8.16 (I H, 
m, CH arom., biphenyl-3 '),9.69 (I H, s, HC=N); Oc (lOO MHz; DMSO-d6, 80°C) 
19.92 (CH), C8), 23.76 (CH), C9), 28.97 (CH), CIO), 33.69 (CH2, C7), 34.80 (CH2, 
CH2N), 40.00 (C quat., C6), 41.12 (CH, C5), 42.15 (CH, C2), 48.36 (CH, Cl), 53.99 
(CH2, C4), 74.28 (CH, C3), 122.23 ( 8 x CH arom., arfha in BP~ gp.), 125.96 (4 x 
CH arom.,para in BP~ gp.), 127.77 (C quat., arom., biphenyl-2), 129.41 (CH arom., 
biphenyl-4), 129.65 (CH arom., biphenyl-6), 129.94 (CH arom., biphenyl-3), 130.31 
(CH arom., biphenyl-5), 130.69 (CH arom., biphenyl-4'), 131.08 (CH arom., biphenyl-
6'),131.12 (CH arom., biphenyl-3'), 135.41 (C quat., arom., biphenyl-i), 135.74 (CH 
arom., biphenyl-5'), 136.55 (8 x CH arom., meta in BPh4 gp.), 137.93 (C quat., arom., 
biphenyl-i '), 141.90 (C quat., arom., biphenyl-2 '), 164.50 (4 x C quat., arom., J 
196.40 Hz, CoB ipsa in BP~ gp.), 171.15 (HC=N). mlz 330.2228; C24H28N (cation) 
requires 330.2222. 
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(-)-2-[(4S,SS)-2,2-dimethyl-4-phenyl-l,3-dioxan-S-yl)-SH-dibenzo[c,e)azepinium 
tetraphenylborate (80): 
15 80 
Prepared according to the general procedure from (+)-(4S,5S)-2,2-Dimethyl-4-phenyl-
1,3-dioxan-5-amine (15) (3.85 g, 18.8 mmol). The product was isolated as yellow 
plates (9.00 g, 68%); m.p. 187-188 DC (dec.); [a)2oD -44.0 (c 1.01, CH)CN); Found C, 
85.23; H, 6.52; N, 1.96. CsoH46BN02 requires C, 85.34; H, 6.59; N, 1.99.; vmax(film) 
fcm-! 3055,3038,2999,1633, 1579, 1480, 1451, 1385, 1203, 1114, 848,735,706; 
oH(400 MHz; DMSO-d6, 115 DC) 1.71 (3 H, s, CH), C7), 1.74 (3 H, s, CH), C8), 4.32 
(1 H, d, J 21.8 Hz, upfield portion of an ABX system, N-CHCHH-O, C6, eq.), 4.49 (1 
H, d, J21.6 Hz, Ar-CHHN), [4.68-4.77 (1 H, m, NCH, CS), 4.72 (1 H, dd, J 5.2,21.8 
Hz, downfield portion of an ABX system, N-CHCHH-O, C6, eq.)], 5.15 (1 H, d, J22.2 
Hz, Ar-CHHN), 5.82 (I H, d, J 4.1 Hz, Ar-CH, C4), 6.75 (4 H, t, J 11.4 Hz, arom., 
para in BPh4 gp.), 6.88 (8 H, t, J11.5 Hz, arom., ortho in BP~ gp.), 7.11-7.16 (5 H, 
m, Ph gp.), 7.20-7.25 (8 H, m, arom., meta in BP~gp.), [7.55-7.63 (3 H, m, arom.), 
7.64-7.69 (3 H, m, arom.), 7.92-7.94 (2 H, m, arom.), biphenyl gp.], 9.03 (1 H, s, 
HC=N); oc(lOO MHz; DMSO-d6, 120°C) 18.05 (CH), C8), 28.41 (CH), C9), 55.77 
(Ar-CH2N), 60.81 (CH2, C6), 66.12 (NCH, CS), 70.49 (Ar-CH, C4), 99.87 (C quat., 
C2), 120.42 (8 x CH arom., ortho in BP~ gp.), 124.10 (4 x CH arom.,para in BP~ 
gp.), 124.16 (2 x CH arom., meta in Ph gp.), 124.19 (2 x CH arom., ortho in Ph gp.), 
124.39 (CH arom.,para in Ph gp.), 127.32 (C quat., arom., biphenyl-4'), 127.59 (CH 
arom., biphenyl-4'), 127.69 (CH arom., biphenyl-6'), 128.19 (CH arom., biphenyl-]'), 
128.26 (CH arom., biphenyl-5'), 129.00 (CH arom., biphenyl-4), 129.31 (CH arom., 
biphenyl-6), 129.39 (CH arom., biphenyl-3), 132.58 (C quat., arom., biphenyl-1 '), 
133.57 (CH arom., biphenyl-5), 134.95 (8 x CH arom., meta in BP~ gp.), 135.23 (C 
quat., arom., biphenyl-i), 140.46 (C quat., arom., biphenyl-2), 163.30 (4 x C quat., 
arom., q, J 196.0 Hz, CoB ipso in BP~ gp.), 170.11 (HC=N); mlz 384.1968; 
C26H26N02 (cation) requires 384.1964. 
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(-)-2-[(4S,5S)-2,2-Dimethyl-4-[4-(nitro)-phenyl]-1,3-dioxan-5-yl]-5H-
dibenzo[c,e]azepinium tetraphenylborate (81): 
" - BPh4 
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Prepared according to the general procedure from (+)-(4S,5S)-2,2-Dimethyl-4-[4-
(nitro )-phenyl]-I ,3-dioxan-5-amine (52) (0.30 g, 1.19 mmol). The product was 
isolated as yellow plates (0.57 g, 64%); m.p. 209-210 °C (dec.); [a]20D -68.0 (c 1.17, 
acetone); Found: C, 85.23; H, 6.52; N, 1.96. CSOH46BN02 requires C, 85.34; H, 6.59; 
N, 1.99.; vmax(film) (cm' I 3055,2998, 1633, 1600, 1579, 1523, 1480, 1451, 1385, 
1349, 1204, 1106,969,852; OH(400 MHz; DMSO-d6, 100°C) 1.67 (3 H, s, CH3, C7), 
1.71 (3 H, s, CH3, C8), 4.35 (I H, d, J 13.2 Hz, upfield portion of an ABX system, N-
CHCHH-O, C6), 4.49 (I H, d, J 12.8 Hz, Ar-CHHN), 4.66 (1 H, d, J 13.2 Hz, 
downfield portion of an ABX system, N-CHCHH-O, C6,), 4.82 (1 H, s, NCH, C5), 
4.99 (1 H, d, J12.8 Hz, Ar-CHHN), 5.91 (I H, s, Ar-CH, C4), 6.71 (4 H, t, J 6.8 Hz, 4 
x CH arom., para in BP~ gp.), 6.85 (8 H, t, J 6.8 Hz, 8 x CH arom., ortho in BP~ 
gp.), 7.17 (8 H, m, 8 x CH arom., meta in BP~ gp.), 7.44 (4 H, m, 2 x CH arom., C12, 
13 & 2 x CH arom., biphenyl gp.), 7.56-7.75 (4 H, m, 4 x CH arom., biphenyl gp.), 
7.84 (2 H, d, J 8.4 Hz, 2 x CH arom., CI0, 11),7.88 (2 H, m, 2 x CH arom., biphenyl 
gp.), 9.19 (I H, s, HC=N); oc(lOO MHz; DMSO-d6, lOO 0c) 19.67 (CH3, C7), 30.05 
(CH3, C8), 58.04 (CH2, Ar-CH2N), 62.65 (CH2, C6), 67.14 (CH, NCH, C5), 71.61 
(Ar-CH, C4), 101.82 (C quat., C2), 122.18 (4 x CH arom.,para in BP~ gp.), 124.21 
(2 x CH arom., CI2,13), 125.91 (8 x CH arom., ortho in BPI4 gp.), 126.91 (C quat., 
arom., biphenyl-2), 127.53 (2 x CH arom., CIO,II), 129.46 (CH arom., biphenyl-5'), 
129.86 (CH arom., biphenyl-4), 130.00 (CH arom., biphenyl-6), 130.81 (CH arom., 
biphenyl-6 '), 130.89 (CH arom., biphenyl-4 ,), 134.09 (C quat., arom., biphenyl-2'), 
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135.75 (CH arom., biphenyl-3), 136.59 (9 x CH arom., 8 CH meta in BPh4 gp. & CH 
biphenyl-5), 137.10 (CH arom., biphenyl-3'), 137.42 (C quat., arom., biphenyl-i), 
142.09 (C quat., arom., biphenyl-i '), 143.97 (C quat., arom., C9), (C quat., arom., 
CI4), 164.60 (4 x C quat., arom., q, J 196.0 Hz, C-B ipso in BP14gp.), 171.97 
(HC=N); mlz 429.1815; C26H2SN204 (cation) requires 429.1814. 
(-)-2-[( 4S,5S)-2,2-Dim ethyl-4-[4-( ID ethy Isulfonyl)-pheny 1)-1,3-dioxan-5-y I) -5H-
dibenzo[c,e)azepinium tetraphenylborate (82): 
57 
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Prepared according to the general procedure from (+)-(4S,5S)-2,2-dimethyl-4-[4-
(methylsulfonyl)-phenyl)-1,3-dioxan-5-amine (57) (0.30 g, 1.05 mmol). The product 
was isolated as yellow plates (0.54 g, 66%); m.p. 162-165 °C (dec.); [afoo -50.3 (c 
1.09, acetone); Found: C, 75.14; H, 5.89; N, 1.75. CSIH4SBN04S.2.0H20 requires C, 
74.87; H, 6.29; N, 1.71.; vrnax(film) fcm· 1 3052,2997, 1636, 1599, 1551, 1479, 1454, 
1385,1304,1205, 1148, 1090,947.6,844; oH(400 MHz; DMSO-d6, lOO 0c) 1.79 (3 
H, s, CH), C7), 2.01 (3 H, s, CH), C8), 3.01 (3 H, s, SCH), CI6), 4.40 (1 H, d, J 13.6 
Hz, upfieId portion of an ABX system, N-CHCHH-O, C6), 4.56 (I H, d, J 13.2 Hz, Ar-
CHHN), 4.66 (I H, dd, J 13.6, 3.2 Hz, downfield portion of an ABX system, N-
CHCHH-O, C6), 4.88 (I H, bs, NCH, C5), 5.15 (I H, d, J 12.8 Hz, Ar-CHHN), 5.91 
(I H, d, J2.8 Hz, Ar-CH, C4), 6.79 (4 H, t, J 6.8 Hz, 4 x CH arom.,para in BP14 gp.), 
6.92 (8 H, t, J 7.6 Hz, 8 x CH arom., ortho in BP14 gp.), 7.17 (8 H, m, 8 x CH arom., 
meta in BP14 gp.), 7.52-7.58 (4 H, m, 2 x CH arom., CI2,13 & 2 x CH arom., 
biphenyl gp.), 7.65-7.74 (4 H, m, 2 x CH arom., CIO,II, & 2 x CH arom., biphenyl 
gp.), 7.91-7.97 (2 H, m, 2 x CH arom., biphenyl gp.), 9.16 (1 H, s, HC=N); oc(100 
MHz; DMSO-d6, lOO CC) 19.28 (CH), C7), 29.67 (CH), C8), 44.23 (SCH), 57.04 
165 
(Ar-CfhN), 62.07 (CH2, C6), 66.80 (NCH, C5), 71.35 (Ar-CH, C4), 101.34 (C quat., 
C2), 121.77 (4 x CH arom., para in BPh4 gp.), 125.50 (8 x CH arom., ortho in BP~ 
gp.), 126.43 (C quat., arom., biphenyl-2), 126.79 (2 x CH arom., CI2,13), 127.39 (2 x 
CH arom., CI2,13), 128.64 (C quat., arom., CI4), 129.02 (CH arom., biphenyl-5'), 
129.48 (CH arom., biphenyl-4), 129.59 (CH arom., biphenyl-6), 130.35 (CH arom., 
biphenyl-6'), 130.61 (CH arom., biphenyl-4'), 130.80 (CH arom., biphenyl-3), 135.06 
(CH arom., biphenyl-5), 136.19 (8 x CH arom., meta in BPh4 gp.), 136.66 (CH arom., 
biphenyl-3'), 137.06 (C quat., arom., biphenyl-2'), 141.48 (C quat., arom., biphenyl-
1), 141.68 (C quat., arom., biphenyl-1 '), 142.02 (C quat., arom., C9), 164.10 (4 x C 
quat., arom., q, J 196.0 Hz, C-B ipso in BPh4 gp.), 171.63 (HC=N); mlz 462.1739; 
C27H28N04S (cation) requires 462.1739. 
(+)-2-[( 4S,5S)-2,2-Dimethy 1-4-[4-( methyloxy )-pheny 1)-1 ,3-dioxan-5-y 1)-5H-
dibenzo[c,e)azepinium tetraphenylborate (83): 
72a 83 
Prepared according to the general procedure from (-)-(4R,5R)-2,2-dimethyl-4-[4-
(methyloxy)-phenyl)-1,3-dioxan-5-amine (72a) (0.13 g, 0.48 mmol). The product was 
isolated as yellow plates (0.23 g, 64%); m.p. 207-209 °C (dec.); [a]2oD +37.8 (c 1.09, 
acetone); Found: C, 76.58; H, 6.02; N, 1.84. CSIH4sBNO)e3.5H20 requires C, 76.84; 
H, 6.52; N, 1.76.; vmax(film) fcm- I 3055,2998, 1633, 1613, 1579, 1557, 1514, 1480, 
1384,1253,1202,1031,966; oH(400 MHz; DMSO-d6, lOO 0c) 1.66 (3 H, s, CH), 
C7), 1.68 (3 H, s, CH), C8), 3.60 (3 H, s, OCH), CI6), 4.28 (I H, dd, J 14.4, 2.0 Hz, 
upfield portion of an ABX system, N-CHCHH-O, C6), 4.43 (I H, d, 14.0 Hz, Ar-
CHHN), 4.65 (2 H, m, downfield portion of an ABX system, N-CHCHH-O, C6 & 
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CRN, C5), 5.02 (1 H, d, J 14.0 Hz, Ar-CHHN), 5.70 (1 H, d, J 2.8 Hz, Ar-CH, C4), 
6.63 (2 H, d, J 8.6 Hz, 2 x CH arom., C12, 13),6.72 (4 H, t, J 7.4 Hz, 4 x CH arom., 
para in BPILt gp.), 6.86 (8 H, t, J 7.4 Hz, 8 x CH arom., artha in BPh4 gp.), 7.08 (2 H, 
d, J 8.6 Hz, 2 x CH arom., CI0, 11),7.18 (8 H, m, 8 x CH arom., meta in BPILt gp.), 
7.52 (3 H, m, 3 x CH arom., biphenyl-3 ',4 ',5 '),7.65 (3 H, m, 3 x CH arom., biphenyl-
3,4,5),7.91 (2 H, m, 2 x CH arom., biphenyl-6,6,), 9.00 (1 H, s, HC=N, CI8); Oc(100 
MHz; DMSO-d6, 100°C) 18.28 (CH), C7), 28.80 (CH), C8), 54.79 (OCH), CI6), 
56.11 (Ar-CH2N), 60.94 (CH2, C6), 66.42 (NCH, C5), 70.45 (Ar-CH, C4), 100.03 (C 
quat., C2), 113.75 (2 x CH arom., C12, 13), 120.81 (4 x CH arom.,para in BPh4 gp.), 
124.58 (8 x CH arom., artha in BPILt gp.), 125.57 (C quat., arom., biphenyl-2), 
125.92 (2 x CH arom., CI0, 11), 127.47 (C quat., arom., C9), 128.02 (CH arom., 
biphenyl-4), 128.49 (CH arom., biphenyl-5'), 128.54 (CH arom., biphenyl-5), 129.37 
(CH arom., biphenyl-6'), 129.60 (CH arom., biphenyl-4 ') 129.67 (CH arom., 
biphenyl-4), 132.92 (C quat., arom., biphenyl-2'), 133.91 (CH arom., biphenyl-3), 
135.21 (8 x CH arom., meta in BPILt gp.), 135.51 (CH arom., biphenyl-6), 136.15 (C 
quat., arom., biphenyl-i), 140.69 (C quat., arom., biphenyl-l '), 158.74 (C quat., arom., 
CI4), 163.25 (4 x C quat., arom., q, J 196.0 Hz, C-B ipsa in BPlLtgp.), 170.21 
(HC=N); mlz 414.2063; C27H2SNO) (cation) requires 414.2069. 
(R)-Trifluoro-methanes ulfonic acid 2' -trifluorom ethanes ulfony Ioxy 
[J,J'[binaphthalenyI-2-yI ester (88R): 
OH 
OH 
6' 4' ... 
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(R)-[I,I']Binaphthalenyl-2,2'-diol (87R) (1.70 g, 5.9 mmol) was dissolved in 
dichloromethane (40 ml) and cooled to -30 DC. To this was added 4-
dimethylaminopyridine (0.289 g, 2.4 mmol), 2,6-lutidine (2.06 ml, 17.7 mmol) and 
triflie anhydride (2.98 ml, 17.7 mmol). The solution was allowed to warm to room 
temperature and stirred for 4 h. Silica gel was added to the solution and the solvent 
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evaporated under reduced pressure. The compound adsorbed on silica was transferred 
to a fritted glass funnel and washed with ethyl acetate/light petroleum until the title 
compound had eluted. Solvents were removed under reduced pressure to yield a crude 
colourless solid, which was recrystallized from hexane to give colourless crystals 
(3.20 g, 99%), m.p. 68-70 °C; [U]20D -145.3 (c 1.08, CHCh) [Lit" +142.0 (c 1.04, 
CHCh), for (S)-enantiomer]; vrnax(film) /cm" 3062, 1508, 1424, 1246, 1140, 1065, 
963,865; /lH (250 MHz; CDCll) 7.25 (2 H, m, 2 x CH arom., binap-3,-3 '),7.40 (2 H, 
m,2 x CH arom., binap-7,-7'), 7.59 (4 H, m, 4 x CH arom., binap-7,-7',-9,-9'), 8.00 
(2 H, d, J 8.2 Hz, 2 x CH arom., binap-4, -4 '), 8.13 (2 H, d, J 9.0 Hz, 2 x CH arom., 
binap-6,-6'); /le (100 MHz; CD Ch) 118.12 (2 x C quat., q J 318.0 Hz, 2 x CFl), 
119.33 (2 x CH arom., binap-3,-3 '),123.46 (2 x C quat., arom., binap-l,-l '), 126.76 
(2 x CH arom., binap-7,-7'), 127.33 (2 x CH arom., binap-9,-9 '), 127.99 (2 x CH 
arom" binap-8,-8'), 128.36 (2 x CH arom., binap-6,-6'), 132.00 (2 x CH arom., binap-
4,-4'),132.37 (2 x C quat., arom., binap-5,-5'), 133.17 (2 x C quat., arom., binap-lO,-
10'), 145.41 (2 x C quat., arom., binap-2,-2 '); mlz 549.9974; C22H'2F60 6S2 (M+) 
requires 549.9980. 
(S)-Trifluoro-methanesulfonic acid 2' -trifluoromethanesulfonyloxy 
[1,1 ')binaphthalenyl-2-yl ester (88s): 
87s 
OH 
OH 
6'" F. 
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88s 
Prepared in an identical manner to the (R)-enantiomer (88R) above, from (S)-
[l,I']binaphthalenyl-2,2'-diol (87s) (6.76 g, 24.0 mmol). Colourless crystals (13.0 g, 
99%); having almost identical spectroscopic data to (88R): m.p. 65-67 °C; [UfOD 
+140.6 (c 1.09, CHCll). 
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(R)-2,2'-Dimethyl-[l,1 ')binaphthalenyl (89R): 
(R)- Trifluoro-methanesulfonic acid 2'-trifluoromethanesulfonyloxy 
[I,I']binaphthalenyl-2-yl ester (88R ) (13.0 g, 23.6 mmol) and 1,3-
bis(diphenylphosphino)propane nickel(II)chloride (1.10 g, 1.7 mmol) were dissolved 
in anhydrous diethyl ether (100 ml). The reaction was cooled to -10°C in a ice/salt 
bath and methylmagnesium bromide (3 M in EtzO, 31.5 ml, 94.4 mmol) was added 
dropwise over 30 min. The reaction was allowed to attain ambient temperature and 
stirred over night. The dark greenlbrown solution was diluted with diethyl ether (150 
ml) and filtered through celite (to remove the nickel catalyst). The filtrate was washed 
with 0.5 M hydrochloric acid (2 x 50 ml) and brine (50 ml). Removal of solvent under 
reduced pressure yielded a red/orange crude oil, which was purified by column 
chromatography eluting with hexane to give a pale yellow oil. Crystallization from 
methanol afforded the product as colourless crystals (6.00 g, 90%); m.p. 68-72 °C 
(LitIZ 67-71 0C); [a]zoD -39.0 (c 1.12, CHCh) [Lit!) [a]Z!D +37.7 (c LOO, CHCl) for 
(S)-enantiomer]; vmax(film) /cm'! 3053,2246, 1594, 1506, 1421, 1379, 1351, 1221, 
1143, 1027,913,865; OH (250 MHz; CDCh) 2.03 (6 H, s, 2 x Ar-CH), 7.04 (2 H, d, J 
8.4 Hz, 2 x CHarom., binap-3,-3,), 7.19 (2 H, m, 2 x CHarom., binap-7,-7'), 7.35 (2 
H, m, 2 x CH arom., binap-8,-8'), 7.37 (2 H, d, J 8.3 Hz, 2 x CH arom., binap-4,-4 '), 
7.86 (2 H, d, J 8.4 Hz, 2 x CH arom., binap-9,-9'), 7.88 (2 H, d, J 8.4 Hz, 2 x CH 
arom., binap-6,-6'); Oc (100 MHz; CDCh) 20.01 (2 x Ar-CH), 124.87 (2 x CH arom., 
binap-7,7'), 125.62 (2 x CH arom., binap-8,-8'), 126.06 (2 x CH arom., binap-4,4'), 
127.41 (2 x CH arom., binap-9,-9,), 127.90 (2 x CH arom., binap-6,-6'), 128.70 (2 x 
CH arom., binap-3,-3 '), 132.20 (2 x C quat., arom., binap-5.-5 '), 132.75 (2 x C quat., 
arom., binap-JO,-JO '), 134.2520 (2 x C quat., arom., binap-2,-2 '), 135.11 (2 x C 
quat., arom., hinap-l,-l '); mlz 300.1747; CzzHzzN (M"'NH4) requires 300.1752. 
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(S)-2,2'-Dimethyl-[1,1 ']binaphthalenyl (89s): 
° F\;ko 
...-'\ \\ 
F F ° 
88s 89s 
Prepared in an identical manner to the (R)-enantiomer (89R) above, from (S)-trifluoro-
methanesulfonic acid 2'-trifluoromethanesulfonyloxy [1,1 ']binaphthalenyl-2-yl ester 
(88s) (5.00 g, 9.0 mrnol). Colourless crystals (2.33 g, 92%); having almost identical 
spectroscopic data to (89R): m.p. 71-73 °C; [a]2oD +37.0 (c 1.01, CHCh). 
(R)-2,2'-Dibromomethyl-[I,1 ']binaphthalenyl (90R): 
Table 7, Method 1: 
(R)-2,2'-Dimethyl-[I,I']binaphthalenyl (89R ) (5.00 g, 17.7 mmol) was dissolved in 
carbon tetrachloride (70 ml) and N-bromosuccinamide (6.63 g, 37.2 mmol), benzoyl 
peroxide (0.057 g, 0.2 mmol) were added. The mixture was heated under reflux for 24 
h and upon cooling the solvent was removed under reduced pressure. The red/brown 
residue which remained, was diluted with chloroform and washed with water and 
brine. The organics were dried (MgS04) and solvent removed under reduced pressure. 
Recrystallization from chloroformlhexane afforded the product as colourless crystals 
(3.5 g, 45%). The remaining filtrate was concentrated and subjected to column 
chromatography eluting with light petroleum/ethyl acetate (97:3). Giving 0.18 g of 
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starting material and a further 1.50 g of product (after recrystallization from 
chloroformlhexane), a total of 5.0 g, 64%. 
Table 7, Method 2: 
(R)-2,2'-Dimethyl-[I,I'Jbinaphthalenyl (89R ) (3.00 g, 10.6 mmol), N-
bromosuccinamide (3.78 g, 21.3 mmol) and AIBN (10 mol%, 0.174 g, 1.1 mmol) 
were stirred in carbon tetrachloride (35 ml). The solution was irradiated with visible 
light (150 Watt Philips tungsten bulb) for 5 h. The reaction mixture was filtered 
through a fritted glass funnel and a scoop of silica added. The solvent was removed 
under reduced pressure to give the reaction mixture adsorbed onto silica. Immediately 
chromatographed eluting with light petroleum/ethyl acetate (97:3) to afford a 
colourless solid, recrystallized from chloroformlhexane. Colourless crystals (4.1 0 g, 
88%). 
Table 7, Method 3: 
Prepared as Method 2, from (R)-2,2'-Dimethyl-[I,I'Jbinaphthalenyl (89R) (4.00 g, 14.2 
mmol), using cycIohexane as reaction solvent (60 ml). Colourless crystals (5.50 g, 
88%). 
m.p. 185-187 °C; [afoo -164.4 (c 1.04, benzene); vrnax(film) /cm· l 3049,2360, 1506, 
1431,1210,818,749,684; OH (400 MHz; CDCb) 4.25 (4 H, s, 2 x Ar-CH2), 7.07 (2 
H, d, J 8.0 Hz, 2 x CH arom., binap-3,-3 '), 7.25 (2 H, m, 2 x CH arom., binap-7,-7 '), 
7.46 (2 H, m, 2 x CH arom., binap-8,-8'), 7.74 (2 H, d, J8.0 Hz, 2 x CH arom., binap-
4,-4,),7.91 (2 H, d,J8.0 Hz, 2 x CHarom., binap-9,-9'), 8.00 (2 H, d,J8.0 Hz, 2 x 
CH arom., binap-6,-6'); oc (100 MHz; CDCb) 32.61 (2 x Ar-CH2), 126.78 (2 x CH 
arom., binap-7,-7'), 126.80 (2 x CH arom., binap-8,-8'), 127.61 (2 x CH arom., binap-
4,-4'), 127.74 (2 x CH arom., binap-9,-9'), 128.02 (2 x CH arom., binap-6,-6'), 
129.35 (2 x CH arom., binap-3,-3'), 132.50 (C quat., arom., binap-5,-5'), 133.25 (C 
quat., arom., binap-IO,-IO'), 134.07 (C quat., arom., binap-2,-2 '), 134.17 (C quat., 
arom., binap-l,-l '); mlz 437.9614; C22Hl6Br2 (M+) requires 437.9619. 
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(S)-2,2'-Dibromomethyl-[l,1 ')binaphthalenyl (90s): 
89s 90s 
Prepared in an identical manner to the (R)-enantiomer (90R) above (method I), from 
(S)-2,2'-dimethyl-[I,I')binaphthalenyl (89s) (2.00 g, 7.1 mmol). Colourless crystals 
(1.87 g, 60%); having almost identical spectroscopic data to (90R): m.p. 181-183 QC 
(litJ3 183-184 QC); [a]20o -159.0 (c 1.17, benzene) [lit ll [a]20o -160.0 (c 1.00, 
benzene)]. 
(R)-(2' -Hydroxym ethyl-[1,1') bin a phthaleny 1-2-yl)-m ethano I (86 R): 
Br 
Br 
A solution of (R)-2,2'-Dibromomethyl-[l,I']binaphthalenyl (90R ) (3.50 g 8.0 mmol) 
was dissolved in dimethylformamide (300 ml) and stirred at 80 QC with potassium 
acetate (3.75 g, 38.2 mmol) and tetrabutylammonium bromide (1.0 g) for 24 h. The 
mixture was allowed to cool, diluted with brine (ISO ml) and extracted with diethyl 
ether (3 x 100 ml). The organics were combined and washed with brine (2 x 50 ml), 
dried (MgS04) and solvents removed under reduced pressure to yield a pale 
yellow/brown oil. Recrystallized from chloroform/hexane. (R)-Acetic acid 2'-
acetoxymethyl-[I,I']binaphthalenyl-2-ylmethyl ester (3.0 g, 7.5 mmol) was 
hydrolysed in refluxing potassium hydroxide (50% in water)I1,4-dioxane (1:1, lOO 
ml) for 24 h. The solution was allowed to cool and extracted with diethyl ether (3 x 
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50ml). The organic layers were combined and washed with brine (2 x 50 ml) to give a 
crude yellow/brown oil. Crystallized from chloroformfhexane to give colourless 
crystals (2.10 g, 88%); m.p. 167-169 °C; [a)20o +63.2 (c 1.35, acetone) [LitlO [a)24o 
-67.5 (c 1.00, acetone) for (S)- enantiomer); vmax(film) fcm- I 3384, 3057, 1648, 1507, 
1428, 1216, 1013,822; OH (250 MHz; CDCb) 3.26 (2 H, bs, 2 x OH), 4.08 (2 H, d, J 
11.1 Hz, Ar-CH2), 4.37 (2 H, d, J11.1 Hz, Ar-CH2), 7.01 (2 H, d, J 8.24,2 x CH 
arom., hinap-3,-3 '),7.22 (2 H, m, 2 x CH arom., hinap-7,-7'), 1.97 (2 H, m, 2 x CH 
arom., hinap-8,-8'), 7.68 (2 H, d,J 8.8 Hz, 2 x CHarom., hinap-4,-4'), 7.94 (4 H, m, 
4 x CH arom., hinap-6,-6', hinap-9,-9'); oc (100 MHz; CDCh) 63.40 (2 x Ar-CH2), 
126.27 (2 x CH arom., hinap-7,-7'), 126.54 (2 x CH arom., hinap-8,-8), 126.66 (2 x 
CH arom., hinap-4,-4'), 127.70 (2 x CH arom., hinap-9,-9'), 128.46 (2 x CH arom., 
hinap-6,-6'), 129.02 (2 x CH arom., 3,-3 '), 133.46 (2 x C quat., arom., hinap-5,5'), 
133.55 (2 x C quat., arom., hinap-10,-1O'), 134.69 (2 x C quat., arom., hinap-l,-l '), 
137.57 (2 x C quat., arom., hinap-2,-2 '); mlz 332.1650; C22HIS02 (M'NH4) requires 
332.1651. 
(R)-3,S-Dihydro-4-oxa-cyclohepta[2,1-a;3,4-a')dinaphthalene (8SR): 
Br 
Br 
(R)-2,2'-Dibromomethyl-[I,I')binaphthalenyl (90R) (0.50 g, 1.1 mmol) was suspended 
in a mixture of sat. aq. sodium carbonate solution and 1,4-dioxane (1:1, 60 ml). The 
solution was heated under reflux for 12 h. Upon cooling the mixture was extracted 
with diethyl ether (3 x 30 ml), washed with brine (2 x 20 ml) and dried. Removal of 
the solvent under reduced pressure afforded a yellow oil (TLC visualised using UV 
shows product as bright blue spot). Column chromatography eluting with ethyl 
acetatellight petroleum (0: 1 00-1 0:90) gave a colourless solid, recrystallized from 
chloroformlhexane, (0.21 g 65%); m.p. 187-188 °C (lit. 14 188-189 0C); [a)20o -551.2 
(c 1.12, CHCI3); vmax{film) fcm- I 3052,2983,2926, 1594, 1508, 1465, 1420, 1368, 
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1265, 1158, 1056,895; OH (250 MHz; CDCb) 4.18 (2 H, d, J 11.33 Hz, Ar-CH20), 
4.64 (2 H, d, J 11.33 Hz, Ar-CH20), 7.29 (2 H, m, 2 x CH arom., binap-3,-3 '),7.50 (4 
H, m, 4 x CH arom., binap-7,-7', binap-B,-B'), 7.61 (2 H, d, J 8.33 Hz, 2 x CH arom., 
binap-4,-4'), 7.97 (4 H, dd, J 7.99 Hz, 4 x CH arom., binap-6,-6', binap-9,-9'); Oc 
(lOO MHz; CDCh) 67.44 (2 x CH2, 2 x Ar-CH2), 125.85 (2 x CH arom., binap-7,-7'), 
125.94 (2 x CH arom., binap-B,-B'), 127.35 (2 x CH arom., binap-4,-4 ,), 127.59 (2 x 
CH arom., binap-9,-9'), 128.35 (2 x CH arom., binap-6,-6'), 129.15 (2 x CH arom., 
binap-3,-3'), 131.16 (2 x C quat., arom., binap-5,-5'), 133.55 (2 x C quat., arom., 
binap-10,-lO'), 133.64 (2 x C quat., arom., binap-2,-2'), 135.46 (2 x C quat., arom., 
binap-l,-l '); mlz 296.1205; C22H'60 (M+) requires 296.1201. 
(S)-3,5-Dihydro-4-oxa-cycIohepta[2,1-a;3,4-a']dinaphthalene (85s): 
Br 
Br 
90s 85s 
Prepared in an identical manner to the (R)-enantiomer (85R) above, from (8)-2,2'-
dibromomethyl-[1,I']binaphthalenyl (90s) (7.00 g, 15.9 mmol). Colourless crystals 
(3.10 g, 66%); having almost identical spectroscopic data to (90R): m.p. 186-188 DC; 
[a]20D +572.6 (c 1.04, CHCh). 
(R)-2'-Bromomethyl-[1,1 ']binaphthalenyl-2-carbaldehyde (84R): 
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To an ice-cooled solution of (R)-3,5-dihydro-4-oxa-cyclohepta[2,I-a;3,4-
d]dinaphthalene (85R) (3.0 g, 9.6 mmol) in carbon tetrachloride (50 ml), molecular 
bromine (1.24 g, 7.8 mmol) as a solution in carbon tetrachloride (5 ml) was added 
over a period of 5 min (solution turned dark red). After a further 5 min the ice bath 
was removed and the reaction mixture heated under reflux until it became pale yellow 
(ca 1 h). The solvent was removed under reduced pressure and the residue obtained 
dissolved in diethyl ether. The organic solvents were washed with sat. aq. sodium 
hydrogen carbonate (2 x 50 ml) and brine (2 x 30 ml). The organic solution was dried 
(MgS04) and solvents were removed under reduced pressure to yield a orange oil. 
Crystallization from ethyl acetate afforded the product as colourless crystals (2.33 g, 
65%); m.p. 151-153 °C; [a)2oD +144.7 (c 1.02, CHCI); Found: C, 70.04; H, 3.78. 
C22H1sBrO requires C, 70.41; H, 4.03.; vmax(film) !cm-I 3058, 1688, 1594, 1430, 1324, 
1212, 1027,821,749; liH (250 MHz; CDCb) 4.07 (I H, d, J 10.2 Hz, Ar-CHH), 4.27 
(I H, d, J 10.2 Hz, Ar-CHH), 7.01 (1 H, dq, J 8.4,2.0 Hz, CH arom., binap-7') 7.22-
7.38 (3 H, m, 3 x CH arom., binap-3 ',-8 ',-4 '),7.50 (1 H, m, CH arom., binap-7), 7.63 
(1 H, m, CH arom., binap-8), 7.72 (1 H, d, J 8.6 Hz, CH arom., binap-4), 7.93-8.12 (4 
H, m, 4 x CH arom., binap-6,-6 ',-9,-9 '), 8.22 (1 H, d, J 8.6 Hz, CH arom., binap-3), 
9.56 (1 H, d, J 0.9 Hz, CHO);); lie (100 MHz; CDCI) 31.92 (Ar-Gh) 122.38 (CH 
arom., binap-3), 126.56 (CH arom., binap-7 '), 126.94 (CH arom., binap-8'), 127.03 
(CH arom., binap-4'), 127.39 (CH arom., binap-8), 127.40 (2 x CH arom., binap-6',-
9'),128.17 (CH arom., binap-4), 128.48 (CH arom., binap-6), 129.20 (CH arom., 
binap-3 ,), 129.34 (CH arom., binap-7), 129.85 (CH arom., binap-9), 132.41 (C arom., 
quat., binap-5'), 132.42 (C arom., quat., binap-IO'), 132.53 (C arom., quat., binap-2), 
132.97 (C arom., quat., binap-5), 133.56 (C arom., quat., binap-2 '), 134.63 (C arom., 
quat., binap-l ,), 136.29 (C arom., quat., binap-IO), 141.59 (C arom., quat., binap-l), 
191.81 (CHO); mlz 374.0310; C22H 1sBrO (M+) requires 374.0306; HPLC retention 
time (Chiracel OD column) 12.75 min; Hex:IPA (90:10), Flow 1.0, Atten 512, C.S. 
0.5. 
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(S)-2'-Brom omethyl-[1,1 '] binaphthalenyl-2-carbaldehyde (84s): 
85s 
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Prepared in an identical manner to the (R)-enantiomer (84R ) above, from (5)-3,5-
dihydro-4-oxa-cyclohepta[2,I-a;3,4-a']dinaphthalene (85s) (2.30 g, 7.8 mmol). 
Colourless crystals (1.87 g, 64%); having almost identical spectroscopic data to (84R): 
m.p. 154-155 °C; [afoD -140.3 (c 1.13, CHCh); HPLC retention time (Chiracel OD 
column) 11.71 min; Hex:IPA (90: 10), Flow 1.0, Atten 512, C.S. 0.5. 
General procedure for the synthesis of 3H-4-azapinium-cyc1ohepta[2,I-a;3,4-
a']dinaphthalene salts from (R) or (S)-2'-Bromomethyl-[I,1 ']binaphthalenyl-2-
carbaldehyde and primary amines: 
A solution of the amine in ethanol, (10 ml per g of amine, I equivalent), was added 
dropwise via a stoppered, pressure equalising, dropping funnel, to a one-neck flask, 
containing a solution of (R) (84R) or (5)-2'-Bromomethyl-[I,I']binaphthalenyl-2-
carbaldehyde (84s), (1.10 equiv.) in ethanol (10 ml/g carbaldehyde) warmed at 35°C. 
After the addition was complete the dropping funnel was removed and replaced by a 
stopper to contain the hydrogen bromide generated temporarily in the reaction. The 
reaction mixture was stirred overnight while attaining ambient temperature. Sodium 
tetraphenylborate, (or any other anion exchanging salt, LID equivalents), in the 
minimum amount of acetonitrile, was added in one portion to the reaction mixture and 
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after 5 minutes of stirring, the organic solvents are removed under reduced pressure. 
Ethanol was added to the residue, followed by water. The resulting solid was collected 
by filtration and washed with additional ethanol followed by hexane. If no solid 
materialises after the addition of the water the suspension is allowed to settle and the 
ethanol/water phase is decanted off. The gummy residue which may be obtained, is 
macerated in hot ethanol or methanol. The organic salt may then precipitate but in 
some rare cases it does so upon slow cooling of the hot alcoholic solution. If solubility 
problems do arise, small amounts of acetonitrile may be added during this process. 
(R)- [( 4S ,5S)-2,2-dim ethy l-4-pheny 1-1 ,3-dioxan -5-yl]-3H-4-azap ini urn-
cyclohepta[2,1-a;3,4-a']dinaphthalene tetraphenylborate (93): 
16 93 
Prepared according to the general procedure from (+)-(4S,5S)-2,2-Dimethyl-4-phenyl-
1,3-dioxan-5-amine (16) (0.15 g, 0.72 mmol). The product was isolated as yellow 
plates (0.39 g, 66%); m.p. 111-113 °C (dec.); [a]20D -98.5 (c 1.04, acetone); Found: C, 
84.44; H, 5.97; N, 1.71. CssHsoBN02e1.0H20 requires C, 84.73; H, 6.13; N, 1.71.; 
vmax(film) /cm-! 3055,2986, 1626, 1610, 1593, 1548, 1478, 1450, 1382, 1266, 1203, 
1110,846,817,735,704; OH(400 MHz; acetone-d6) 1.79 (3 H, s, CH), C7), 1.85 (3 H, 
s, CH), C8), 4.43 (1 H, d, J 13.2 Hz, Ar-CHHN), 4.51 (I H, d, J 13.6 Hz, upfield 
portion of an ABX system, N-CHCHH-O, C6), 4.86 (2 H, m, downfield portion of an 
ABX system, N-CHCHH-O, C6, & NCH, C5), 5.98 (2 H, m, Ar-CH, C4 & Ar-
CHHN), 6.76 (4 H, t,J7.2 Hz, 4 x CHarorn.,para in BP\4 gp.), 6.93 (8 H, t,J7.6 
Hz, 8 x CH arorn., ortho in BPI4 gp.), 6.95-7.10 (5 H, rn, 5 x CH arorn., Ph gp.), 7.18-
7.32 (2 H, rn, 2 x CH arorn., binaphthyl gp.), 7.34 (8 H, rn, 8 x CH arorn., meta in 
BP\4 gp.), 7.45 (3 H, rn, 3 x CH arorn., binaphthyl gp.), 7.45-7.65 (2 H, rn, 2 x CH 
arom., binaphthyl gp.), 7.78 (I H, rn, CH arorn., binaphthyl gp.), 7.88 (1 I;I, d, J 8.4 
Hz, CH arorn., binap-4 '), 8.10 (I H, d, J 8.4 Hz, CH arorn., binap-4), 8.17 (I H, d, J 
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8.4 Hz, CH arom., binap-6 ,),8.23 (I H, dd, J 8.4,2.4 Hz, CH arom., binap-6), 9.29 (1 
H, s, HC=N); OH(400 MHz; acetone-d6) 19.34 (G!), C7), 29.69 (Gi), C8), 57.00 (Ar-
GhN), 62.26 (Gh, C6), 68.42 (NCH, C5), 72.94 (Ar-CH, C4), 102.06 (C quat., C2), 
120.51 (C quat., arom., binap-2), 122.67 (4 x CH arom., para in BP14 gp.), 126.33 
(CH arom., para in Ph gp.) 126.40 (8 x CH arom., ortho in BPh4 gp.), 126.58 (C quat., 
arom., binap-10), 127.30 (C quat., arom., binap-5 '), 128.11 (CH arom., binap-7'), 
128.15 (CH arom., binap-8'), 128.38 (2 x CH arom., ortho in Ph gp.), 129.05 (2 x CH 
arom., meta in Ph gp.), 129.19 (2 x CH arom., binap-7,8), 129.88 (2 x CH arom., 
binap-6, 9), 130.04 (CH arom., binap-3), 130.12 (CH arom., binap-4 '),130.57 (CH 
arom., binap-4), 130.65 (CH arom., binap-9'), 131.70 (CH arom., binap-6'), 132.16 
(C quat., arom., binap-IO '), 132.57 (C quat., arom., binap-5), 132.92 (CH arom., 
binap-3'), 133.25 (C quat., arom., binap-2'), 135.25 (C quat., arom., binap-l '),136.61 
(C quat., arom., binap-l), 137.43 (8 x CH arom., meta in BPh4 gp.) 142.75 (C quat., 
arom., ipso in Ph gp.), 165.25 (4 x C quat., q, J 196.0 Hz, arom., CoB ipso in BP14 
gp.), 171.37 (HC=N); mlz 484.2275; CJ4HJoN02 (cation) requires 484.2277. 
(S)-[(4R,5R)-2,2-dimethyl-4-phenyl-I,3-dioxan-5-yl]-3H-4-azapinium-
cyclohepta[2,1-a;3,4-a']dinaphthalene tetra phenyl borate (ent-93): 
oXo 
Y).,'Ph 
NH2 
ent-16 
6' 4' 7'~ ..... 5'"" ~3' I 11 1 
8'~ ....... 10', ~2'~ 6-0 7 
9 " \ + / \ / I N",,5 2 
9 '.....JJ \ I' e7 ..... '0 ....... ~2 .. 4-0 8 
1 11 1 •• '7"",,/5,~3 Ph 
6 4 
ent-93 
Prepared according to the general procedure from (-)-(4R,5R)-2,2-Dimethyl-4-phenyl-
1,3-dioxan-5-amine (ent-16) (0.16 g, 0.77 mmol). The product was isolated as yellow 
plates (0.40 g, 64%), having almost identical spectroscopic data to its enantiomer (93): 
m.p. 109-112 °C (dec.); [uj20D +95.3 (c 1.01, acetone). 
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(S)-[(4S,SS)-2,2-dimethyl-4-phenyl-l,3-dioxan-S-yl]-3H-4-azapinium-
cyclohepta[2,I-a;3,4-a']dinaphthalene tetraphenylborate (94): 
6' 4' 
7'.-:7 ..... 5',,; ~3' 
I 11 I 
s'':::' "...,. .. -::>"---, 6-0 7 
9 I' \ + / \ / I N-5 , 
9, 1 /, \ I" 87 10 ......... ~2~ 4-0 8 
I 11 I I 
7.:::, ... "" ..... 'i-' Ph 
6 4 
16 94 
Prepared according to the general procedure from (+)-(4S,5S)-2,2-Dimethyl-4-phenyl-
1,3-dioxan-5-amine (16) (0.20 g, 0.97 mmol). The product was isolated as yellow 
plates (0.50 g, 64%); m.p. 218°C (dec.); [a]20D +360.4 (c 1.10, acetone); Found: C, 
84.33; H, 6.06; N, 1.64. C58H50BN02.1.0H20 requires C, 84.73; H, 6.13; N, 1.71.; 
vrnax(film) fem· l 3054,2998, 1626, 1609, 1579, 1545, 1477, 1458, 1383, 1266, 1201, 
1110,840,817,733,704; oH(250 MHz; acetone-d6) 1.72 (3 H, s, CH], C7), 1.78 (3 H, 
s, CH], C8), 4.23 (1 H, d, J 13.4 Hz, Ar-CHHN), 4.31 (l H, d, J 13.9 Hz, upfield 
portion of an ABX system, N-CHCHH-O, C6, eq.), 4.73 (l H, dd, J 13.8, 3.0 Hz, 
downfield portion of an ABX system, N-CHCHH-O, C6, ax.), 4.90 (l H, bs, NCH, 
C5), 5.35 (I H, d, J 13.5 Hz, Ar-CHHN), 5.86 (l H, d, J2.3 Hz, Ar-CH, C4) 6.76 (4 
H, t, J 7.1 Hz, 4 x CH arom., para in BPh4 gp.), 6.93 (8 H, t, J 7.1 Hz, 8 x CH arom., 
artha in BP~ gp.), 6.90-6.95 (5 H, m, 5 x CH arom., Ph gp.), 7.21 (8 H, m, 8 x CH 
arom., meta in BP~ gp.), 7.26-7.33 (3 H, m, 3 x CH arom., binap-3 ',-7 ',-B), 7.44 (l 
H, m, CH arom., binap-7), 7.58 (l H, m, CH arom., biphenyl-B'), 7.77 (l H, m, CH 
arom., binap-3), 7.93 (2 H, dd,J8.6, 2.2 Hz, 2 x CHarom., binap-4,-4'), 8.13 (1 H, d, 
J7.9 Hz, CH arom., binap-9'), 8.17 (I H, d, J8.4 Hz, CH arom., binap-6'), 8.29 (2 H, 
dd, J 8.6,5.3 Hz, CH arom., binap-6,-9), 9.30 (l H, s, HC=N); OH(400 MHz; acetone-
d6) 19.13 (CH], C7), 29.75 (CH], C8), 57.29 (Ar-CH2N), 61.31 (CH2, C6), 67.00 
(NCH, C5), 71.47 (Ar-CH, C4), 100.64 (C quat., C2), 115.57 (C quat., arom., binap-
2), 121.88 (4 x CH arom., para in BPh4 gp.), 125.47 (CH arom., para in Ph gp.) 
125.66 (8 x CH arom., artha in BP~ gp.), 126.47 (C quat., arom., binap-lO), 126.94 
(CH arom., binap-7 '), 127.04 (CH arom., binap-B '), 127.31 (2 x CH arom., artha in 
Ph gp.), 127.77 (2 x CH arom., meta in Ph gp.), 127.88 (2 x CH arom., binap-7,-B), 
128.13 (2 x CH arom., binap-6,-9), 128.67 (C quat., arom., binap-5 '), 128.87 (CH 
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arom., hinap-3), 129.28 (CH arom., hinap-4 '), 129.49 (CH arom., hinap-4), 130.56 
(CH arom., hinap-9'), 130.89 (CH arom., hinap-6'), 131.09 (C quat., arom., hinap-
10 '), 131.15 (C quat., arom., hinap-5), 131.98 (C quat., arom., hinap-2 '), 133.42 (CH 
arom., hinap-3 '), 133.70 (C quat., arom., binap-l '), 134.43 (C quat., arom., hinap-l), 
141.08 (C quat., arom., ipso in Ph gp.), 163.75 (4 x C quat., q,J 196.0 Hz, arom., CoB 
ipso in BPI4 gp.), 170.82 (HC=N); mlz 484.2282; C)4H)oN02 (cation) requires 
484.2277. 
(-)-( R)-6-[(lR,2R,3R,5S)-2,6,6-trim ethy Ibicyclo [3.1.1] hept-3-yl]- 3H-4-aza pini urn-
cyclohepta[2,1-a;3,4-a']dinaphthalene tetraphenylborate (95): 
6' 4' 7'.r ..... 5' / ~3' I 11 1 
a'~ ........ '0' ...... ~2'~ 4-5 9 
9 ,. \ + / l\ / I N""3 7 6 9,~' /' \ \/ "-8~ 10""" ':::::::2--!J 2-1 8 
1 11 1 ,~ 7..::::::::. ,.......5,-;::::-3 
6 4 
8 95 
Prepared according to the general procedure from (-)-isopinocampheylamine (8) (0.25 
g, 1.6 mmol). The product was isolated as yellow plates (0.82 g, 73%), mp 219-221 °C 
(dec); [afoD -318.8 (c 1.37, acetone); Found: C, 88.22; H, 6.81; N, 1.79%. 
C48H48BNeO.5H20 requires C, 88.61; H, 6.91; N, 1.85%.; vmax(nujol)!cm') 3055, 
2997,1629,1612,1588,1551,1155,818,734,706; OH (400 MHz; acetone-d6) 1.10 (3 
H, s, CCH), CS), 1.21 (3 H, d, J 6.8 Hz, CHCH), CI0), 1.32 (3 H, s, CCH), C9), 1.53 
(1 H, d, J 10.4 Hz, CH, Cl), 2.01-2.08 (l H, m, CHH, C7), 2.15-2.17 (l H, m, CHH, 
C7) 2.42 (l H, m, CH, C5), 2.63-2.70 (3 H, m, CH, C2, CH2, C4), 4.80 (l H, dd, J 
13.6, 1.2 Hz, Ar-CHH) 5.06 (l H, q, J 7.6 Hz, CH, C3), 5.48 (1 H, d, J 14.0 Hz, Ar-
CHH) 6.73 (4 H, t, J 8.0 Hz, 4 x CH arom., para in BPh4 gp.), 6.88 (8 H, t, J 8.0 Hz, 8 
x CH arom., ortho in BPh4 gp.), 7.06 (1 H, d, J 8.4 Hz, CH arom., binap-3 '), 7.27 (8 
H, t, J 8.0 Hz, 8 x CH arom., meta in BPh4 gp.), 7.45-7.49 (3 H, m, 3 x CH arom., 
binap-8,8', 7'), 7.56-7.63 (l H, m, CH arom., binap-3), 7.77-7.80 (l H, m, CH arom., 
binap-7), 7.99 (l H, d, J 8.8 Hz, CH arom., hinap-4 '), 8.03 (l H, d, J 8.4 Hz, CH 
arom., hinap-4), 8.08 (1 H, d, J 8.4 Hz, CH arom., hinap-9 '), 8.20 (1 H, d, J 8.4 Hz, 
CH arom., hinap-6'), 8.26 (l H, d, J 8.4 Hz, CH arom., binap-6), 8.31 (l H, d, J 8.4 
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Hz, CH arom., hinap-9), 9.62 (1 H, s, HC=N); oc (100 MHz; acetone-d6) 20.32 (CH], 
C8), 23.86 (CH], C9), 28.78 (CH], CID), 34.07 (CH2, C7), 35.22 (Ar-CHzN), 40.64 (C 
quat., C6), 42.09 (CH, CS), 42.60 (CH, C2), 48.59 (CH, Cl), 54.24 (CH2, C4), 75.64 
(CH, C3), 122.69 (4 x CH arom.,para in BPI4 gp.), 126.45 (8 x CH arom., ortho in 
BPI4 gp.), 127.17 (CH arom., hinap-7'), 127.56 (CH arom., hinap-B'), 128.15 (C 
quat., arom., hinap-2), 128.33 (CH arom., hinap-B), 128.58 (CH arom., hinap-7), 
129.05 (CH arom., hinap-3), 129.99 (CH arom., hinap-6'), 130.07 (C quat., arom., 
hinap-IO), 130.14 (C quat. arom., hinap-5 '),130.60 (CH arom., hinap-4), 130.76 (CH 
arom., hinap-9'), 131.64 (CH arom., binap-6'), 132.81 (CH arom., binap-9), 132.92 
(CH arom., binap-6), 133.14 (CH arom., binap-3 '), 133.26 (C quat., arom., binap-
10'), 135.15 (C quat., arom., binap-5), 135.38 (C quat., arom., binap-2 '), 136.74 (C 
quat., arom., binap-l '), 137.47 (8 x CH arom., meta in BPh4 gp.), 142.81 (C quat., 
arom. hinap-l), 165.35 (4 x C quat., arom., J 196.40 Hz, 4 x C-B ipso in BPh4 gp.) 
170.77 (HC=N); mlz 430.2540; CJ2HJ2N (cation) requires 430.2535. 
(+ )-(S)-6- [(lR,2R ,3R,5S)-2,6,6-trim ethy Ibicyclo [3.1.1] hept-3-y 1]- 3H-4-aza pinium-
cyclohepta[2,1-aj3,4-a']dinaphthalene tetraphenylborate (96): 
~ 
NH2 
8 96 
Prepared according to the general procedure from (-)-isopinocampheylamine (8) (0.25 
g, 1.6 mmol). The product was isolated as yellow plates (0.82 g, 73%), mp 225-227 QC 
(dec); [a]2oD +359.1 (c 1.31, acetone); Found: C, 88.38; H, 6.86; N, 1.80%. 
C4sH4sBNeO.5H20 requires C, 88.61; H, 6.91; N, 1.85%.; vmax(nujol)!cm'! 3053, 
2996, 1627, 1610, 1580, 1549, 1206,750,705; OH (400 MHz; acetone-d6) 0.84 (3 H, 
d, J 4.0 Hz, CHCH], CI0), 1.13 (3 H, s, CCH], C8), 1.32 (3 H, s, CCH], C9), 1.51 (1 
H, d, J 8.0 Hz, CH, Cl), 2.04 (1 H, m, CHH, C7), 2.18 (l H, m, CHH, C7) 2.35 (1 H, 
m, CH, CS), 2.67 (l H, m, CH, C2), 2.78 (2 H, CH2, C4), 4.80 (l H, dd, J 13.6, 1.2 
Hz, Ar-CHHN) 5.14 (l H, q, J 7.6 Hz, CH, C3), 5.50 (l H, d, J 14.0 Hz, Ar-CHHN) 
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6.74 (4 H, t, J 8.0 Hz, 4 x CH arom.,para in BPh4 gp.), 6.89 (8 H, t, J 8.0 Hz, 8 x CH 
arom., ortho in BP~ gp.), 7.06 Cl H, d, J 8.4 Hz, CH arom., binap-3 '),7.33 (8 H, t, J 
8.0 Hz, 8 x CH arom., meta in BPh4 gp.), 7.50 (3 H, m, 3 x CHarom., binap-8,-8',-
7'),7.75 (I H, m, CHarom., binap-3), 7.77-7.80 (I H, m, CHarom., binap-7), 7.94 (1 
H, d, J 8.8 Hz, CH arom., binap-4 '),7.99 (1 H, d, J 8.4 Hz, CH arom., binap-4), 8.08 
(1 H, d, J 8.4 Hz, CH arom., binap-9 '),8.20 (I H, d, J 8.4 Hz, CH arom., binap-6'), 
8.24 (I H, d, J 8.4 Hz, CH arom., binap-6), 8.29 (1 H, d, J 8.4 Hz, CH arom., binap-
9),9.72 (1 H, s, HC=N); Oc (100 MHz; acetone-d6) 19.35 (CH), C8), 23.36 (CH), C9), 
28.45 (CH), CI0), 33.78 (CH2, C7), 35.05 (Ar-CH2N), 40.22 (C quat., C6), 41.63 
(CH, C5), 42.26 (CH, C2), 48.23 (CH, Cl), 54.65 (CH2, C4), 75.38 (CH, C3), 122.23 
(8 x CH arom., ortho in BPh4 gp.), 125.94 (4 x CH arom., para in BP~ gp.), 125.97 
(CH arom., binap-7'), 126.00 (CH arom., binap-8'), 126.01 (C quat., arom., binap-2), 
126.03 (CH arom., binap-8), 126.38 (CH arom., binap-7), 127.87 (CH arom., binap-
3), 127.93 (CH arom., binap-6 '), 128.00 (C quat., arom., binap-JO), 128.04 (C quat. 
arom., binap-5'), 128.07 (CH arom., binap-4), 128.57 (CH arom., binap-9'), 129.57 
(CH arom., binap-6'), 129.63 (CH arom., binap-9), 130.21 (CH arom., binap-6), 
130.24 (CH arom., binap-3 '), 131.19 (C quat., arom., binap-lO '), 132.33 (C quat., 
arom., binap-5), 137.01 (C quat., arom., binap-2 '), 137.03 (C quat., arom., binap-l '), 
137.04 (8 x CH arom., meta in BP~ gp.), 142.38 (C quat., arom. binap-l), 164.90 (4 x 
C quat., arom., J 196.40 Hz, 4 x C-B ipso in BPh4 gp.), 171.15 (HC=N). mlz 
430.2536; CJ2HJ2N (cation) requires 430.2535. 
General procedure for catalytic asymmetric epoxidation of simple alkenes 
mediated by iminium salts using Oxone: 
To an ice cooled solution of sodium carbonate, (4 equivalents), in water (12 ml per 
1.50 g of sodium carbonate), Oxone™ (2 equivalents), was added with stirring and the 
resulting foaming solution was left to stir for 5-10 minutes, so that most of the initial 
effervescence subsides. The iminium salt, (10 mol% with respect to the substrate), 
was then added as a solution in acetonitrile, (6 ml per 1.50 g of sodium carbonate 
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used), followed by the alkene substrate, (1 equivalent, 100 mol%), also as a solution 
in acetonitrile of the same volume as the solution of the catalyst. The suspension was 
stirred at the same temperature until the substrate was completely consumed by TLC. 
The reaction mixture was then diluted with ice cooled diethyl ether (20 ml per 100 mg 
substrate) and was immediately followed by the addition of the same volume of water. 
The aqueous phase was washed 4 times with diethyl ether and the organics are 
combined, washed with brine and dried. Filtration and evapouration of the solvents 
furnishes a yellow or light brown residue. Column chromatography was then 
performed typically using ethyl acetate: Light petroleum I :99 to produce the pure 
epoxide. 
Tetraphenylphosphonium monoperoxysulfate: 
Oxone™ triple salt (2 KHSOs:KHS04:K2S04) (15.0 g, 48.8 mmol, w.r.t. KHSOs) was 
dissolved in deionised water (300 ml) in a conical flask (IL) and kept under magnetic 
stirring at 10-15 °C (water bath). To this solution tetraphenylphosphonium chloride 
(15.0 g, 40.0mmol) in distilled dichloromethane (300 ml) was gradually added over 5 
min. After an additional 30 min, stirring was interrupted, the organic layer was 
separated and solvent was removed under vacuum at room temperature. The crude 
white salt was then transferred to a fritted glass funnel and washed with distilled water 
(2 x 75 ml). The solid was dissolved in dichloromethane (180 ml), dried (MgS04) and 
hexane was added until cloudiness develops and the flask was placed in the freezer 
(-20°C) overnight, producing a solid white precipitate. Ca 85% pure in peroxide, 
yield 15.4 g, 70%. OH (250 MHz; CD Cb) 7.64 (8 H, m, 8 x CH arom.), 7.78 (8 H, m, 8 
x CHarom.), 7.89 (4 H, m, 4 x CH arom.,para to P), 8.92 (1 H, s, OH). 
General procedure for catalytic asymmetric epoxidation of simple alkenes 
mediated by iminium salts using Tetraphenylphosphonium monoperoxysulfate: 
183 
Tetraphenylphosphonium monoperoxysulfate (2 eq with respect to the substrate) was 
dissolved in the desired solvent (2 ml per 0.1 g oxidant) and cooled to the required 
temperature. To this was added the iminium salt as a solution in the solvent (0.5 ml 
per 0.1 g oxidant). This iminium salt solution was cooled to the same temperature as 
the solution containing the oxidant and added dropwise over 15-20 min, the 
temperature of the reaction vessel was monitored to minimize increase in temperature 
during the addition. The substrate (lOO mol%) was also added as a solution in the 
reaction solvent (0.5 ml per 0.1 g oxidant) in the same manner as the catalyst. The 
reaction was stirred at the same temperature until the substrate was completely 
consumed by TLC. Diethyl ether (pre-cooled to the reaction temperature) (20 ml per 
0.1 g oxidant) was then added to precipitate the remaining oxidant. The solution was 
then filtered through Celite. Solvents are removed. Diethyl ether (40 ml) was then 
added to the brown residue obtained and the solution passed through a short pad of 
silica (to remove catalyst residues). Solvent was again removed to yield the pure 
epoxide. If the reaction did not go to completion the epoxide can be separated from 
the alkene through the use of column chromatography eluting with ethyl acetatellight 
petroleum 1 :99. 
General procedure for the formation of authentic racemic epoxides for ee 
determinations: 
The alkene (1 eq.) was dissolved in DCM (10 ml/g) and cooled to 0 QC. m-CPBA (2 
eq.) was added as a solution also in DCM (10 ml/g, pre-dried over MgS04). The 
reaction was allowed to attain ambient temperature and stirred until complete 
consumption of the substrate was observed by TLC. The reaction was quenched with 
the addition of sat. aq. NaHC03 (10 ml/g) and the layers separated. The organic layer 
was washed with sat. NaOH (1.0 M) (10 ml/g) and dried (MgS04). Solvents were 
removed under reduced pressure and analytically pure samples of the epoxides were 
obtained through column chromatography, typically eluting with ethyl acetate/light 
petroleum (1 :99). 
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Alkene Synthesis: 
General procedure for the formation of l-aryl-cycloalkenes: 
Ar Q 
The Cyclo-ketone (1.0 equiv.) in THF (10 ml/g) was cooled to 0 QC and 
phenylmagnesium bromide (freshly prepared, 2.0 equiv.) was added dropwise over 10 
min. The reaction was stirred for 4 h and quenched by addition of sat. aq. ammonium 
chloride (I ml/g). Diethyl ether was added reaction mixture, the organics were 
separated and dried (MgS04). Solvents were removed under reduced pressure to yield 
a crude oil, ca 95% pure. The crude product was then dissolved in chloroform (7 ml/g) 
and cooled to 0 QC. TFA (4 equiv.) was then added in one portion and the reaction 
stirred for 5 min. The reaction was quenched by dropwise addition of sat. aq. Sodium 
hydrogen carbonate (10 ml/g). The organic layer was separated and washed with a 
further portion of sat. aq. Sodium hydrogen carbonate (10 ml/g), brine (10 ml/g) and 
dried (MgS04). Solvents were removed under reduced pressure to yield the desired 
product. 
Cyclopent-l-enyl-benzene (109): 
'rh 
, 
5/~2 
\ I 
4-3 
109 
Prepared according to the general procedure from cyc1opentanone (10.0 g, 120.0 
mmol) giving I-Phenyl-cyc1opentene as a pale yellow oil (17.1 g, 99%); vrnax(neat) 
/cm- l 3076, 3054, 2953,2842,1684,1597,1493,1447,1179,1073,1037,957,752, 
691; (OH (250 MHz; CDCh) 2.10-2.30 (2 H, m, CH2, C4), 2.70-2.78 (2 H, m, CH2, 
C3), 2.87-2.96 (2 H, m, CH2, C5), 6.36-6.40 (I H, m, CH, C2), 7.33-7.70 (5 H, 5 x 
CH arom., Ph gp.); oc (62.5 MHz; CDCh) 23.87 (CH2, C4), 33.67 (CH2, C3), 33.88 
(CH2, C5), 125.99 (2 x CH arom., artha in Ph gp.), 126.37 (CH, C2), 127.24 (CH 
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arom., para in Ph gp.), 128.66 (2 x CH arom., meta in Ph gp.), 137.19 (C quat., arom., 
ipso in Ph gp.), 142.85 (C quat., Cl). 
I-Phenyl-cycloheptene (110):15 
6--rol- ~h 7 ......... '.:::::::.2 I \ '\ /3 
,-4 
110 
Prepared according to the general procedure from cyc1oheptanone (10.0 g, 89.2 mmol) 
giving I-Phenyl-cycloheptene as a pale yellow oil (14.9 g, 99%); vrnax{film) !cm'l 
3078,3054,2926,2848, 1700, 1596, 1490, 1444, 1354, 1281, 1076,964,853,754, 
699; (OH (400 MHz; CDCh) 1.68 (2 H, m, CH2, C5), 1.78 (2 H, m, CH2, C6), 1.96 (2 
H, m, CH2, C4), 2.42 (2 H, dd,J6.4 Hz, CH2, C7), 2.74 (2 H, m, CH2, C3), 6.22 (I H, 
t, J 6.8 Hz, CH, C2), 7.30-7.74 (5 H, 5 x CH arom., Ph gp.); Oc (100 MHz; CDCh) 
27.26 (CH2, C7), 27.39 (CH2, C4), 29.30 (CH2, C6), 33.22 (CH2, C5), 33.24 (CH2, 
C3), 126.09 (2 x CH arom., artha in Ph gp.), 126.67 (CH, C2), 128.54 (2 x CH arom., 
meta in Ph gp.), 130.82 (CH arom., para in Ph gp.), 145.41 (C quat. arom., ipso in Ph 
gp.), 145.44 (C quat., Cl). 
Cis-Propenyl-benzene (111): 
~''''''f V 3 
111 
Lindlars catalyst (5 % Pd on Calcium Carbonate) (0.10 g), was placed in a Schlenk 
round bottom flask (150 ml). To this was added I-phenyl-I-propyne (1.0 g, 8.62 
mmol) as a solution in hexane (40 ml). The flask was cooled to 0 °C, evacuated and a 
ballon of hydrogen added. The reaction was monitored by TLC every 5 min to avoid 
complete hydrogenation to the alkane. After 20 min TLC showed complete 
consumption of starting material. The reaction mixture was filtered through a bed of 
celite and solvents removed under reduced pressure to afford (111) as a volatile 
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colourless oil (0.88 g, 87 %); vmax(film) !cm'l 3058, 3018, 2959, 2936, 1600, 1494, 
1445, 1367,913,766,697; OH (250 MHz; CDCh) 1.84 (3 H, dd, J 7.2, 1.9 Hz, CH3, 
C3), 5.73 (I H, dq, J7.2 Hz, CH, Cl) 6.40 (I H, dq, J 7.2, 1.9 Hz, CH, C2), 7.80-7.28 
(5 H, m, 5 x CH arom., Ph gp.); Oc (62.5 MHz; CDCh) 15.10 (CH), C3), 126.83 (CH, 
C2), 127.11 (CH arom., para in Ph gp.), 128.56 (2 x CH arom., meta in Ph gp.), 
129.30 (2 x CH arom., artha in Ph gp.), 130.40 (CH, Cl), 138.07 (C quat., arom., ipso 
in Ph gp.). 
3-Methyl-but-2-enal (U9): 
5 1-0 \ 1-
3=2 
/ 
4 
119 
3-Methyl-but-2-en-I-ol (10.0 g, 99.0 mmol) was added to a stirred solution of DCM 
(140 ml) and PDC (55.6 g, 147.0 mmol). The reaction was stirred at room temperature 
for 5 h. Hexane (50 ml) was added and the solution filterd through a pad of 
celite/silica to give the product as a colourless oil, containing a substantial amount of 
pyridine. The oil was re-dissolved in DCM (75 ml), washed with aq. CUS04 solution 
(50 %) (2 x 50 ml) and dried (MgS04). Solvents were removed under reduced 
pressure to afford (119) as a colourless oil; vmax(neat) Icm'l 2978, 2939, 1684, 1642, 
1447, 1256, 1174, 1156; OH (250 MHz; CDCh) 1.99 (3 H, d, J 1.2 Hz, CH3, C4), 2.18 
(3 H, d, J 1.2 Hz, CH3, C5), 5.90 (I H, dquint, J 1.3, 8.2 Hz, CH, C2), 9.95 (I H, d, 
8.2 Hz, CHO, Cl); Oc (lOO MHz; CDCh) 19.27 (CH3, C4), 27.60 (CH3, C5), 128.51 
(CH, C2), 160.95 (C quat., C3), 191.45 (CHO, Cl). 
1,I-Diethoxy-3-methyl-but-2-ene (U8): 
119 
~o 
5 H-I-o 
\_1 ) 3-2 
/ 
4 
118 
187 
To absolute ethanol (23.9 ml, 416.5 mmol) at 4 QC were sucessively added: triethyl 
orthoformate (13.9 ml, 83.3 mmol) and 3-methyl-but-2-enal (119) (6.00 g, 83.3 
mmol). The colourless solution was further cooled to 2 QC and potassium hydrogen 
sulfate (0.60 g, 4.3 mmol) was added. The solution was allowed to warm to room 
temperature over 45 min and stirred for a further 15 min. The insoluble material was 
removed by filtration and washed with ethanol (2 x 5 ml). To the combined filtrate 
was added potassium carbonate (1.22 g, 8.9 mmol). After stirring for I hour the 
solution was filtered and the solvents removed under reduced pressure to afford the 
title compound as a colourless oil, which was ca 95% pure by 'H-NMR spectroscopy. 
2,2-Dimethyl-2H-chromene-6-carbonitrile (116): 
NCU I + 
~ OH 
117 118 116 
To a round bottom flask (lOO ml), fitted with dean-stark apparatus, was added 1,1-
diethoxy-3-methyl-but-2-ene (118) (1.79 g, 11.3 mmol), p-xylene (20 ml) and 4-
cyanophenol (117) (1.00 g, 8.4 mmol). The reaction mixture was heated to 120 QC 
(external temp). After 24 h the reaction was allowed to cool to room temperature and 
the reaction mixture directly chromatographed, eluting with light petroleum/ethyl 
acetate (100:0-97-3) affording the title compound as colourless crystals (1.32 g, 63%); 
m.p. 45-47 QC (Iit'6 47 QC); vmax(film) /cm-' 3049, 2978, 2934, 2612, 2555, 2225, 
1641, 1604, 1570, 1487, 1464, 1368, 1278, 1212, 1170,961; OH (400 MHz; CDCb) 
1.46 (6 H, s, 2 X CH), CII,12), 5.70 (1 H, d, J 10.0 Hz, CH, C3), 6.28 (1 H, d, J 10.0 
Hz, CH, C4), 6.79 (1 H, d, J 8.4 Hz, CH arom., C9), 7.24 (I H, m, CH arom., C8), 
7.37 (1 H, dd, J8.4, 2.0 Hz, CH, C6); oe (100 MHz; CDCh) 28.73 (2 x CH), Cll,12), 
78.23 (C quat., C2), 104.12 (CH quat. arom., C7), 117.56 (CH arom., C9), 119.63 
(CN quat., C13) 121.01 (CH, C4), 122.08 (C quat. arom., CS), 130.47 (CH arom., 
C6), 132.57 (CH, C3), 133.66 (CH arom., C8), 157.13 (C quat. arom., CI0); mlz 
185.0837; C12H llNO (M+) requires 185.0841. 
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(Z)-Triroethyl-styryl-siIane (122): 17 
123 
"'" ~2 (Y' 10 -81-
I 
122 
To a solution ofDIBAL-H (1.0 M in hexane) (20 rol, 20 mmol) in hexane (20 ml) was 
added I-methylpyrrolidine (1.70 g, 20 mmol) at room temperature. After stirring for 5 
min I-phenyl-2-(trimethylsilyl)acetylene (123) (3.48 g, 20 mmol) was added. The 
solution was stirred at 70°C for 12 h. After the reaction mixture had cooled to room 
temperature cone. H2S04 (1 ml) was added cautiously, immediately followed by water 
(20 ml). The layers were separated and the aqueous layer extracted with hexane (2 x 
20 ml). The combined organic layers were washed with brine and dried (MgS04) 
Solvents were removed under khrugleroh distillation to give the title compound as a 
volatile colourless oil (1.94 g, 55%), vmax(film) (cm-! 3059,2958,2899, 1592, 1571, 
1492, 1445, 1246, 1156, 1072, 910; OH (400 MHz; CDCh) 0.00 (9 H, s, 3 X CH3, 
Si(CH3)3), 5.77 (I H, d, J 15.2 Hz, CH, C2), 7.17-7.27 (5 H, m, 5 x CH arom., Ph gp, 
C4-8), 7.31 (I H, d, 15.2 Hz, CH, C2); Oc (100 MHz; CDCh) 0.00 (Si(CH3h), 127.13 
(CH, Cl), 127.71 (2 x CH arom., ortho in Ph gp.), 127.93 (2 x CH arom., meta in Ph 
gp.), 132.65 (CH arom., para in Ph gp.) 139.91 (C quat., arom., ipso in Ph gp.), 
146.41 (CH, C2). 
The Epoxides: 
2-Methyl-2-phenyl-oxirane (17):7,8 
17a 
a-Methylstyrene oxide:!8 Colourless oil; vmaxCneat)(cm-! 3034, 2958, 2929, 2872, 
1604,1496,1447,1381,1343,1061,1027,860,759,699; oH(250 MHz; CDCh) 0.86 
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(3 H, d, J 6.6 Hz, C3), 2.79 (I H, dd, J 0.8 and 5.4 Hz, HCH, Cl ci, to Ph gp.), 2.96 (I 
H, d, J 5.4 Hz, HCH, CI',an, to Ph gp.), 7.24-7.38 (5 H, rn, arorn., Ph gp.); oc(62.5 
MHz; CDCb) 21.7 (CH), C3), 56.7 (C quat., C2), 56.9 (CH2, Cl), 125.2 (2 x CH, 
arorn., ortho in Ph gp.), 127.4 (CH, arorn., para in Ph gp.), 128.3 (2 x CH, arorn., 
meta in Ph gp.), 129.0 (C quat., arorn., ipso in Ph gp.). 
2-Methyl-(E)-2,3-diphenyloxirane (18): 
97 18 
Trans-(a-Methyl)-stilbene oxide:21 Colourless oil; vmax(neat)/crn-1 3061, 1602, 1495, 
1449, 1381, 1279, 1157, 1118, 1065, 1027,980; oH(400 MHz; CDCb) 1.46 (3 H, s, 
C3), 3.96 (1 H, s, Cl), 7.30-7.46 (10 H, rn, arorn., 2 x Ph gp.); oc(lOO MHz; CDCb) 
17.1 (CH), C3), 63.5 (C quat., C2), 67.5 (CH, Cl), [125.6,126.9,127.7,127.9,128.6, 
129.2 (10 x CH, arorn.), 136.4, 142.8 (2 x C quat., arorn.) 2 x Ph gp.]. 
2,2,3-Triphenyloxirane (19): 
Triphenylethylene oxide: 19.20 Colourless oil which slowly solidified, rnp 66-67 °C, (lit. 
rnp 75°C); vmax(neat)/crn- I 3062, 3030, 2957, 2925, 2856, 1605, 1596, 1499, 1471, 
1448,1262, 1221,741,698,621; oH(250 MHz; CDCI3) 4.40 (I H, rn, PhCH), 7.10-
7.47 (15 H, rn, 3 x Ph gp.); oc(62.5 MHz; CDCb) 68.0 (CH, PhCH), [68.3 (C quat., 
Ph2C), 126.3, 126.8, 127.5, 127.6, 127.7, 127.8 128.0, 128.2, 128.6 (15 x CH, arorn.), 
135.42, 135.9, 141.1 (3 x C quat., arorn.) 3 x Ph gp.]. 
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1-Phenyl-7-oxa-bicyclo[4.1.0]heptane (20): 
46 20 
I-Phenylcyclohex-l-ene oxide:2o Colourless oil; vmaxCneat)/cm· 1 3084, 1602, 1495, 
1446,1359, 1249, 1173, 1132, 1079, 1030,993,974; oH(250 MHz; CDCb) [1.22-1.35 
(1 H, m), 1.53-1.64 (3 H m), 1.99-2.06 (2 H, m) 2.16-2.18 (l H, m), 2.26-2.32 (l H, 
m), C3, 4, 5 & 6], 3.10 (1 H, t, J2.0 Hz, CH at C2), 7.28-7.44 (5 H, m, arom., Ph gp.); 
oe (62.5 MHz; CDCIl ) [19.8, 20.1, 24.7, 28.2 (4 x CH2, C3, 4, 5 & 6)], 60.1 (C quat, 
Cl), 61.8 (CH, C2) 1253 (2 x CH arom., ortho in Ph gp.), 127.1 (CH arom.,para in 
Ph gp.), 128.2 (2 x CH arom., meta in Ph gp.), 142.8 (C quat, arom., ipso in Ph gp.). 
6,6a-Dihydro-laH-indeno[1,2-b ]oxirene (21): 
112 21 
Indene oxide:21 Colourless oil; vmax(neat)/cm·1 3027,2917, 1482, 1464, 1390, 1372, 
1232, 1183, 1142,829,758,745,723; oH(250 MHz; CDCb) 2.97 (I H, dd, J 2.7 and 
18.1 Hz, HCH, C3 syn to C2), 3.21 (l H, d, J 17.6 Hz, HCH, C3 anti to C2), 4.13 (l 
H, t, J 3.0 Hz, C2), 4.26 (1 H, dd, J 1.1 and 2.8 Hz, Cl), [7.14-7.29 (3 H, m), 7.49 (1 
H, dd, J 1.7 and 6.6 Hz) C5, 6, 7 & 8]; oe(lOO MHz; CDCb) 34.6 (CH2, C3), 57.6 
(CH, C2), 59.1 (CH, Cl), 125.2 (CH, arom., C6), 126.1 (CH, arom., C5), 126.3 (CH, 
arom., C4), 128.6 (CH, arom., C7), 141.0 (C quat., arom., C4), 143.6 (C quat, arom., 
C9). 
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7b-Phenyl-1 a,2,3, 7b-tetrahydro-1-oxa-cyclopropa la I naphthalene (22): 
99 22 
I-Phenyl-3,4-dihydronaphthalene oxide:'o,,, Pale yellow solid; rnp 104-106 °C, (lit. 22 
rnp 94-97 0C); vmax(nujol)/crno1 1602, 1486, 1307, 1155, 1074, 1042,953; liH(250 
MHz; CO Ch) 2.10 (I H, td, J 5.8 and 13.7 Hz, HCH, C3), 2.49-2.60 (I H, rn, HCH, 
C4), 2.77 (I H, dd, J 5.6 and 15.5 Hz, HCH, C3), 2.98-3.06 (I H, rn, HCH, C4), 3.71 
(I H, d, J3.1 Hz, C2), [7.11-7.31 (4 H, rn, arorn.), 7.45-7.61 (5 H, rn, arorn.), 9 x CH 
at C6, 7, 8, 9 & Ph gp.]; lic(62.5 MHz; COCh) 22.1 (CH2, C4), 25.4 (CH2, C3), 6009 
(C quat., Cl), 63.0 (CH, C2) [126.0, 127.7, 127.9, 128.1, 128.2, 128.6, 129.8 (9 x CH, 
arom.), 135.0, 137.5, 138.8 (3 x C quat., arorn.), CS, 6, 7, 8,9, 10 & Ph gp.]. 
(E)-2,3-Diphenyloxirane (75):7,8 
Ph~Ph 
101 
o 
PhAL-Ph 
75 
Trans-stilbene oxide:,o.'3 Colourless solid; rnp 66-67 °C, (lit.23 rnp 61-63 0C). 
vmax(nujol)/crno1 1601, 1492, 1284, 1176, 1157, 1094, 1072, 1025; liH(400 MHz; 
COCb) 3.84 (2 H, s, 2 x PhCH-O), 7.28-7.37 (ID H rn, arorn., 2 x Ph gp.); lic(IOO 
MHz; COCh) 63.3 (2 x CH, 2 x PhCH-O), 126.0 (4 x CH, arorn., ortho in 2 x Ph gp.), 
128.6 (2 x CH, arorn., para in 2 x Ph gp.), 129.3 (4 x CH, arorn., meta in 2 x Ph gp.), 
137.6 (2 x C quat., arorn., ipso in 2 x Ph gp.). 
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2-Biphenyl-4-yl-oxirane (100a): 
~ 
PhA)J 
100 100a 
para-Phenylstyrene oxide:'6 Colourless solid; rnp 94-96 QC, (lit.24 rnp lIS-117°C). 
oH(400 MHz; CDCh) 2.85 (1 H, dd, J 2.6 and 5.5 Hz, C2), 3.91 (1 H, dd, J 2.5 and 
4.0 Hz, Cl), 7.30-7.68 (9 H, rn, arorn., 2 x Ph gp.); oc(lOO MHz; CDCh) 51.2 (CH, 
C2), 52.2 (C quat., C3), 126.0, 127.1, 127.3, 127.4, 128.8 (9 x CH, arorn., BiPh gp.), 
136.6,140.7, 141.2 (3 x C quat., arorn., BiPh gp.). 
I-tert-Butyl-7 -oxa-bicyclo[ 4.I.O)heptane (102a): 
102 
'to 
,........1 ....... 1 
6 2 
I I 
5 ................ 3 
4 
102a 
l-tert-Butyl-cyclohex-I-ene oxide: Colourless oil; vmax(nujol)/crn- I 2938,2868, 1481, 
1433,1363, 1036,921,767; oH(250 MHz; CDCh) 0.73 (9 H, s, C(CH))), 0.91-1.10 
(2 H, rn, CH2, C4), 1.12-1.36 (2 H, rn, CH2, CS), 1.46-1.61 (2 H, rn, CH2, C6), 1.64-
1.81 (2 H, CH2, C3), 2.91-2.93 (l H, rn, CH, C2); oc(62.5 MHz; CDCh) 19.69 (CH2, 
CS), 21.09 (CH2, C4), 24.82 (CH2, C6), 25.29 (CH2, C3), 25.53 (3 x CH), qCH))), 
44.77 (C quat., C(CH)3), 55.16 (CH, C2), 64.66 (C quat., Cl). 
la,2,3, 7b-Tetrahydro-1-oxa-cyclopropa[ a )naphthalene (103a): 
co 
103 103a 
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1,2-Dihydronapthylene oxide:26 Colourless oil; vma,(neat)/crn·1 3059, 3028, 2930, 
2850,1602,1493,1316,1129,1088,1030,964; 8H(400 MHz; CDCb) 1.67 Cl H, rn, 
HCH at C3), 2.33 (I H, rn, HCH at C3), 2.45 Cl H, dd, J 15.6,5.6 Hz, HCH, C4), 2.67 
(1 H, rn, HCH, C4), 3.65 (1 H, t, J 4.0 Hz, CH, C2), 3.78 (I H, d, J 4.4 Hz, CH, Cl), 
7.01 (I H, d, J7.2 Hz, CH arorn., C6), 7.17 (2 H, rn, CH arorn., C7, 8), 7.33 (1 H, d,J 
7.2 Hz, CH arorn., C9); 8c(100 MHz; CD Cb) 22.19 (C4), 24.78 (C3), 55.16 (Cl), 
55.52 (C2), 126.51 (CH arorn., C6), 128.80 (CH arorn., C7), 128.83 (CH arorn., C8), 
129.94 (CH arorn., C9), 132.91 (C quat., arorn., CS), 137.07 (C quat., arorn., CIO). 
(3-Phenyl-oxiranyl)-methanol (104a): 
~OH ______ __ 
104 104a 
Trans-Cinnamyl alcohol oxide:25 Colourless solid; vmaxCneat)/crn·1 3322, 3266, 2863, 
1664,1494,1449,1091,1007,733; 8H(400 MHz; CDCb) 1.92 (1 H, s, OH), 3.22 Cl 
H, ddt, JO.l, 2.0 and 3.8 Hz, HCH, C3), 3.80 (1 H, dd, J 3.8 and 12.7 Hz, HCH, C3), 
3.93 (1 H, d, J2.1 Hz, Cl), 4.02-4.08 (I H, dd, J2.3 and 12.7 Hz, C2), 7.26-7.41 (5 
H, rn, arorn., Ph gp.); 8c(100 MHz; CDCh) 55.7 (CH, Cl), 61.3 (CH, C2), 62.6 (CH, 
C3), 125.8, 128.3, 128.5 (5 x CH, arorn., Ph gp.), 136.7 (C quat., arorn., ipso in Ph 
gp.). 
I-Phenyl-8-oxa-bicyclo [5.1.0) octane (110a): 
cS 
110 110a 
l-Phenylcyclohept-l-ene oxide: Colourless oil; vmaxCneat)/crn· 1 3084, 1602, 1494, 
1445,1358,1255,1166,1128,1088,1030,964,855,738; 8H(250 MHz; CDCh) 1.50-
1.85 (6 H, rn, 3 x CH2, C4, 5, 6), 1.90-2.20 (2 H, rn, CH2, C3), 2.38-2.50 (2 H, rn, 
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CH2, C7), 3.04 (1 H, q, J 3.8 Hz, CH, C2), 7.25-7.40 (5 H, m, 5 x CH arom., Ph gp.); 
Oc(62.5 MHz; CDCh) 24.90 (CH2, C6), 25.47 (CH2, C4), 29.85 (CH2, C3), 31.69 
(CH2, C5), 33.87 (CH2, C7), 63.38 (CH, C2), 65.78 (C quat., Cl), 125.38 (2 x CH 
arom., ortho in Ph gp.), 127.25 (CH arom.,para in Ph gp.), 128.45 (2 x CH arom., 
meta in Ph gp.), 143.97 (C quat., arom., ipso in Ph gp.). 
(Z)-2-Methyl-3-phenyl-oxirane (111a): 
(JI 
111 Ilia 
Cis-f3-methylstyrene oxide:26 Colourless oil; vmax(neat)!cm-1 3061,2994, 1604, 1496, 
1450, 1258, 1149,9563, 853, 742, 700, 619; oH(250 MHz; CD Ch) 1.12, (3 H, d, J 5.4 
Hz, CH), C3), 3.32-3.40 (1 H, m, CH, C2), 4.08 (l H, d, J 4.3 Hz, CH, Cl), 7.24-7.39 
(5 H, m, 5 x CH arom., Ph gp.); oc(62.5 MHz; CDCh) 12.84 (CH), C3), 55.37 (CH, 
C2), 57.78 (CH, Cl), 126.85 (2 x CH arom., ortho in Ph gp.), 127.74 (CH arom.,para 
in Ph gp.), 128.26 (2 x CH arom., meta in Ph gp.), 135.84 (C quat., arom., ipso in Ph 
gp.). 
(Z)-2-Methyl-3-butyloxirane (l13a): 
113 Il3a 
Cis-2,3-Epoxyheptene:27 Colourless oil, 68% yield; vmax(neat)!cm- 1 2959, 2930 2874, 
1390,1259,1218,1151,1114,1032,752; OH(400 MHz; CDCh) 0.93 (3 H, t,J8.0Hz, 
C7), 1.20 (3 H, d, J 4.0 Hz, Cl), 1.32-1.50 (6 H, m, C4, 5 & 6), 2.86-2.91 (l H, m, 
C3), 2.99-3.06 (1 H, m, C2); oc(lOO MHz; CDCh) 12.2 (CH), C7), 13.0 (CH), Cl), 
21.6 (CH2, C6), 26.2 (CH2, C5), 27.6 (CH2, C4), 51.6 (CH, C2), 56.1 (CH, C3). 
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2-Phenyl-oxirane (120a): 
() 
120 
Styrene oxide:'6 Colourless oil; vma.(neat)!cm-1 3037, 2987, 1606, 1496, 1476, 1451, 
1387, 1252, 1201,984,876,751,698; oH(400 MHz; CDCh) 2_84 (l H, dd, J 2.8,5.6 
Hz, CHH, C3), 3.18 (I H, dd, J 4.0 and 5.6 Hz, CHH, C2), 3.90 (l H, dd, J 2.4,4.0 
Hz, CH, Cl) 7.36 (5 H, m, 5 x CH arom., Ph gp.); oc(100 MHz; CDCI3) 51.65 (C2), 
52.77 (Cl), 125.91 (2 x CH arom., meta in Ph gp.), 128.61 (C quat., arom., para in Ph 
gp.), 128.71 (2 x CH arom., ortho in Ph gp.), 138.02 (C quat., arom., ipso in Ph gp.). 
(-)-3S,4S-2,2-Dim ethyl-l a, 7b-dihydro-2H-l ,3-dioxa-cycIopropa [a) na phthalene-6-
carbonitrile (115): 
NC'CQ-"'" I~ 
o 
116 115 
Prepared according to the TPPP general epoxidation procedure in 59% yield, 97% ee. 
Colourless oil which solidified: [a]20o -59.5 (c 1.09, CHCl), [lit28 +62.7 (c 0.71, 
CHCh) for (+)-3R,4R enantiomer); vrnax(film)!cm-1 3089, 3038, 2979, 2934, 2226, 
1615, 1579, 1490, 1346, 1279, 1157, 1107, 1046,955; oH(400 MHz; CD Ch) 1.22 (3 
H, s, CH), Cl1), 1.52 (3 H, s, CH), Cl I), 3.47 (l H, d, J 4.4 Hz, CH, C3), 3.86 (l H, 
d, J 4.4 Hz, CH, C4), 6.79 (l H, d, J 8.4 Hz, CH arom., C9), 7.45 (l H, dd, J 2.0, 8.4 
Hz, CH arom., C8), 7.58 (l H, d, J 2.4 Hz, CH arom., C6); oc(lOO MHz; CDCh) 
23.41 (Cl1), 25.88 (CI2), 50.26 (C4), 62.69 (C3), 75.07 (C quat., C2), 104.65 (C 
quat., arom., C7), 118.97 (C quat., C13), 119.15 (CH arom., C9), 121.51 (C quat., 
arom., C5), 134.21 (CH arom., C8), 134.80 (CH arom., C6), 156.87 (C quat., arom., 
CIO); mlz 219.1132; C12HllN02 (M""NH4) requires 219.1134. 
196 
(-)-(3S,4R)-3-Hydroxy-2,2-dimethyl-4-(2-oxo-cycIopentyl)-chroman-6-
carbonitrile (114): 
115 114 
PyrroIidin-2-one (2.12 g, 2.49 mmol) was treated with NaH (60 %) (0.06 g, 2.49 
mmol) and (-)-3S, 4S-2,2-Dimethyl-la,7b-dihydro-2H-I,3-dioxa-cyclopropa[a] 
naphthalene-6-carbonitrile (115) (0.50 g, 2.49 mmol) in DMSO (20 ml). The reaction 
was left to stir and after 6 h cautiously quenched with water and extracted with ethyl 
acetate (3 x 50 ml). The organic layer was washed with water (2 x 30 ml), brine (30 
ml) and dried (MgS04). Solvents were removed under reduced pressure to give a pale 
yellow oil. Purified by column chromatography eluting with hexane/ethyl acetate. 
Crystallized from ethanol, colourless crystals (0.37 g, 52%); m.p. 237-240 °C (lit29 
" 242-244 °C); [a]2oD -53.1 (c 1.12, CHCh), [lit [a]26D -52.2 (c 1.00, CHCh)]; 
vmax(film)/cm,1 3229,2975,2222, 1650; oH(250 MHz; CDCh) 1.28 (CH3, Cl I), 1.55 
(CH3, CI2), 2.07-2.17 (2 H, m, CH2, CI7), 2.55-2.61 (2 H, m, CH2, CI6), 3.00-3.09 
(I H, m, CHH, CI8), 3.36-3.43 (I H, m, CHH, CI8), 3.67-3.78 (2 H, m, OH & CH, 
C3), 5.23 (I H, d, J 10.4 Hz, CH, C4), 6.88 (l H, d, J 8.6 Hz, CH arom., C6), 7.24 (l 
H, t, J 1.9 Hz, CH arom., C8), 7.45 (1 H, dd, J 8.5,2.0 Hz, CH arom., C9); oc(62.5 
MHz; CDCh) 18.39 (CH2, CI7), 18.73 (Oh CII), 26.97 (CH3, CI2), 42.38 (CH, 
C4), 51.95 (CH2, CI8), 69.99 (C quat., C2), 80.78 (CH, C3), 104.16, (C quat., arom., 
C7), 118.90 (CH arom., C9), 119.25 (C quat., CN), 121.08 (C quat., arom., CS), 
131.87 (CH arom., C8), 133.27 (CH arom., C8), 157.65 (C quat., CIO), 178.23 (C 
quat., C=O). 
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X-Ray Reports 
Appendix A 
X-ray Reports 
The crystallographic data for the structures presented in the text are given in this 
section. Crystallographic analyses were carried out at Loughborough University by 
Professor V. McKee (68), Dr M. R. J. Elsegood (58, 79) and Dr A. M. Z. Slawin (14, 
16). 
Crystal data and structure refinement for (-)-(IR,2R,3R,5S)-N-(3-isopinocampheyl)-
dihydroisoquinolinium tetraphenylborate (14): 
Data collection method 
Empirical formula 
Formula weight 
Temperature 
Wavelength 
Crystal system 
Space group 
Unit cell dimensions 
Volume 
Z 
Density (calculated) 
Absorption coefficient 
F(OOO) 
Crystal size 
Crystal description 
Theta range for data collection 
Reflections collected 
Absorption correction 
Refinement method 
Rigaku AFC7S diffractometer 
C4)H46BN 
587.65 
20.0°C 
1.54178 A 
Orthorhombic 
P2 12121 
a = 16.807(5) A 
b = 19.921(3) A 
c = 10.161(2) A 
3402.0(1) A3 
4 
1.147 g/cm3 
4.83 cm-1 
1264.00 
0.10 x 0.20 x 0.50 mm3 
Clear, block 
65.7 to 74.8°. 
2892 
Lorentz-polarization absorption 
Direct methods (SIR92) 
200 
Data 1 restraints 1 parameters 
Goodness-of-fit on F2 
Final R indices [I>2sigma(I») 
Largest diff. peak and hole 
2279/407/5.60 
2.77 
RI = 0.038, wR2 = 0.035 
0.17 and -0.16 e.k3 
Crystal data and structure refinement for (+)-2-[( 4S,5S)-2,2-dimethyl-4-phenyl-1 ,3-
dioxan-5-yl)-3,4-dihydroisoquinolinium tetraphenylborate (16): 
Data collection method 
Empirical formula 
Formula weight 
Temperature 
Wavelength 
Crystal system 
Space group 
Unit cell dimensions 
Volume 
z 
Density (calculated) 
Absorption coefficient 
F(OOO) 
Crystal size 
Crystal description 
Theta range for data collection 
Reflections collected 
Independent reflections 
Absorption correction 
Refinement method 
Data 1 restraints 1 parameters 
Goodness-of-fit on F2 
Final R indices [I>2sigma(I») 
Largest diff. peak and hole 
Rigaku AFC7S diffractometer 
C4SH44BN02 
641.47 
20.0°C 
1.54178 A 
Monoclinic 
P2\ 
a = 9.37(1) A 
b = 22.1 04(8) A 
c = 9.457(5) A 
1957.0(3) A3 
p= 92.84(7)°. 
2 
1.188 glcm3 
5.60 cm- I 
748.00 
0.20 x 0.20 x 0.30 mm3 
Pale, prism 
60.6 to 73.9°. 
3210 
3010 [R(int) = 0.134) 
Lorentz-polarization absorption 
Direct methods (SnB) 
1914/479/4.00 
4.16 
RI = 0.059, wR2 = 0.045 
0.17 and -0.15 e.k3 
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Crystal data and structure refinement for (+)-{(4S,5S)-2,2-dimethyl-4-[4-
(methy Isulfony 1)-pheny 1]-1,3 -dioxan-5-y I } -3, 4-dihydroisoquinolini urn 
tetraphenylborate (58): 
Data collection method 
Empirical formula 
Formula weight 
Temperature 
Wavelength 
Crystal system 
Space group 
Unit cell dimensions 
Volume 
Z 
Density (calculated) 
Absorption coefficient 
F(OOO) 
Crystal size 
Crystal description 
Theta range for data collection 
Index ranges 
Reflections collected 
Independent reflections 
Completeness to theta = 25.00° 
Absorption correction 
Max. and min. transmission 
Refinement method 
Data / restraints / parameters 
Goodness-of-fit on F2 
Final R indices [I>2sigma(I)] 
R indices (all data) 
Absolute structure parameter 
Bruker SMART 1000 CCD 
diffractometer ill rotation with narrow 
frames 
C46H46BN04S 
719.71 
150(2) K 
0.71073 A 
Monoclinic 
tetragonal, P4, 
a = 9.9705(4) A 
b = 9.9705(4) A 
c = 38.749(2) A 
3852.0(3) A3 
4 
1.241 g/cm3 
0.129 mm-I 
1528 
0.51 x 0.36 x 0.30 mm3 
Pale yellow 
2.04 to 28.74°. 
a= 90°. 
~= 99.005(2)°. 
y= 90°. 
-J3<=h<=J3, -13<=k<=13, -51<=1<=51 
32885 
9155 [R(int) = 0.0241] 
100.0% 
Semi -empirical from equivalents 
0.937 and 0.962 
Full-matrix least-squares on F2 
9155/309/563 
1.049 
RI = 0.0410, wR2 = 0.1021 
RI = 0.0459, wR2 = 0.1053 
-0.07(6) 
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Largest diff. peak and hole 0.257 and -0.237 e.A-3 
Crystal data and structure refinement for Methyl (4S,5R)-5-[ 4-(methyloxy)phenyl]-2-
oxo-I,3-oxazolane-4-carboxylate (68): 
Data collection method 
Empirical formula 
Formula weight 
Temperature 
Wavelength 
Crystal system 
Space group 
Unit cell dimensions 
Volume 
Z 
Density (calculated) 
Absorption coefficient 
F(OOO) 
Crystal size 
Crystal description 
Theta range for data collection 
Index ranges 
Reflections collected 
Independent reflections 
Completeness to theta = 25.00° 
Absorption correction 
Max. and min. transmission 
Refinement method 
Data / restraints / parameters 
Goodness-of-fit on F2 
Final R indices [I> 2sigma(I)] 
R indices (all data) 
Absolute structure parameter 
Largest diff. peak and hole 
Bruker SMART 1000 CCD 
diffractometer 0) rotation with narrow 
frames 
CI2HI3NOS 
251.23 
150(2) K 
0.71073 A 
Monoclinic 
P2(l) 
a = 7.0103(8) A 
b = 5.5734(6) A ~= 99.005(2)°. 
c = 15.6004(18) A 
602.01(12) A3 
2 
1.386 Mg/m3 
0.109 mm-I 
264 
0.41 x 0.09 x 0.08 mm3 
Colourless needle 
2.64 to 28.44°. 
-8<=h<=9, -7<=k<=7, -20<=1<=20 
5035 
2684 [R(int) = 0.0122] 
99.8 % 
Multiscan 
1.00000 and 0.956062 
Full-matrix least-squares on F2 
2684/ I / 166 
1.033 
RI = 0.0315, wR2 = 0.0744 
RI = 0.0356, wR2 = 0.0766 
0.2(8) 
0.231 and -0.158 e.A-3 
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Crystal data and structure refinement for (+)-6-[(1R,2R,3R,5S)-2,6,6-
trimethy Ibicyclo[3 .1.I]hept-3-yl]-5H-dibenzo[ c, e ]azepinium tetraphenylborate (79): 
Data collection method 
Empirical formula 
Formula weight 
Temperature 
Wavelength 
Crystal system 
Space group 
Unit cell dimensions 
Volume 
Z 
Density (calculated) 
Absorption coefficient 
F(OOO) 
Crystal size 
Crystal description 
Theta range for data collection 
Index ranges 
Reflections collected 
Independent reflections 
Completeness to theta = 25.00° 
Absorption correction 
Max. and min. transmission 
Refinement method 
Data 1 restraints 1 parameters 
Goodness-of-fit on F2 
Final R indices [I>2sigma(I)] 
R indices (all data) 
Absolute structure parameter 
Largest diff. peak and hole 
Bruker SMART 1000 CCD 
diffractometer (J) rotation with narrow 
frames 
C48H48N 
649.68 
150(2) K 
0.71073 A 
Orthorhombic 
P2 j 2 j 2 j 
a = 12.8066(7) A 
b = 15.5040(8) A 
c = 18.5443(10) A 
3682.0(3) A3 
4 
1.172 glcm3 
0.066 mm-l 
1392 
0.78 x 0.61 x 0.49 mm3 
Colourless 
1.93 to 29.03°. 
-16<=h<=17, -19<=k<=20, -24<=1<=23 
32341 
8865 [R(int) = 0.0387] 
100.0 % 
Semi-empirical from equivalents 
0.950 and 0.968 
Full-matrix least-squares on F2 
8865/0/454 
1.052 
RI = 0.0363, wR2 = 0.0843 
RI = 0.0451, wR2 = 0.0908 
-2(2) 
0.218 and -0.171 e.A-3 
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Appendix B 
Determination of enantiomeric excess: Examples 
Determination of enantiomeric excess for 1-PhenyI-7-oxa-bicyclo[4.1.0]heptane (20): 
'H-NMR conditions: 
Racemic: 
P(j® 
8-10 mg substrate 
3-5 mg (+)-Eu(hfc)3 
'~ *'~ 1 ~ ~ ii··~· 'In' i 11 .. ~ . if n i· 
~ 
EnantiomericaIIy enriched: 
I~; 'lr 
~'~ ~ ~ W'.i~ ~ ~ a ~ u ~'u'a 
i~ 
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Detennination of enantiomeric excess for 2-Methy1-(E)-2,3-dipheny1oxirane (18): 
IH-NMR conditions: 
Racemic: 
~Q 
Phi
Ph 
8-10 mg substrate 
3-5 mg (+)-Eu(hfc)3 
Enantiomerically enriched: 
. .' i 
4.5 4.4 4.3 4.2 
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Determination of enantiomeric excess for 2,2,3-Triphenyloxirane (19): 
IH-NMR conditions: 
®~o Ph~Ph 
Ph 
8-10 mg substrate 
3-5 mg (+)-Eu(hfc)J 
Racemic: Enantiomerically enriched: 
I 
/! ~ ~ 
1\ ir J,--.JL 
")c.,.)(,, 
4.65 4.60 4.55 4.50 4.45 4.1 
(ppm) , ",,:J~,C:: .44 4.42 4AO 4.38 4.36 
(ppm) 
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Detennination of enantiomeric excess for (E)-2,3-Diphenyloxirane (75): 
IH-NMR conditions: 
Racemic: 
• 
• ~ 
• ,
i 
I I (\ 
I I I 
I \ I \ 
I 1\ I \ I I I \ I \ 
\ ! \ 
V \ 
~?~ Ph" (lDPh 
8-10 mg substrate 
3-5 mg (+)-Eu(hfc)3 
Enantiomericallyenriched: 
I I; 
I 
~ 
~~CJ§L iiji"\,,,t~'~j~"i"""'i ~L~~~~,~I~.~,~, T~:'T'-'-:~[ . ":,,, .O~ 4.~1 4140 4.0il 4.'~ 4.~J I.~O. 4.011 4.010 4.005 4 
10 4.19 4.18 4.17 4.16 4.15 4.14 4.13 4.1 
(ppm) Iwml 
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Determination of enantiomeric excess for la,2,3,7b-Tetrahydro-l-oxa-
cyclopropa[a]naphthalene (103a): 
IH-NMR conditions: 
Racemic: 
8-10 mg substrate 
3-5 mg (+)-Eu(hfc») 
Enantiomerically enriched: 
I.. . ... 0;; 
" I ~ H5 5.30 us S.iO 
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Determination of enantiomeric excess for (Z)-2-Methyl-3-phenyl-oxirane (IlIa): 
'H-NMR conditions: 
Racemic: 
I I 
8-10 mg substrate 
3-5 mg (+)-Eu(hfc)J 
I I 
Enantiomerically enriched: 
Ill,! ~:t r ,I If! 
1/ \ I \ 
r \ Nr ~.,.J ~, 
",:, ',If,,, :,:,' J~L, : 
5.05 5.00 4.95 4.90 4.85 
(ppm) 
5.04 5.00 4.96 4.92 4.88 4.84 00 
(pprn) 
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Determination of enantiomeric excess for 2-Biphenyl-4-yl-oxirane (lOOa): 
HPLC conditions: Flow 
CS 
Atten 
Hex:IPA 
o ~ Ph~ 
: 1.5 
: 0.5 
: 512 
: 95:15 
Racemic: Retention times: (R) = 6.54; (S) = 7.41. 
~ , 
'" 
!< 
e 
I 
.. 
" ~
! 
'a :! fHHi:E~E~~~;;:: 
..,;..; ...... ~~....;N • ..; ~ 
Enantiomerically enriched: Retention times: (R) = 6.60; (S) = 7.49. 
-' 
'" ., 
.! 
'" ;. 
- ~ 
=- = ~ '" ~ 
'"' == lIS Il> Id =~U.Ila:;; 
"I l = '" "'''';;:,..,~~." ,;, 
'" ~i=~~t; ~ ! l} 
'" 
~~~",!~i::;~~ 
.. .-
__ ...... 'f'>< ........ .;::~ 
~ - ! ~ z !1!;;;1Slil>l..,::;lil ~ ~ .. l': 1" .. --=-,:0;----
- 10 '~ ..: r .:J I c !OO i - ... "'.- ..... -~-
" 
\ is ;;;, 
il g 
!! 
'" 
., 
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Determination of enantiomeric excess for 7b-Phenyl-1a,2,3,7b-tetrahydro-l-oxa-
cycIopropa[a]naphtha1ene (22): 
HPLC conditions: Flow 
CS 
Atten 
Hex:IPA 
: 1.0 
: 0.5 
: 512 
: 90:10 
Racemic: Retention times: (lS,2R) = 9.88; (lR,2S) = 12.16. 
~ ; 
f 
lii 
~ 
>; 
-I 
" Ol ~ 
J! 
lii 
~ 
" 
&~Gi:;: .. _~a:~ 
~ ~ ~"'!~--~"'~ ~~ U~"" ~ - re~-
~ :::~~:;~;;;~ 
~ ~:>;!'ilili~<i"ll!li1 
'" ~ -----~-:$-
..: 
~ " 
_ .......... .,. .... ro- .. _ 
'" 
EnantiomericaIIy enriched: Retention times: (lS,2R) = 9.78; (lR,2S) = 11.81. 
..! !!! 
. ~ 
::: .. 
~ ;. 
-,. ! ~ 
I' ~ i t.; '" ::2 ~ 
:5 l!! l'< 
::I 1Il ===~~~~:= 
-t ~ ~ ! ~:;jn~:iH ~ 11 I'; • :;:~i!"'l~:!~ ~ ~ ~ a:;:;-""--;t 
J; 1; .. ...,:; .. :s:::~ .. 
.. ~ .. ...:..ti, • ....;.,~~= 
- \! ~ .• ~ w ~:T' ~ ~~~~~i;~~ ~ ;.,;; ~ :3 :; '! ~~_ ..... N_'$._ '" ~ ~ IT - ... 1 IIi ..: • ~ ~ i -,...; ............... 11 ;;:: 
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Determination of enantiomeric excess for 2,2-Dimethyl-1 a, 7b-dihydro-2H-1 ,3-dioxa-
cyclopropa[ a ]naphthalene-6-carbonitrile (115): 
HPLC conditions: Flow 
CS 
Atten 
Hex:IPA 
I"" NC'C(t0 
~ 0 
:1.3 
: 0.5 
: 512 
: 90:10 
Racemic: Retention times: (3R,4R) = 12.98; (3S,4S) = 15.46 . 
.. 
-_ ..... -- ..... _-- ~ 
Enantiomerically enriched: Retention times: (3R,4R) = 13.28; (3S,4S) = 15.79 . 
...: 
10 ~ ;;; 
-
;. 
~ i5 ;;; 
e 
~ ~ i ;; 
;'l ~ i '" ;&f~S:I:;3;; ;;; ~ ~ ,,~=pr;;* ~ ;.; ;;; 
'i' :Ii £!O:"'''''~l!i iil Z 
'" 
~~;;~~~ 
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